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Alexander B. Briggs - ISB No. 6251

BRIGGS LAW OFFICE
706 E. Chicago
P.O. Box 1274
Caldwell, Idaho 83606
Telephone (208) 459-4446
Fax (208) 459-7771
Attorney for Defendant

IN THE DISTRICT COURT OF THE THIRD JUDICUL DISTRICT OF THE
STATE OF IDAHO, IN AND FOR THE COUNTY OF CANYON

*****
STATE OF IDAHO,
Plaintiff
'

I

)
)
)
)
)
)

vs.

)

SHANNON MARIE McKEAN,
Defendant.

-----------------

)
)
)
)

CASE NO. CR-2012-148~6

~
PETITION FOR AUTHORIZATION
FOR USE OF COUNTY FUNDS
PURSUANT TO §19-851 AND §19-852

COMES NOW, the defendant, defendant by and through her attorney,
.ALEXANDER B. BRIGGS, and petitions this Court for an order providing payment for services,
i.e. expert "W-itness, Owen McDouga~ Ph.D. This petition is brought before this Honorable Court
for the following reasons and pursuant to the following statutory authority:
1. The defendant is a needy person as defined by §19-851(c) and is currently being

charged with a serious crime as defined by §19-851(d)(1); (see attached affidavit of indigency)
2. Counsel for the defendant has determined such expenses are necessary to
adequately defend the defendant.

PETITION FOR AUTHORIZATION FOR USE
OF COUNTY FUNDS PURSUANT TO §19-851
AND §19-852 - 1
0

3. §19-852(a)(2) provides that costs of expert witnesses are contemplated as
necessary for preparation of defense.

CERTIFICATE OF SERVICE: I HEREBY CERTIFY that a true and correct
copy of the above and foregoing document was delivered to the office of the CA..NYON COUNTY
PROSECUTING ATTORNEY by leaving a copy of the same .in his basket at the Canyon County
Courthouse, Caldwell, Idaho, on this date.
DATED

trusi./rday of December, 2012
BRIGG;·W OFFICE

,V

?7l

lb~

ALEXANDER B. BRibs
Attorney for Defendant

PETITION FOR AUTHORIZATION FOR USE
OF COUNTY FUNDS PURSUANT TO §19-851
AND §19-852 - 2

Alexander B. Briggs - ISB No. 6251
BRIGGS LAW OFFICE
706 E. Chicago
P.O. Box 1274
Caldwell, Idaho 83606

Telephone(208)459-4446
FAX(208) 459-7771
Attorney for Defendant

IN THE DISTRICT COURT OF THE THIRD JUDICIAL DISTRICT OF THE
STATE OF IDAHO, IN AND FOR THE COl.JNTY OF CAN'YON

*****

STATE OF IDAHO,
Plaintiff,
vs.
SHANNON .MARIE McKEAN,
Defendant.

STATE OF IDAHO

)
)
)
)
)
)
)
)
)
)
)

CASE NO. CR-2012-14826-C
AFFIDAVIT OF INDIGENCY

)
)ss.
)

County of Canyon

SHANNON lVfARIE McKEAN, being first duly sworn, upon her oath, deposes and
says:
1.

That I am the defendant in the above entitled action.

2.

I am indigent, and therefore unable to pay for the expert testimony of a

chemist at this time.

As evidence thereof, I state the following:
a.

I am currently unemployed and have no income.

-1

b.

I have the following assets (real estate, vehicles, firearms, appliances,

c.

I have the following financial obligations: (rent, child support,

utilities, debts, other bills):

:=R:e."1-\- l ~-t,:t\'e::; )-f)ccL
i,

I hereby state the above informakon is true and correct to the best of my knowledge.

2

r

Dated t h i s ~ day of November, 2012.
~

L ('i
f\~
c;::\::v~Y\J\.(\
~:CJ c~~ ~f\1,
SHANNON MARIE Mc -

SUBSCRIBED AND SWORN to.
~·/·
./,a'

-2

'\
/

wkf
BRYAN F. TAYLOR
CANYON COUNTY PROSECUTING ATTORNEY
Canyon County Courthouse
1115 Albany Street
Caldwell, Idaho 83605
Telephone: (208) 454-7391

IN THE DISTRICT COURT OF THE THIRD JUDICIAL DISTRICT OF
THE STATE OF IDAHO, IN AND FOR THE COUNTY OF CANYON

THE STATE OF IDAHO
CASE NO. CR2012-14826/CR2012-21064
Plaintiff,
vs.
Shannon Marie McKean
Defendant.

THE STA TE OF IDAHO

CASE NO. CR2012-14825/CR2012-21093

Plaintiff,
vs.

MEMORANDUM IN SUPPORT OF
MOTION FOR DECLARATION THAT AM2201 IS A CONTROLLED SUBSTANCE AS
A MATTER OF LAW

Troy Harrell
Defendant.

The state of Idaho, through its representative, Will Fletcher, Deputy Canyon County
Prosecuting Attorney, hereby provides the following memorandum in support of its motion in
limine requesting the court declare, as a matter oflaw, that the substance AM-2201 is a Schedule
I controlled substance pursuant to LC. 37-2705(d)(30). This motion is necessary in anticipation
PRETRIAL MOTION IN LIMINE

1

of trial because the section of Idaho's Controlled Substances Act dealing with synthetic
cannabinoids does not list specific compounds such as AM-2201. Rather, the code regulates
synthetic cannabinoids by banning their parent compounds.
FACTUAL & PROCEDURAL SUMMARY
This case involves the City County Narcotics Unit's (CCNU) investigation of the
defendants, wife-and-husband Shannon McKean and Troy Harrell, for possessing and selling
various brands of synthetic cannabinoids known as "spice" or "potpourri." These designer drugs
are manufactured with the intent that when ingested, they will mimic the intoxicating effects of
marijuana. (See State's Exhibit I-Affidavit of Corinna Owsley, 15-17).The defendants are
alleged to have owned and operated Smoke Effecz, a Caldwell business that specialized in
selling spice and marijuana-themed paraphernalia. Police first became aware of Smoke Effecz
after seein~ Wesley Reed, a store employee and former codefendaL, standing by the road
outside Smoke Effecz holding a sign advertising the store to passing drivers. On May 3, 2012,
CCNU Investigator Chuck Gentry went undercover to Smoke Effecz, where he purchased from
McKean and Harrell a 1.2 gram package of spice with the brand name Fire and Ice. Gentry
returned on May 21 and purchased from McKean a 4.8 gram package of Fire and Ice, as well as
an 8.8 gram package of Johnny Clearwater brand spice. Thee total price for the Fire and Ice
purchased on May 3 was $12. 72. The price for the two packages purchased on May 21 was
$56.16.
Investigators sent these packages to the Idaho State Police Forensics Lab to be tested for
the presence of controlled substances. A forensic analysis performed by ISP Forensic Scientist
Heather Campbell confirmed that both of the Fire and Ice packages contained the Schedule I

PRETRIAL MOTION IN LIMINE

2

controlled substances JWH-122 and JWH 210. (State's Exhibits 2 &3-Controlled Substance
Analyses). The Johnny Clearwater package did not contain any substance controlled in Idaho.
On June 6, CCNU investigators executed search warrants on Smoke Effecz, the
defendants McKean and Harrell's residence, and a Caldwell storage unit McKean rented.
Investigators seized from the store 535 different packages of spice weighing approximately 25 80
grams, 30 marijuana-design t-shirts, several pot ashtrays, $26,357 in cash, and numerous receipts
and records. Investigators seized from McKean and Harrell's residence 90 packages of spice,
numerous other records and receipts, and a small smoking pipe that contained AM-2201 residue.
(State's Exhibit 4-Controlled Substance Analysis). Lab analyses from some of the packages
taken from Smoke Effecz confirmed the defendants were selling JWH-210 and AM-2201.
(State's Exhibit 5-Controlled Substance Analysis).
Ultimately, a krand jury indicted McKean and Harrell on the followink seven charges:
One count of Delivery of a Schedule I Controlled Substance (JWH 122 and JWH 210), IC 3 72732(a(l )(B),for the Fire and Ice investigators purchased on May 3; five counts of Possession of
a Schedule I Controlled Substance (JWH 210 and AM-2201 ), IC 37-2732(a)(l )(B), as a result of
the spice seized from Smoke Effecz during the search warrant; and one count of Possession of
Drug Paraphernalia (AM-2201) for the smoking pipe recovered from the defendants' home.
McKean also faces a an 8th charge of Delivery of a Controlled Substance (JWH 210 and JWH
122) for the Fire and Ice she sold to Investigator Gentry on May 21. McKean's eight charges arc
spread across two cases, CR-2012-14826 and CR-2012-21064, which have been consolidated for
trial. Harrell's charges are contained in CR-2012-14825 and CR-2012-21093, which have also
been consolidated for trial.

PRETRIAL MOTION IN LIMINE

3

On October 30, the state filed in McKean and Harrell's cases a motion in limine asking
the court to declare as a matter of law that all three substances at issue-JWH 122, JWH 210,
and AM-2201-are a schedule I controlled substances under IC 37-2705(d)30. The court in
McKean's cases set this matter for hearing in order for the state to offer expert testimony by
Idaho State Police Forensic Scientist Corinna Owsley that the specific chemical structures of the
three substances fall under the parent chemical structures described in IC 37-2705(d)30. At that
hearing, the court granted McKean a continuance in order to hire at public expense an expert to
counter the state's position.
On December 3, the court denied a defense motion to consolidate McKean and Harrell· s
cases for trial, but granted a motion to consolidate the cases for disposition of the state's motion
for declaration oflaw. The court, however, denied a joint-defense motion to consolidate McKean
and Harrell's cases for trial, citihg grounds that the cases presented evidentiary issues uAder

Bruton v. US., 391 U.S. 123 (1968). At the December 3 hearing, counsel for both defendants
indicated that they would stipulate that JWH 122 and JWH 210 were controlled substances, but
still wished to dispute the status of AM-2201.
The court set December 21 as a simultaneous deadline for all parties to submit briefing.
To date, the defense has not framed its challenge to the state's motion other than to say it wishes
to contest whether AM-2201 is a controlled substance in Idaho.

SUMMARY OF ARGUMENT
The court should grant the state's request that the court declare as a matter of law that
AM-2201 is a Schedule I controlled substance under J.C. 37-2705(d)(30) because: 1.) AM-2201
is structurally derived from the parent structure 3-(1-napthoyl) indol by substitution at the
nitrogen atom of the indole ring by an alkyl, and is therefore is included under LC. 37-

PRETRIAL MOTION IN LIMINE
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2705(d)(30)(ii)(a); and 2.) the legislature in enacting I.C. 37-2705(d)(30) intended to ban
categories of synthetic substances known as spice, not just particular, named compounds. In
doing so, the legislature used broad language that encompasses AM-2201.
LAW AND ANALYSIS
The state's motion requires an exercise in statutory construction and a determination of
the legislative intent behind Schedule I ofldaho's Controlled Substances Act, LC. 372705(d)(30). The version of the statute at issue was enacted on March 10, 2011 to address the
emergence of synthetic drugs designed to mimic the impairing effects of marijuana. (See
generally State's Exhibit 6-2011 Idaho Laws Ch. 47 (H.B. 139)).

When deciding a statute's meaning, the court must construe the statute as a whole, and
consider all sections of applicable statutes together to determine the intent of the legislature.
Hillside Landscape Const., Inc. v. City oflewiston, 151 Idaho 749, 753 264 P.3d 388 (2011). It

is incumbent upon the court to give the statute an interpretation that will not deprive it of its
potency. Id. In determining the ordinary meaning of a statute, a court must give effect to all of
the words in the statute if possible so that none will be void, superfluous, or redundant. State v.
Mercer, 143 Idaho 108, 109, 138 P.3d 308,309 (2006). Statutory interpretation must begin with

the literal words of the statute, and these words must be given their plain, usual, and ordinary
meaning. State v. Schwartz, 139 Idaho 360, 362, 79 P.3d 719, 721 (2003).
A statute is ambiguous where the language is capable of more than one reasonable
construction. Id. Ambiguity, however, is not established merely because differing interpretations
are presented to the court. Id. If the statute is not ambiguous, the court does not construe it, but
follows it as written. Id. Also, where statutory language is unambiguous, legislative history and
other extrinsic evidence should not be consulted for the purpose of altering the clearly expressed

PRETRIAL MOTION IN LIMINE
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intent of the legislature. Verska v. St. Alphonsus Reg'l Med. Ctr., 151 Idaho 889,893,265 P.3d
502, 506, (2011 ). Whether a substance is a controlled substance is a question of law for the court,
and not for the jury. State. v. Hobbs, 101 Idaho 262, 611 P.2d 1047 (1980). Substance
identification, however, is a question for the jury. State v. Griffith, 130 Idaho 64, 936 P.2d 707
(Ct. App. 1997).
J.C. 37-2705 lists Schedule I controlled substances. Subsection (d) deems any material
containing any quantity of one or more of 30 listed categories of hallucinogenic substances a
Schedule I controlled substance. J.C. 37-2705(d)(30) specifically regulates the class of
hallucinogenic substances known as tetrahydrocannabinols. The most widely known example of
a tetrahydrocannabinol is Delta-9-THC (6-9-THC), the substance found in the marijuana plant
that, when ingested, causes the desired pharmacological effect. (State's Exhibit 7Cannabimimetic Indole Derivatives, World Intellectjal Property Organization (April 26, 2001 ),
lines 10-35). Delta-9-THC works by interacting with certain receptors in the human brain and
peripheral tissues. Id. Synthetic cannabinols are designer substances that have been invented to
interact with the same receptors as marijuana, producing similar pharmacological effects. Id.
The version of LC. 37-2705(d)(30) at issue in this case was enacted on March 10 through
House Bill-139. The bill's intent was to create a permanent ban of synthetic
tetrahydrocannabinols, i.e., "spice" and "potpourri." (State's Exhibit 2--House Bill 139,
Statement of Purpose.); (State's Exhibit 8-Minutes, House Judiciary, Rules, & Administration
Committee, pg. 2, 2/15/2011). There are thousands of such synthetic compounds, and new ones
are being developed all of the time. Rather than attempting the impossible task of listing these
compounds by name, the Legislature instead chose to control synthetic cannabinols by listing
specific parent compounds-also known as backbone structures-that are used to make the
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many variations of spice. Due to the numerous possible variations to spice's parent compounds,
regulating spice by naming specific compounds would necessitate a very long list of substances
in the code. Doing so would also require perpetually changing legislation as designers continue
to come up with new variations. By instead naming parent compounds, the Legislature intended
to solve the "spice problem," and prevent those who chose to manufacture, possess, or distribute
spice from avoiding prosecution by continually coming up with small changes to the parent
compounds. (State's Exhibit 9-Senate Judiciary, Rules, & Administration Committee-Minutes-pg. 3, 3/2/2011); (See State's Exhibit IO-State v. Alley, et al., CR-FE-2011-15480,
Corrected Memorandum Decision and Order Re: Motion to Dismiss, The Honorable Richard
Greenwood, ID 4th Jud. Dist. (April 9, 2012)).
Idaho Code 37-2705(d)(30) makes controlled tetrahydrocannabinols or synthetic
equivalents bf the substances contained in the plant, or in the resinols extractive of Cannabis, sp.
and/or synthetic substances, derivatives, and their isomers with similar chemical structure such

as the following .... " LC. 37-2705(d)(30) (emphasis added.). Subsection (d)(30)(ii) states:
ii. The following synthetic drugs:
a.
Any compound structurally derived from 3-(1-naphthoyl)indole or lHindol-3-yl-(1-naphthyl)methane by substitution at the nitrogen atom of the
indole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, or 2-(4morpholinyl) ethyl, whether or not further substituted in the indole ring to any
extent, whether or not substituted in the naphthyl ring to any extent.
LC. 37-2705(d)(30)(ii)(a) (emphasis added).
Idaho State Police Forensic Chemist Corinna Owsley, testifying before the House
Judiciary, Rules, and Administration Committee that considered HB-139, stated that the bill
addressed seven compounds forming the backbone of spice. (State's Exhibit 8-House Judiciary,
Rules, & Administration Committee, Tuesday, Feb. 15, 2011-Minutes-pg. 2). The
amendment works by creating an umbrella covering possible chemicals that could be substituted
PRETRIAL MOTION IN LIMINE

7

by those wishing to make a spice-like drug. Id. The bill's purpose was to identify additional
substance to be classified in Schedule I and create safe regulations for the public concerning
tetrahydrocannibinols from synthetic drugs (spice) that mimic the effects of cannabis. (State's
Exhibit 6-House Bill 139, Statement of Purpose). On February 15, 2011, the House Committee
gave the bill a "do pass" recommendation. (State's Exhibit 8). On March 2, the Senate Judiciary
& Rules Committee gave the bill the same recommendation. (State's Exhibit 9-Senate
Judiciary & Rules Committee-Minutes-pg. 2). On March 10, 2011, the Governor signed the
bill into law. (State's Exhibit 6).
The March, 2011 amendments to 37-2705 make clear that AM 2201 is a controlled
substance because its parent structure is specifically listed in I.C. 37-2705(d)(30)(ii). That
subsection deems a controlled substance any compound structurally derived from the 3-(1napthyl)indole-AMJ20 l's parent structure-by substitution at the nitrogen a~om of the indole
ring by an alkyl group. In the case of AM-2201, the alkyl is a fluoropentyl group substituted at
the nitrogen atom of the indole ring. (See State's Exhibit 11 ).
In order to understand why AM-2201 is covered by I.C. 37-2705(d)(30)(ii), an
understanding of standard chemical nomenclature is necessary. The scientific community's rules
for such chemical naming are prescribed by the International Union of Pure and Applied
Chemistry (IUPAC). IUP AC nomenclature is used by scientists around the globe; it is considered
the "bible" for chemistry nomenclature. (See State's Exhibit I-Affidavit of Corinna Owsley).
When naming a compound, IUPCA nomenclature generally requires identifying a parent
structure, followed by any modifying prefixes, infixes, and suffixes, which conveys precisely the
structural changes required to generate the actual compound from the parent structure. Id.
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Using IUPAC nomenclature, AM-2201 is described as (1-(5-fluoropentyl)-3-(1naphthoyl)indole). The below diagram provides a visual depiction of AM-2201 's components.

(Also included as State's Exhibit 11.). Labeled on the diagram are the two components of the 3(1-naphthoyl)indole parent structure. The squigley line with an "F" at its end that is connected to
the "N"-a nitrogen atom-on the Indole portion of the compound represents a flourine atom at
the end of a carbon chain. (See State's Exhibit I-Affidavit of Corinna Owsley). This squiggly
line is the 1-(5-fluoropentyl) component of the compound; it is also a haloalkyl. Because IUP AC
naming requires first referencing the parent alkane, the haloalkyl shown in the AM-2201 diagram
represents a substituted alkyl group. Using IUPAC nomenclature, then, the below diagram
demonstrates that AM-2201 is a compound structurally derived from a 3-(1-naphthoyl)indole by
substitution at the nitrogen atom of the indole ring by alkyl. AM-2201 is therefore a Schedule I
controlled substance.

I

I

AM-2201

Naphthoyl
lndole >

F

AM-2201

(l-(S-f!uoropentyl)-3-(l·naphthoyl)indole)

Naphthoylindo!e
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Even if the court is not convinced that AM-2201 is exactly described by I.C.
3702705(d)(30)(ii)(a), it should still grant the state's motion for the reason that the list of
synthetic cannabinols provided in the code is illustrative, not exhaustive. This is demonstrated
by the legislature's use of the words "such as" rather than "limited to" in IC-27-2705(d)(30)(ii).
As Fourth Judicial District Judge Greenwood found in State v. }vforgan Alley, CR-FE-11-15480,
"the Idaho Legislature unambiguously intended to add synthetic imitators of marijuana to
Schedule I and it did so in broad language that encompasses AM-2201." (State's Exhibit 10, pg.
12.). Judge Greenwood continued by stating that it was the Legislature's intent "to not deal with
the so-called 'spice' problem by constantly amending the statute as new analogs for THC are
developed or discovered in the scientific literature by purveyors of mind altering substances." Id.
Accordingly, the state respectfully requests the court declare AM-2201 a controlled substance as
a matter of law.

I

DATED this _ _
Qr---t7"-~--"r,-_day of December, 2012.

~·--~FLETCl!E~~~
Deputy Prosecuting Attorney
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CERTIFICATE OF SERVICE
I HEREBY CERTIFY that on or about this -f- ~
day of December, 2012,
'-----+----I caused a true and correct copy of the foregoing instrume t to be served upon the attorney for
the defendant by the method indicated below and addresse to the following:
Alexander B. Briggs
P.O. Box 1274
Caldwell, ID 83606
FAX: 459-7771
Canyon County Public Defender
510 Arthur Street
Caldwell, Idaho 83605

() U.S. Mail, Postage Prepaid
() Hand Delivered
(X) Placed in Court Basket
() Overnight Mail
() Facsimile
() E-Mail

WILLIAM K. FLETCHER
Deputy Prosecuting Attorney

I
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ATTACHED EXHIBIT LIST
1.

Affidavit and Curriculum Vitae of Corinna Owsley, Idaho State Police Forensic Scientist

2.

Controlled Substance Analysis, Crime Date May 3, 2012, by Heather Campbell, Idaho
State Police Forensic Scientist II.

3.

Controlled Substance Analysis, Crime Date May 21, 2012, by Heather Campbell, Idaho
State Police Forensic Scientist II.

4.

Controlled Substance Analysis, Crime Date June 6, 2012, by Heather Campbell, Idaho
State Police Forensic Scientist II.

5.

Controlled Substance Analysis, Crime Date June 6, 2012, by Heather Campbell, Idaho
State Police Forensic Scientist II.

6.

House Bill 139-Amending I.C. 37-2705 to Identify Additional Substance to be
C/assified in Schedule I, Session Law Chapter 4 7, Effectite March 10, 2011.

7.

Cannabimimetic Indole Derivatives, World Intellectual Property Organization,
International Publication Number WO 01/28557 Al, (April 26, 2001).

8.

House Judiciary, Rules, & Administration Committee, Minutes, 2/15/2011.

9.

Senate Judiciary, Rules, & Administration Committee, Minutes, 3/2/2011.

IO.

State v. Alley, CR-FE-2011-15480, Corrected Memorandum Decision and Order Re:
Motion to Dismiss, Idaho 4th Judicial District, The Honorable Richard Greenwood (April
9, 2012).

11.

Chemical Diagram of AM-2201.
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dlt
BRYANF. TAYLOR
CANYON COUNTY PROSECUTING AITORNEY
Canyon County Courthouse
1115 Albany Street
Caldwell, Idaho 83605
Telephone: (208) 454-7391

IN THE DISTRICT COURT OF THE THIRD JUDICIAL DISTRICT OF
THE STATE OF IDAHO, IN AND FOR THE COUNTY OF CANYON

THE STATE OF IDAHO
CASE NO. CR2012-14826/CR2012-21064
Plaintiff,
vs.
SHANNON MAfIE MCKEAN,
Defendant.

THE STA TE OF IDAHO
CASE NO. CR2012-14825/CR2012-21093

Plaintiff,
vs.
TROY LAMAR HARRELL,
Defendant.

STATE OF IDAHO )
County of Canyon

ss.
)

I, Corinna Owsley, being first duly sworn, upon oath, deposes and says

1. I am a Forensic Scientist with the Idaho State Police Forensic Laboratory;

AFFIDAVIT OF CORINNA OWSLEY

000162

2. I have attached, as Exhibit A, my Curriculum Vitae describing my education,
training, experience and current duties and responsibilities;
3. I am familiar with I.C. § 37-2705, Schedule I, controlled substances; including
the controlled substances so scheduled pursuant to §37-2705(d)(30)(ii);
4. During the 2011 Legislative session, I was asked to assist and did assist in the
drafting and presentation of both House Bill 139 and House Bill 119;
5. I know that both pieces of legislation were passed by the Idaho Legislature and
signed by Governor Otter and became effective as of March l 0, 2011, adding
synthetic cannabinoids and substituted cathinones to Schedule I in Idaho.
6. It is my opinion that AM-2201 is one of the many chemicals or compounds
within Idaho's Schedule I;
7. I know, based upon my involvement in assisting with the drafting of the above
mentioned legislation, that it was the legislative intent to include within
Schedule I a brlad range of compounds that could be created by substitrion of
the described parent structures;
8. In order to accurately include these compounds I know that the International
Union of Pure and Applied Chemistry (IUPAC) nomenclature was used in
describing the substituted groups;
9. I also know that since 1919, IUPAC has worked to standardize the
nomenclature of chemistry. No matter what language is spoken, the IUPAC is
the body that sets the rules for chemists around the world on how to name
chemicals.
10. The latest publication of the IUPAC Blue book states in the introduction
(section R 1.0) "Systematic naming of an organic compound generally requires
the identification and naming of a parent structure. This name may then be
modified by prefixes, infixes, and, in the case of a parent hydride, suffixes,
which convey precisely the structural changes required to generate the actual
compound from the parent structure";
AFFIDAVIT OF CORINNA OWSLEY
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I I. I also know that section R 1.2.1 on substitutive operation further states as
follows: "The substitutive operation involves the exchange of one or more
hydrogen atoms for another atom or group. This process is expressed by a
prefix or suffix denoting the atom or group being introduced ... ";
12. Further, I know that since it was first published in I 959 "Morrison and Bovd ",
has been one of the standards by which organic chemistry textbooks are
judged. In a large number of universities it has been used to teach several
generations of chemists the basics of organic chemistry.
13. In the beginning section on nomenclature, in regard to alkanes and thus alkyl
groups "Morrison and Boyd" (at page 91 of the 6 th edition) states, following
the IUPAC rules, "The alkyl halides which appear so often in alkane chemistry
are named as haloalkanes; that is, halogen is simply treated as a side chain. We
first name the alkane as though no halogen were present, and then addfluoro,

chloro, bromo, or iodo, toglther with any needed numbers and prefixes";
14. In another university textbook entitled Organic Chemistrv written by .L

McMurry (3 rd edition at pg 77), "If a hydrogen atom is removed from an
alkane, the part-structure that remains is called an alkyl group. Alkyl groups
are named by replacing the -ane ending of the parent alkane with an -yl
ending. For example, removal of a hydrogen from methane, CH4, generates a

methyl group,-CH3, and removal of a hydrogen from ethane, CH3CH3,
generates an ethyl group, -CH2CH3 ..... The combination of an alkyl group
with any of the functional groups listed earlier allows us to generate and name
many hundreds of thousands of compounds."
15. I know that AM-2201 contains an alkyl group and thus is covered under the
current law as written, prohibiting AM-2201 as the law was intended to do.
I 6. I know that cannabinoids, such as THC, produce their pharmacological effects
by binding to cannabinoid receptors.
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17. Finally. US Paknl 7.241.799 B2. which covers .:\t'v1-2201. lisb 1.hc ldd ol

invention as .. nrw and improved indolc carnrnbinrnd analogs o:hihi1

hi:..'h

binding aflinitics for cannabinoid rcct:plors ... "

DATED This

. day or Dcccmbcr.2012.

1!

1,

f

C'Ul<I'\:\.\ O\\'S!.LY

SUBSCRIBED AND SWOR!'\ to before me this

(

!1

I

'

.,,

:0£;~;~;~;/{ir·-l_d_.,.,.ach.ico---'~---"'·-'

'Residing at: _""v\ (l/1-'1- ,,
l'v!y Commission
"'

AlTlDA VJT OF CORINNA OWSLEY

{

I
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STATE OF IDAHO
IDAHO STATE POLICE
Colonel G. Jerry Russell

C.L. "Butch" Otter

Direct(){'

Gowmor

CURRICULUM VITAE
Corinna Owsley
700 S. Stratford Dr. Meridian, ID 83642
corinna.owsley@isp.idaho.gov

(208)884-7181 Office
(208)884-7197 Fax

EDUCATION
Bachelors of Science degree in Chemistry, Albertson College ofldaho 1998.

EXPERIENCE
August 1998-MJch 2000
Analytical chemist with Analytical Laboratories, Inc. Boise, Idaho.
April 2000-April 2006
Forensic Scientist II with Idaho State Police Forensic Services. Duties include controlled substance analysis and
Breath Alcohol Program Manager. Member of the Clandestine Laboratory Team. Court testimony.
April 2006-present
Forensic Scientist II with Idaho State Police Forensic Services. Duties include controlled substance analysis and

Deputy Quality Manager. Member of the Clandestine Laboratory Team. Court testimony.

CERTIFICATION/MEMBERSHIPS
Fellow- American Board ofCriminalistics (ABC)- 2007 to present
Diplomate- American Board of Criminalistics (ABC) - 2000-2007
Member- Northwest Association of Forensic Scientists (NWAFS) - 2004 to present
Member- Association of Forensic Quality Assurance Managers (AFQAM) - 2006 to present
Member- Clandestine Laboratory Investigating Chemists Association (CUC) - 2008 to present

TRAINING
May2000
The Robert F. Borkenstein Course on Alcohol, Drugs and Highway Safety; Testing, Research and Litigation.
Center for Studies of Law in Action, Indiana University.

August 2000
Clandestine Lab Investigations. Rocky Mountain High Intensity Drug Trafficking Area. Riverton, Wyoming.
September 2000
Drug Enforcement Administration Forensic Chemist Seminar. Fairfax, Virginia,

May2001
Drug Enforcement Administration Clandestine Laboratory Investigation/Safety. Quantico, Virginia.
October 2001
Intoxilyzer 5000EN Operation, Maintenance & Calibration. Owensboro, Kentucky.

May2003
Drug Evaluation and Classification Training: DRE School (Audit). POST Meridian, Idaho.

May2003
Courtroom Presentatir of Evidence. Meridian, Idaho.
October 2003

Mass Spectral Interpretation and MS Applications in Forensics.
Clandestine Laboratory Workshop: Detennining Production Capacity and a Phenyl-2-propanone Refresher.
Column Systems and Maintenance. NW AFS. Portland, Oregon.
March 2005
Effective Supervision I-fV. Northwest Training and Development. Meridian, Idaho.
February 2006
Alco Sensor III Operator, Calibratio~ Accuracy Check, and Maintenance training. St. Louis, Missouri

April 2006
Laboratory Safety Institute's 3-day Lab Safety Short Course. Meridian, Idaho.
September 2006
Agilent Technologies Northwest Speed School. Boise, Idaho.
October 2006
Association of Forensic Quality Assurance Managers Annual Meeting. Missoula, Montana
November 2006

Courtroom Testimony Workshop. NWAFS meeting. Colorado Springs, Colorado.
IR Interpretation and Forensic Application. NWAFS meeting. Colorado Springs, Colorado.
Streamlining Analysis: Overview of Drug Analysis. NWAFS meeting. Colorado Springs, Colorado.
A2LA ISO/IEC 17025:2005 and Laboratory Accreditation Training. Las Vegas, Nevada

January 2007
ASCLD/LAB-Intemational Assessor/Auditor Training. Clearwater, Florida.

November 2007
Northwest Association of Forensic Scientists Annual Meeting. Salt Lake City, Utah.
April 2008
FBI Crime Laboratory Development Symposium. St. Louis, Missouri

September 2008
Clandestine Laboratory Investigating Chemists Technical Training Seminar. San Antonio, Texas.
October 2008
Association of Forensic Quality Assurance Managers Annual Meeting. Virginia Beach, Virginia.
November 2008
Explosives Analysis Workshop. NWAFS meeting. Boise, Idaho.
Agilent Fast GC/MS - LC/Ms. NWAFS meeting. Boise, Idaho.
Clandestine Laboratory Myths and Realities. NWAFS meeting. Boise, Idaho.
September 2009
Clandestine Laboratory Investigating Chemists Technical Training Seminar. Birmingham, Alabama.
Instrumental Theory. NWAFS meeting. Fort Collins, Colorado.

May 2010

/
Ethics in Forensic Science. West Virginia University Extended Leaming.

September 20 I 0
Association of Forensic Quality Assurance Managers Annual Meeting. New Orleans, Louisiana
Northwest Association of Forensic Scientists Annual Meeting. Portland, Oregon.
September 2011
Association of Forensic Quality Assurance Managers Annual Meeting. Albuquerque, New Mexico
Clandestine Laboratory Investigating Chemists Technical Training Seminar. Seattle, Washington.
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05/16/2012

Idaho State Police Forensic Services
700 South Stratford Drive, Ste 125 Meridian ID 83642-6202

CL Case No.:
Agency:
ORI:

M20121975
CCNU - CITY COUNTY NARCOTICS UNIT

Page 1
(208)884-7170

Agency Case No.:

12N4295

Crime Date: May 3, 2012

Crirninalistic Analysis Report - CONTROLLED SUBSTANCE ANALYSIS
Evidence Received Information
Evidence Received:
Add. Crime Date:
How Received:
Haz. Materials:
Inv. Officer:
Delivered By:
Received By:

05/11/2012
IN PERSON
BIOHAZARD/CHEMICAL
ELDRIDGE 136
M HOBBS
JUDY PACKER ph. (208)884-7170

Victims and Suspects
Vic/Susp
Suspect
Suspect

Name
HARREL, TROY
MCKEAN, SHANNON

EVIDENCE DESCRIPTION AND CONCLUSION:

1)
Ag e ncy Exhibit 2.
One(l) hea ~ -sealed plastic bag with 0.66g of b r own /
plant material. The sample contains JWH-210 (Schedule I,
37-2705(d)30 . ii.a) and JWH-122 (Schedule I, 37-2705(d)30.ii.a).
This report does or may contain opinions and interpretations of the
undersigned analyst bas e d on s c ientific data.

Rea~~-

~a~q(j/

Forensic Scientist II
DATE: _s_(_tw-'-+(-l"""tz
_

_ __
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06/05/2012
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Idaho State Police Forensic Services

700 South Stratford Drive, Ste 125 Meridian ID 83642-6202
CL Case No.:
Agency:
ORI:

M20122217

(208)884-7170

Agency Case No.:

12N4300

CCNU - CITY COUNTY NARCOTICS UNIT
Crime Date: May 21, 2012

Crimlnallstfc AnalYJIS Report• CONTROLLED SUBSTANCE ANALYSIS
Evidence

Received Information

Evidence Received:
Add. Crime Date:
How Received:
Haz. Materials:
Inv. Officer:
Delivered By:
Received By:

REC~-:::~:l'JE~, ·
1

05/29/2012
IN PERSON

BIOHAZARD/CHEMICAL
MIKE ELDRIDGE 136
MICHAEL ELDRIDGE
JUDY PACKER ph. (208)884-7170

JU:; J 7 2012
PROSECt; · ,NG ATTO!~ ,.
CA~,JV-'..JN COUNT'·

Victims and Suspects

YJc!Susp
Suspect
Suspect
Suspect

~
HARRELL, TROY
MCKEAN, SHANNON
REED, WESLEY

EVIDENCE DESCRIPTION AND CONCLUSION:
/1) Agency Exhibit lb. One(l) heat-s~aleJ plastic bag with 2.93g of plant
material. The sample contains JWH-122 {Schedule I, 37-2705(d)30.ii.a) and
JWH-210 {Schedule I, 37 - 2705(d)30 . ii.a).
2) Agency Exhibit 2b. One(l) heat-sealed plastic bag with 4.32g of plant
material. Results of testing indicate the presence of a substance not
currently controlled in Idaho.
This report does or may contain opinions and interpretations of the
undersigned analyst based on scientific data.
Heather B. Campbell
Forensic Scientist II

DATE:_t_e----'--1{-"_~.,...,!j~2_ _ __
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Idaho State Police Forensic Services

08/05/2012

700 South Stratford Drive, Ste 125 Meridian ID 83642-6202

CL Case No.:

M20122217
CCNU - CITY COUNTY NARCOTICS UNIT

Agency:

{208)884-7170

Agency Case No.:

ORI:

12N4300

Crime Date: May 21, 2012
Criminalistic AnaJysls Report - CONTROLLED SUBSTANCE ANALYSIS

AFFIDAVIT
STATE OF IDAHO}

}

ss.

COUNTY OF ADA }

Heather B. Campbell, being first duly sworn, deposes and says the
following:
1.

That I am a Forensic Scientist II with Forensic Services and am

qualified to perform the examination and draw conclusions of the type shown
on the attached report;
2.

That Forensic Services is part of the Idaho State Police;

3. Thai I conducted a scientific examination of ~vidence described in the
attached report in the ordinary course and scope of my duties with Forensic
Services;
4. That the conclusion(s) expressed in that report is/are correct to the
best of my knowledge;

5. That the case identifying infonnation reflected in that report came
from the evidence packaging, a case report, or another reliable source.
6.

That a true and accurate copy of that report is attached to this

affidavit.

Heather B. Campbelli
Forensic Scientist II
DATE:

ii; (

q{2

I

SUBSCRIBED AND SWORN TO BEFORE ME___1.-'---.~-l---;l,_._}..,..1,_,._J,.;...;·'....:·-..L/....:.'·s:...l)_'---.-----.-i.

'

'&" ta~y

i-t.1,

?/ •

-j-

L;daho
.,') / ~
1

I

Public, S te ~f
Commission Expires: s-_~

000039
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)
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Idaho State Police Forenslc Services

07/02/2012

700 South Stratford Drive, Ste 125 Meridian ID 83642-6202

Cl Case No.:

M20122602

Agency:
ORI:

CCNU "CITY COUNTY NARCOTICS UNIT

(208)884-7170

Agency Case No.:

12N4310

Crime Date: Jun 6, 2012

CrlmlnallstJc Analysts Report • CONTROLLED SUBSTANCE ANALYSIS

Evidence Rec;efved !nfonnat12n
Evidence Received:
Add. Crime Date:
How Received:
Haz. Materials:
Inv. Officer:

06/21/2012

IN PERSON
BIOHAZARD/CHEMICAL
ELDRIDGE #136

Delivered By:

SUYEHIRA 5385

Received By:

JANE DAVENPORT ph. (208)884-7170

YJc;tlms and Suspects

v.c1suso
Suspect

~
MCKEAN, SHANNON

EVIDENCE DESCRIPTION AND CONCLUSION:
1) Agency Exhib~t 6. Two(2) metal smoking devices and a black container
with plant resid9e. Analyzed one (1) smoking device. The sja rnple contains
AM-2201 (Schedule I, 37-2705{d)30.ii.a) and UR-144.

2) Agency Exhibit 9. One(l) package labeled in part "SCOOBY SNAX
POTPOURRI" containing 4.07g of green plant material. The sample contains
AM-2201 (Schedule I, 37-2705(d)30.ii.a).
This report does or may contain opinions and interpretations of the
undersigned analyst based on scientific data.

iktfu.1 ~>

l~JJU)
k{f/,,
1

Heather B. Campbell
Forensic Scientist II
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Idaho State Police Forenslc Services
700 south Stratford Drive, Ste 125 Meridian ID 83642-6202

07/02./2012
CL Case No.:

Agency:

M201228O2
CCNU ~ CITY COUNTY NARCOTICS UNIT

Pege 1
(208)884-7170

Agency Case No.:

12N4310

Crime Date: Jun 6, 2012

ORI:

CrlmlnallstJc Analysts Report" CONTROLLED SUBSTANCE ANALYSIS
Evidence Received lnfgnngt12n

Evlckmce Received:

06121/2012

Add. Crime Date:

How Received:
Delivered By:

IN PERSON
BIOHAZARD/CHEMICAL
ELDRIDGE #136
SUYEHIRA 5385

Received

JANE DAVENPORT ph. (208)884-7170

Haz. Materials:

Inv. Officer.
By:

Victims and Suspec;ts

Vic/Sy§g

limm

Suspect

MCKEAN, SHANNON

EVIDENCE DESCRIPTION AND CONCLUSION:
1) Agency Exhibit 6. Two(2) metal smoking devices and a black container
with plant residue. Anaiyzed one(l) smoking device. The sample cqntains
AM-2201 (Schedule I, 37-2705{d)30.ii.a) and UR-144.
I
2)

Agency Exhibit 9.

One{l} package labeled in part "SCOOBY SNAX

POTPOURRI" containing 4.07g of green plant material.

The sample contains

AM-2201 (Schedule I, 37-2705(d)30.ii.a).
This report does or may contain opinions and interpretations of the

undersigned analyst based on scientific data.

tl<APu1.1

7
6L11iptt't!f
Campbell

15

Heather B.
Forensic Scientist II
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Idaho State Police Forensic Services

700 South Stratford Drive, Ste 125 Meridian ID 83642-6202
CL Case No.:
Agency:
ORI:

M20122603
CCNU - CllY COUNlY NARCOTICS UNIT

(208)884-7170

Agency Case No.:

12N4309

Crime Date: Jun 6, 2012

Crlmlnallstlc Analysis Report - CONTROLLED SUBSTANCE ANALYSIS

Evlgence Received Information
Evidence Received:

06/21/2012 ·

Add. Crime Date:

How Received:
Haz. Materials:
Inv. Officer:
Delivered

By:

Received By:

IN PERSON
BIOHAZARD/CHEMICAL
ELDRIDGE #136
SUYEHIRA 5385

JANE DAVENPORT ph. (208)884-7170

Victims and Suspects
Vic/Susp
Suspect
Suspect
Suspect

Name
HARRELL, TROY
MCKEAN, SHANNON
REED, WESLEY

EVIDENCE DESCRIPTION AND CONCLUSION:
1) Agency Exhibit 8. One(l) pjckage labeled in part "Fire-n-Ice" with
1.13g of green plant material. The sample contains JWH-210 (Schedule I,
37-2705{d)30.ii.a).
2) Agency Exhibit 10. One(l) ziplock containing l.OOg of green plant
material. The sample contains UR- 144.
3) Agency Exhibit 20. One(l) package labeled in part "AK-47" containing
2 . 78g of green plant material. The sample contains AM-2201 (Schedule I,
37-2705(d)30.ii.a).
4) Agency Exhibit 22. Two(2) packages labeled in part "Mad Hatter
incense", analyzed one(l) with 2.57g of green plant material. The sample
contains AM-2201 (Schedule I, 37-2705(d)30.ii.a).
5) Agency Exhibit 40. Two(2) packages labeled in part "SCOOBY SNAX
POTPOURRI", analyzed one(l) containing 3.40g of green plant material.
sample contains AM-2201 (Schedule I, 37-2705(d)30.ii.a).
6)

Agency Exhibit 46.

Not opened; not analyzed.

7)

Agency Exhibit 48.

Not opened; not analyzed.

8) Agency Exhibit 49. One(l) package labeled in part "DOWN2EARTH"
containing 1.llg of green plant material. The sample contains
AM-2201(Schedule I, 37-2705(d)30.ii.a).
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9)

Agency Exhibit 50.

Not opened; not analyzed.

l0) Agency Exhibit 51. One(l) package labeled in part "Jonny Clearwater's
Creamsicle" containing 3.59g of green plant material. The sample contains
UR-144.

11) Agency Exhibit 52. One{l) jar labeled in part "Maui Tai., containing
2.60g of green plant material. Results of testing indicate the presence of
a substance not currently controlled in Idaho.
12) Agency Exhibit 53. One (1) jar labeled in part "Cotton Candy"
containing 1. 71g of green plant material. Results of testing i.ndicate the
presence of a substance not currently controlled in Idaho.
13)

Agency Exhibit 54.

Not opened; not analyzed.

14)

Agency Exhibit 56.

Not opened; not/analyzed.

15)

Agency Exhibit 58.

Not opened; not analyzed.

This report does or may contain opinions and interpretations of the
undersigned analyst based on scientific data.

Heather B. Campbell '
Forensic Scientist II

DATE:
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A F F I DA V I T
STAtr'E OF IDAHO}

}

ss.

COUNTY OF ADA }

Heather B. Campbell, being first duly sworn, deposes and says the
following:
1. That I am a Forensic Scientist II with Forensic Services and am
qualified to perform the examination and draw conclusions of the type shown
on the attached report;
2.

That Forensic Services is part of the Idaho State Police;

3. That f conducted a scientific examination of evidence described in the
attached Feport in the ordinary course and scope ofjmy duties with Forensic
Services;
4.

That the conclusion(s) expressed in that report is/are correct to the
best of my knowledge;
That the case identifying information reflected in that report came
from the evidence packaging, a case report, or another reliable source.

5.

6. That a true and accurate copy of that report is attached to this
affidavit.
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LEGISLATURE OF THE STATE OF IDAHO
First Regular Session - 2011
Sixty-first Legislature
IN THE HOUSE OF REPRESENTATIVES
HOUSE BILL NO. 139
BY JUDICIARY, RULES, AND ADMINISTRATION COMMITTEE

4

AN ACT
RELATING TO UNIFORM CONTROLLED SUBSTJl,NCES; AMENDING SECTION 37-2705, IDAHO
CODE, TO IDENTIFY ADDITIONAL SUBSTANCES TO BE CLASSIFIED IN SCHEDULE I;
AND DECLARING AN EMERGENCY.

5

Be It Enacted by the Legislature of the State of Idaho:

6

SECTION 1. That Section 37-2705, Idaho Code, be, and the same is hereby
amended to read as follows:
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37-2705.
SCHEDULE I. (a) The controlled substances listed in this section are included in schedule I.
(b)
Any of the following opiates, including their isomers, esters,
ethers, salts, and salts of isomers, esters, and ethers, unless specifically
excepted, whenever the existence of these isomers, esters, ethers and salts
is possible within the specific chemical designation:
(1) Acetyl-alpha-methylfent~nyl (N-[l-(l-methyl-2-phenethyl) 4-piperidinyl]-N-phenylacetamide);
( 2) Acetylmethadol;
(3) Allylprodine;
(4) Alphacetylmethadol (except levo-alphacetylmethadol also known as
levo-alpha-acetylmethadol, levomethadyl acetate or LA.AM) ;
(5) Alphameprodine;
(6) Alphamethadol;
(7) Alpha-methylfentanyl;
(8) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
( 9) Benzethidine;
(10) Betacetylmethadol;
(11) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide);
(12) Beta-hydroxy-3-methylfentanyl (N-(1-(2-hydroxy-2-phenethyl) 3methyl-4-piperidinyl)-N-phenylpropanamide);
(13) Betameprodine;
(14) Betamethadol;
(15) Betaprodine;
(16) Clonitazene;
(17) Dextromoramide;
(18) Diampromide;
(19) Diethylthiambutene;
(20) Difenoxin;
(21) Dimenoxadol;
( 22) Dimepheptanol;
(23) Dimethylthiambutene;
(24) Dioxaphetyl butyrate;
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(25) Dipipanone;
(26) Ethylmethylthiambutene;
(27) Etonitazene;
(28) Etoxeridine;
(29) Furethidine;
(30) Hydroxypethidine;
(31) Ketobemidone;
(32) Levomoramide;
(33) Levophenacylmorphan;
(34) 3-Methylfentanyl;
(35) 3-methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
(36) Morpheridine;
(37) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
(38) Noracymethadol;
(39) Norlevorphanol;
(40) Normethadone;
( 41) Norpipanone;
(42) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4
piperidinyl] propanamide);
(43) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);
(44) Phenadoxone;
(45) Phenampromide;
(46) Phenomorphan;
(47) Phenoperidine;
(48) Piritramide;
(49) Proheptazine;
(50) Properidine;
(51) Propiram;
( 52) Racemoramide;
(53) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide);
( 5 4) Tilidine;
( 55) Trimeperidine.
(c) Any of the following opium derivatives, their salts, isomers and
salts of isomers, unless specifically excepted, whenever the existence of
these salts, isomers and salts of isomers is possible within the specific
chemical designation:
(1) Acetorphine;
(2) Acetyldihydrocodeine;
( 3) Benzylmorphine;
(4) Codeine methylbrornide;
(5) Codeine-N-Oxide;
( 6) Cyprenorphine;
(7) Desornorphine;
( 8)
Dihydromorphine;
( 9)
Drotebanol;
(10) Etorphine (except hydrochloride salt);
( 11) Heroin;
(12) Hydromorphinol;
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(13) Methyldesorphine;
(14) Methyldihydromorphine;
( 15) Morphine methylbromide;
(16) Morphine methylsulfonate;
(17) Morphine-N-Oxide;
( 18) Myrophine;
(19) Nicocodeine;
(20) Nicomorphine;
(21) Normorphine;
(22) Pholcodine;
( 2 3) Thebacon.
(d)
Hallucinogenic substances. Any material, compound, mixture or
preparation which contains any quantity of the following hallucinogenic
substances, their salts, isomers and salts of isomers, unless specifically
excepted, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation (for purposes of
this paragraph only, the term "isomer" includes the optical, position and
geometric isomers) :
( l) 4-bromo-2, 5-dimethoxy amphetamine;
( 2) 2, 5-dimethoxyamphetamine;
( 3)
4-bromo-2, 5-dimethoxyphenethylamine ( some other names: alpha-desmethyl DOB, 2C-B);
(ll4) 2, 5-dimethoxy-4-ethylamphetamine ( another\ name: DOET) ;
(5) 2,5-dimethoxy-4-(n)-propylthiophenethyla±ine;
(6) 4-methoxyamphetamine (PMA);
(7) 5-methoxy-3,4-methylenedioxy-amphetamine;
(8) 5-methoxy-N,N-diisopropyltryptamine;
(9) 4-methyl-2,5-dimethoxy-amphetamine (DOM, STP);
( 10) 3, 4-rnethylenedioxy amphetamine;
(11) 3,4-methylenedioxymethamphetamine (MOMA);
(12) 3,4-methylenedioxy-N-ethylarnphetamine (also known as N-ethyl-alpha-methyl-3,4 (methylenedioxy) phenethylamine, and N-ethyl MDA, MDE, MDEA);
(13)
N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy-alpha-methyl-3,4(methylenedioxy) phenethylamine, and N-hydroxy MDA);
(14) 3,4,5-trimethoxy amphetamine;
(15)
Alpha-ethyltryptamine (some other names: etryptamine, 3-(2-aminobutyl) indole);
(16) Alpha-methyltryptamine;
(17) Bufotenine;
(18) Diethyltryptamine (DET);
(19) Dimethyltryptamine (DMT);
( 20) Ibogaine;
(21) Lysergic acid diethylamide;
(22) Marihuana;
(23) Mescaline;
( 2 4) Parahexyl;
(25) Peyote;
(26) N-ethyl-3-piperidyl benzilate;
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(27) N-methyl-3-piperidyl benzilate;
(28) Psilocybin;
(29) Psilocyn;
(30) Tetrahydrocannabinols~
or ~Synthetic equivalents of the substances contained in the plant, or in the resinous extractives of
Cannabis, sp. and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity such
as the following:
i. Tetrahydrocannabinols:
a. ~ 1 cis or trans tetrahydrocannabinol, and their optical isomers, excluding dronabinol in sesame oil and encapsulated in a soft gelatin capsule in a drug product approved by
the U.S. Food and Drug Administration.
~ ~ 6 cis or trans tetrahydrocannabinol, and their optical
isomers.
.s:...:_ ~ 3 , 4 cis or trans tetrahydrocannabinol, and its optical
isomers. (Since nomenclature of these substances is not internationally standardized, compounds of these structures,
regardless of numerical designation of atomic positions are
covered.)
~ [(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2rnethyloctan-2- l)-6a,7,10,10a-tetrah drobenzo[c]chromen1-ol) J,
also
known
as
6aR-trans-3- ( 1, -dimeth lhe tyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6- imethyl-6Hdibenzo[b,dJpvran-9-methanol (HU-210) and it's geometric
isomers (HU211 or dexanabinol).
i
The following synthetic drugs:
~ Any
compound structurally derived from 3-(1-naphthoyl) indole or lH-indol-3- yl- ( 1-naphthyl) methane by subs ti tut ion at the nitrogen a tom of the indole ring by alkyl,
alkenyl, cycloalkylmethyl, cycloalkylethyl or 2- (4-morpholinyl) ethyl, whether or not further substituted in the
indole ring to any extent , whether or not substituted in the
naphthyl ring to any extent.
~ Any
compound structurally derived from 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the
pyrrole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2- ( 4-morpholinyl) ethyl, whether or not
further substituted in the pyrrole ring to any extent,
whether or not substituted in the naphthyl ring to any extent.
.s:...:_ Any compound structurally derived from 1-(1-naphthylmethyl) indene by substitution at the 3-position of
the indene ring by alkyl, alkenyl, cycloalkylmethyl, cycloal kylethyl or 2- ( 4-morpholinyl) ethyl, whether or not
further substituted in the indene ring to any extent,
whether or not substituted in the naphthyl ring to any extent.
~ Any
compound
structurally
derived
from
3-phenylacetylindole by substitution at the nitrogen atom of the

5

1

2

3
4
5

6
7
8

9
10
11

12
13

14
15

16
17
18
19

20

indole ring with alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2- (4-morpholinyl) ethyl, whether or not
further substituted in the indole ring to any extent,
whether or not substituted in the phenyl ring to anv extent.
.:=..:.. Any compound structurally derived from 2-(3-hydroxvcyclohexvl)phenol by substitution at the 5-position of the
phenolic ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethvl or 2- ( 4-morpholinyl) ethyl, whether or not
substituted in the cyclohexyl ring to any extent.
L:__ Any compound structurally derived from 3-(benzoyl)indole structure with substitution at the nitrogen atom
of the indole ring by alkyl, alkenyl, cycloalkylmethyl,
cycloalkylethyl, l-(N-methyl-2-piperidinyl)methyl or
2- ( 4-morpholinyl) ethyl, whether or not further substituted
in the indole ring to anv extent and whether or not substituted in the phenyl ring to any extent.
Sl__:_ [2,3-Dihydro-5-methyl-3-(4-morpholinylmethvl)pyrrolo[l,2,3-de)-1,4-benzoxazin-6-yl]-l-napthalenylmethanone
(WIN-55, 212-2) .
~ 3-dimethylheptvl-11-hydroxyhexahydrocannabinol
(HU-
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9-hydroxy-6-methyl-3-[5-phenylpentan-2-yl]oxy5,6,6a, ,8,9,10,lOa-octah dro henanthridin-1- l]acdtate
(CP 50, 561).
(31) Ethylamine analog of phencyclidine (N-ethyl-l-phenylcyclohexylamine (1-phenylcyclohexyl) ethylamine; N-(l-phenylcyclohexyl) ethylamine, cyclohexamine, PCE;
(32) Pyrrolidine analog of phencyclidine: 1-(phenylcyclohexyl) pyrrolidine, PCPy, PHP;
(33) Thiophene analog of phencyclidine l-[l-{2-thienyl)-cyclohexyl]piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP;
(34) 1-[l- (2-thienyl) cyclohexyl] pyrrolidine another name: TCPy;
(35) Spores or mycelium capable of producing mushrooms that contain
psilocybin or psilocin.
(e) Unless specifically excepted or unless listed in another schedule,
any material, compound, mixture or preparation which contains any quantity
of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the
existence of such salts, isomers, and salts of isomers is possible within the
specific chemical designation:
(1) Gamma hydroxybutyric acid (some other names include GHB; gamma-hydroxybutyrate, 4-hydroxybutyrate; 4-hyroxybutanoic acid; sodium oxybate; sodium oxybutyrate);
(2) Flunitrazepam (also known as "R2," "Rohypnol");
(3) Mecloqualone;
( 4) Methaqualone.
( f)
Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on
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the central nervous system, including its salts, isomers, and salts of ,iso-

2

rners:

3

( 1)
Aminorex ( some other names: aminoxaphen, 2-amino-5-phenyl-2-oxazoline, or 4,5-dihydro-5-phenyl-2-oxazolamine);
(2)
Cathinone (some other names: alpha-aminopropiophenone, 2-amino
propiophenone and norephedrone};
(3) Fenethylline;
(4) Methcathinone (some other names: 2-(methyl-arnino)-propioph
enone, alpha-(methylamino)-propiophenone, N-methylcathinone, AL4 64, AL-422, AL-4 63 and UR1423) ;
(5) (+/-)cis-4-methylaminorex ( (+/-)cis-4,5-dihydro-4-methyl-5
phenyl-2-oxazolamine];
( 6) N-benzylpiperazine (also known as: BZP, 1-benzylpiperazine);
( 7) N-ethylamphetamine;
(8) N,N-dimethylamphetamine (also known as: N,N-alpha-trimethyl-benzeneethanamine) .
(g) Temporary listing of substances subject to emergency scheduling.
Any material, compound, mixture or preparation which contains any quantity
of the following substances:
(1)
N-[1-benzyl 4-piperidyl]-N-phenylpropanamide (benzylfentanyl),
its optical isomers, salts and salts of isomers.
( 2)
N- [ 1- ( 2-thienyl) methy)-4-piperidyl] -N-phenylpropanamide ( thenylfentanyl), its optical i,omers, salts and salts of isomers.
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SECTION 2. An emergency existing therefor, which emergency is hereby
declared to exist, this act shall be in full force and effect on and after its
passage and approval.

STATEMENT OF PURPOSE
RS20305Cl
The purpose of the legislation is to create safe regulations for the public concerning
Tetrahydrocannibinols from synthetic drugs (Spice) that mimic the effects of Cannabis and
identifying additional substances to be classified in schedulel. This legislation continues what 1s
currently being enforced by the Board of Pharmacy. Declaring an emergency.

FISCAL NOTE
There is no additional Fiscal Impact
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Name: Representative Richard Wills
Office: House Judiciary, Rules and Administration
Phone: (208) 332-1181

Statement of Purpose/ Fiscal Note

H0139

(12) INTERNATIONAL APPLICATION l'llBLISIIED llNOl-:R TIIE PATENT ( '001'~:RATION TRI::ATY (PCT)

( 19) World Intellectual Property Organization
lntcrn;1tional Bureau

llllll llllllll IIIIIIII 111111111111111lllll lllll lll ll lllll llll lllllll llll llllllll
(10) International Publication Number

(43) International Publication Date
26 April 200 I (26.04.200 I)
(51) I nteroational Patent Classific~tion 1 ;
.Jl/4045. C07D209/12
(21) International Application Number:

PCT

\VO 01/28557 A 1·

A6 I K 31/405.

(74) Agents: YALE, Guy, D. et i.l.; Alix, Yale & Ristas. LLP.
750 Main Street. Hartford . CT 06103 (US).
·

PCT/US00/28832

(81) Desi~nated States {naliona/): AE. AG. AL. AM. AT. AU.
AZ. BA. BB. BG, BR. BY. BZ. CA, CH, CN. CR. CU. CZ.
DE. DK. DM. DZ. EE. ES. FI. GB, GD. GE. GH. GM. HR.
HU, ID, IL. IN. IS, JP. KE. KG. KP, KR. KZ, LC. LK, LR.
LS. LT, LU. LV. MA. MD. MG. MK. MN. MW, MX. MZ.
NO. NZ. PL. PT. RO. RU. SD, SE. SG. SI, SK. SL TJ. TM.
TR. TT, TZ. UA, UG, US, UZ.,VN. YU . ZA. ZW.

(22) International Filing Da te; 18 Octobe r 2000 (l 8.10.2000i
(25) Filing Language;

English

(26) Publication Language:

English

(84) Designated States (regional): AR!PO patent (GH, GM.
(30) Priority Data:
60/159,997

! 8Oc1ober l999(18I0.1999)·

KE, LS, MW, MZ. SD, SL, SZ. TZ. UG. ZW), Eurasian
patent (AM. AZ. BY. KG. KZ. MD. RU. TJ. TM), European
patent (AT. BE, Cl;'!, CY, DE, DK. ES. Fl, FR, GB . GR. IE.
IT. LU, MC, NL. PT. SE), OAP! patent (BF. BJ; CF. CG.
CI, CM. GA. GN. GW. ML, MR, NE. SN, TD, TG).

u·s

(71) Applicant (for all designated Stales except US): UNIVERSITY OF CONNECTICUT [US/US); 263 Farmington
Avenue, Farmington, CT 06032 (US).

_ r2)

=
-

--

Inventors; and
.
· 5) Inventors/Applicants (for US only); MAKRIYANNIS,
Alexandros [US/US]; 348G Foster Drive, Willimantic,
CT 06226 (US). DENG, Hongfeng [CN/USJ; Apt. 64 , I
Northwood Road, Storrs, CT 06268 (US).

Published:
Wi1h inlernational search reporl.

codL

For two:l{!ller
and other abbreviations. refer to lhe "Cui~ance No tes on Codes and Abbreviations" appearing al 1he beginning of each regular issue of 1he PCT Gazel/e.

=

-=

r---

'-

tn

l£)

00

N

---.---------------------------------------

1'""'(

(54) Title: CANNABIMIMETIC INDOLE DERIVATIVES

0

0

(57) Abstract: Novel cannabimimetic ·indole' derivatives are prese~ted which have preferentially high affinities for one of the
:;... cannabinoid CB I or CB2 receptor sites. The improved receptor affinity ruakes .these analogs therapeutically useful as medications
;.-,- in individuals and animals for treatment of pain, glaucorua, epilepsy, nausea associated with chemotherapy.
·

0001.86

WO 01/28557

PCT/US00/28832

)

CANNABIMIMETIC INDOLE DERIVATIVES
Field of the Invention
The present invention relates generally to cannabinoid analogs and is more
5

particularly concerned with new and improved indole cannabinoid an alogs
exhibiting high binding -affinities for cannabinoid receptors, pharmaceutical
preparations

employing

these

ana-logs

and

methods

of

administering

therapeutically effective amounts of the preparations to provide a physiological
effect.
10
Background of the Invention

pharmacological effects.
20

See, for example, Pertwee, R.G., Pharmacology of

cannabinoid CB1 and CB2 receptors, Pharmacol. Ther., (1997) 74:129 - 180 and
Di Marzo, V., Melck, D., Bisogno,

t.,

DePetrocellis, L., Endocannabinoids:

endogenous cannabinoid receptor ligands with neuromodulatory action, Trends
Neurosci. (1998) 21 :521 - 528.
There is
25

considerable

interest in developing

cannabinoid

analogs

possessing high affinity for one of the CB 1· or CB2 receptors and/or metabolic
stability. Such analogs may offer a rational therapeutic approach to a variety of
disease states.

One class of cannabimimetic analogs encompasses indole

derivatives such as the well known aminoa\kylindoles represe~ted by WIN
55212-2 {(RH+ )-[2,3-dihydro-5-methyl-3--((4-morpholinyl}methyl]-pyrrolo[ 1,2,330

de]-1,4-benzoxazin-6-yl]( 1-naptha-lenyl)methanone}. Aminoalkylindoles of this
type typically have a carbon linked alkylheterocyclic substituent at the indole-1
position, which is believed to be important for their canabimimetic activities .

000187
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These known materials are not selective for preferential activation of one of the
CB 1 or CB2 receptors.

Summary of the lnventi9n
5

Aminoalkylindoles have been found to _act as agonists for. the CB 1 and
CB2 receptors and occasionally as antagonists for the CB1 and CB2 receptors.
The invention includes compounds selective for either the CB 1 or CB2 receptors.
Further, some of the compounds have agonistic or antagonistic properties.
One aspect of the invention includes several novel aminoalkylindole

10

cannabinoid analogs and physiologically acceptable salts thereof.

In one

embodiment of the invention, straight carbon chains were introduced to the
indole-1 position.

Different functional groups were also introduced to the

straight carbon chains. Thi~ embodiment is shown as A.

15

z-(r(-R,
~1-·J
.
N
.

A

R2

I

R,
I
X

20

Z may be in the 4-, 5-, 6- or 7- position and is selected from the group
con::,isting of nitro; nitroso; amino; alkylamino; dialkylamino; azido (N 3 ); cyano;
isothiocyano and phenyl.
X is selected from the group consisting of halogen; hydrogen; hydroxy;
low alkanoate; formyl; amino; cyano; isothiocyano and azido.

25

R, is selected from the group consisting of saturated or unsaturated
straight carbon chains with a maximum length of seven carbon atoms;
saturated or unsaturated bra_nched carbon chains with a maximum length of
seven carbon atoms; cyclic aliphatic rings interconnected to the indole-1
position with one or two carbon atoms; bicyclic aliphatic rings interconnected

30

to the indole-1 position with one or two carbon atoms; and heterocyclic rings
interconnected to the indole-1 position with one or two carbon atoms.
2
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R2 is selected from the group consisting _of H and lower alkyl.
Y is selected from the group consisting of carbonyl and CH

CH (cis or

trans).
R3 is selected from the group consisting of phenyl; napthyl; 9-anthracenyl;
5

phenyl with no more than two substituents selected from the group consisting
of halogen, nitro, nitroso, amino, alkylamino, dialkylamino, hydroxy, methoxy,
lower alkyl, azido, cyano and isothiocyano; napthyl with no more than two
substituents selected from the group consisting of halogen, nitro, nitroso, amino,
alkylamino, dialkylamino, hydroxy, methoxy,
lower alkyl, azido, cyano and
. .
.

10

isothiocyano; and 9-anthracenyl with no more than two substituents selected
from the group consisting of halogen, nitro, nitroso, amino, alkylamino,
dialkylamino, hydroxy, methoxy, lower alkyl, azido, cyano and isothiocyano.
The analogs of this embodiment show high binding affinities for the CB 1
and CB2 cannabinoi_d receptors. More importantly, some of these compounds

15

show not only comparable cannabimimetic activity with the compound WIN

55212-2 but also a surprisingly 1igher selectivity for one of the CB1 or CB2
receptors.

More specificallx, the inventive analogs showed similar or higher

receptor binding affinity than the well-known indole cannabinoid WIN_ 55212-2.
Another embodiment of the invention is shown as B. In this embodiment
20

the functionalities of the_ novel cannabimimetic indole analogs were modified in
the indole-3 and/or indole-6 positions.

z~Y-R3

25

~
.. /'R
. N

B

z

I

R,
I
X

Z may be in the 4-, 5-, 6- or 7- position c:md is selected from the group
30

consisting of halogen; hydroxy; methoxy and lower alkyl.
X is selected from the _group consisting of hydrogen; hydroxy; lower
3
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alkanoate; formyl; amino; cyano and isothiocyano.
R 1 is selected from the group consisting of saturated or unsaturated
straight carbon chains with a maxim.um length of seven carbon atoms; saturated
or unsaturated branched carbon chains with a maximum length of seven carbon
5

atoms; cyclic aliphatic rings interconnected to the indole-1 position with one or
two carbon atoms; ·and bicyclic aliphatic rings interconnected to the indole-1
position with one or two carbon atoms.
R2 is selected from the group consisting of H and lower alkyl.
Y is selected from the group consisting of carbonyl and CH= CH (cis or

10

trans).
R 3 is selected from the group consisting of phenyl; napthyl; 9-anthracenyl;
phenyl with no more than two substituents selected from the group consisting
of halogen, nitro, nitroso, amino, alkylamino, dialkylamino, hydroxy, methoxy,
· lower alkyl, azido, cyano and isothiocyano; napthyl with no more than two

15

substituents selected from the group consisting of halogen, nitro, nitroso, amino,
alkylamino, dialkylamino, hydroxy, methoy, lower alkyl, azido, cyano and
isothiocyano, and 9-anthracenyl with no mdre than two substituents selected
from the group· consisting of halogen, nitro, nitroso, amino, alkylamino,
dialkylamino, hydroxy, methoxy, lower alkyl, azido, cyano and isothiocyano.

20

The analogs of this embodiment are surprisingly potent cannabimimetic
compounds with high CB1 and/or CB2. selectivity.
Since CB2 selective cannabinoids are able to activate the CB2 receptor
and thereby modulate the immune system with little psychoactivity or other CNS
effects, these analogs are possible therapeutic agerits. Additionally, some of the

25

iodide and fluoride containing analogs are potential radioactive probes for imaging

in vivo the distribution of cannabinoid receptors. The azido modified analogs are
excellent affinity probes for characterizing binding pockets of cannabinoid
receptors.
The analogs disclosed herein .are relatively easy to manufacture.
30

Additionally these analogs have better physiochemical properties than naturally
occurring cannabinoids. Thus, the novel cannabimimetic indole derivatives
4
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described herein, and physiologically acceptable salts thereof, represent
potentially useful materials for providing a physiological effect to treat pain,.
peripheral pain, glaucoma, epilepsy, nausea such as associated with cancer
chemotherapy, AIDS Wasting Syndrome, cancer; neurodegenerative diseases
5

including Multiple Sclerosis, Parkinson's Disease, Huntington's Chorea and
Alzheimer's Disease, mental disorders such as Schizophrenia and depression; to
prevent or reduce endotoxic shock and hypotensive shock;_ to modulate appetite;
to reduce fertility; to prevent or reduce diseases associated with motor function
such as Tourette's syndrome; to prevent or reduce inflammation; to provide

10

neuroprotection and to effect memory enhancement.
The novel cannabimimetic indole derivativ.es described herein also provide
useful materials for testing the cannabinoid system. Thus, another aspect of the
invention is the administration of a therapeutically effective amount of an
inventive compound, or a physiologically acceptabfe salt thereof, to an individual

15

or animal to provide a physiological effect ..

IDescription of Some Preferred

Embodi~ents

As used herein, a "therapeutically effective a·mount" of a compound, is the
quantity of a compound which, when administered to an individual or animal,
20

results in a sufficiently high level of that compound in the individual or animal to
cause a discernible increase or decrease in stimulation of cannabinoid receptors.
Physiological effects that result from cannabinoid receptor stimulation include
analgesia, decreased nausea resulting from chemotherapy, sedation and
increased appetite.· Other physiological functions include relieving intraocular

25

pressure in glaucoma patients and suppression of the immune system. Typically,
about 10 mg/day to about 1 ,000 mg/day is a possible "therapeutically effective
amount" for the inventive compounds.
As used herein, an "individual" refers to a human. An "animal" refers to,
for example, veterinary animals, such as d_ogs, cats, horses and the like, and

30

farm animals, such as cows, pigs and the like.

5
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The compound of the pres~nt invention can be administered by a variety
of known methods, including orally,· rectally, .or by parenteral routes (e.g.,
intramuscular, intravenous, subcutaneous, nasal or topical). The form in which
the
5

compounds

are

administered . will

be

determined

by the

route

of

administration. Such forms include, but are not limited to, capsular and tablet
formulations (for oral and rectal administration), liquid formulations (for oral,
intravenous, intramuscular or subcutaneous administration) and slow releasing
microcarriers (for rectal, intramuscular or intravenous administration).

The

formulations can also contain a physiologically acceptable vehicle and optional
10

adjuvants, flavorings, colorants and preservatives.

Suitable physiologically to

acceptable vehicles may include, for example, saline, sterile water, Ringer's
solution, and isotonic ·sodium chloride solutions.

The sp.ecific dosage level of

active ingredient will depend upon a number of factors, including, for example,
biological activity of the particular preparation, age, body weight, sex and general
15

health of the individual being treated.
.

The inventive cannabinoid analogs are generally described bYi the structural

formulas Jreviously disclosed. The following examples are giveri for purposes
of illustration only in order' that the present invention may be more fully
understood. These examples are not intended to limit in any way the practice
20

of the invention. The prepared cannabimimetic indole derivatives can generally
be described with reference to structural formulas 1 and 2 below and include
physiologically acceptable salts thereof.
The inventive cannabimimetic indole derivatives of structural formula 1
include both racemics and two enantiomers.

25

Y-R 3

CD

z

N
I

. structural formula 1

R2

R,

30

I
X
Z is in the indole-6 position and is selected from the group consisting .of

6

PCT/US00/28832

WO 01/28557

H; N0 2 ; NH 2 ; N 3 and NCS.
. R 1 is a heterocyclic ring interconnected to the indole-1 position with
one carbon atom.
X is hydrogen.
5

R2 is selected from the group consisting of H and methyl.
Y is carbonyl.
R3 is selected from the group consisting of phenyl; napthyl;
adamantanyl; pyrenyl and su~stituted versions of any of the above.
The inventive materials of structural formula 1 are listed in TABLE 1. It

10

should be noted that R1 for all of the materials of TABLE 1 was 1-(N-Methyl-2piperidinyl)methyl. All of the materials of TABLE 1 have a chiral center and the
binding affinities of the materials of TABLE 1 were obtained by evaluating their
racemic samples.

TABLE 1

z

analog

R,

R1

K1 nM
CB1
CB2

I

AM664
AM665
AM671
AM684
AM1215
AM.1216
AM2209
AM2223
AM1221
AM1225
AM1231
AM1218
AM1219
AM1224
AM1217
AM1299
AM1296
AM1220
AM2212
AM2215
AM1248

NO,
NH,
N3
NCS
N1
NCS
N,
NCS
NO.,
NH.,
N1
NO,
NH,
N.,
NCS
H

H
H
N1
NCS
H

CH,
CH 3
CH 3
CH.,
CH 3
CH 1
H
H
CH,
CH 1
CH 1
H
·H
H
H
H
H
H

H
H
H

2-iodophenyl
2-iodophenyl
Phenyl
Phenyl
2-iodophenyl
2-iodophenyl
5-azido-2-iodophenyl
5-isothiocyahato-2-iodophenyl
1-naphthyl
1-naphthyl
1-naphthyl
1-naphthyl ·
1-naphthyl
1-naphthyl
1-naphthyl
4-nitro-1-naphthyl
1-naphthyl
1-naphthyl
4-iodo-1-riaphthyl
4-isothiocyanato-1-naphthyl
adamantanyl
7

40
206
155
181
40.7
210
48.8
64.8
52.3
439.6
31.2
11.2
96.6
20.2
255
12.4
7.57
3.88
31.0
235
100

80.0
20.3
59.1
44.8
21.9
25.2
41.8
29.9
0.28
38.5
34.2
3.98
31.3
0.73
81.5
13.5
3.88
73~4
2.90
99.6
332

I
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TABLE 1

K,

z

analo1=1

AM1253

H

R,

R7
H

2-pyrenyl

C81

nM
CB2

60.3

126

structural formu_la 2
5

Z is in the indole-6 position and is selected from the group consisting of
10

hydrogen; N0 2 ; NH 2 and halogen.
Xis selected from the group consisting of halogen; H; OH; OCOCH 3 ;
OTs; NCS; OAc and CN.
R 1 is a saturated lower tlkane with a maximum length of seven carbon
atoms.

15

R2 is selected from the group consisting of H and methyl.
Y is carbonyl.
R 3 is selected from the group consisting of phenyl; napthyl; and
substituted versions of any of the above.

20

The inventive materials of structural formula 1 are listed in TABLE 2. R 1
lists _the number of carbon atoms in the chain at that position.

8
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TABLE 2
analo~

z

R,

AM683
AM669
AM682
AM672
AM689
AM690
AM2227
AM2229
AM2230
AM2225
AM679
AM692
AM693
AM697
AM698
AM1201
AM694
AM1202

H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H

4
H
5
H
6
H
7
H
.5 OCOCH 1
5·
OH
5
· OTs
5
I
5
NCS
F
5
5
H
5 OCOCH,
5
OH
5
OTs
I
5
5
NCS
F
5
5
H

AM1203

H

5

H.

H

AM1204

H

5

H

H

AM1205

H

5

H

H

AM1206
AM1284
AM1289
AM1292
AM1294
AM1282
AM1283
AM1286
AM1288
AM1291
AM1295
AM2232
AM2231
AM2.202
AM2203

H
H
H
H
H
H
H
H

5.
3
3
3
3
4

H
OCOCH,
OTs
I
NCS
OCOCH,
OH
OTs
I
NCS

H
H
H
H
H
H
H
H
H
H
H
H
H
H
H

H
H
H
H
N0 7
H
H

4
4
4
4
4.
4
4

5
5

X

F
CN
CN
OH

I

R,

Ra

CH1
CH 1
CH.,
CH 1
CH_,
CH,
CH,
CH,,
CH;
CH,
H
H
H
H
H
H
H
H

2-iodophenyl
2-iodophenyl
2-iodophenyl
2-iodophenyl
2-iodophenyl
2-iodophenyl
2-iodophenyl
2-iodophenyl
2-iodophenyl
2-iodophenyl
2-iodophenyl
_2-iodophenyl
2-iodophenyl
2-iodophenyl
2-iodophenyl
2-iodophenyl
;2-iodophenyl
,?-iodo-·
5-nitrophenyl
2-iodo5-aminophenyl
2-iodo-5isothiocyanophenyl
2-iodo5-azidophenyl
2, 5-diiodophenyl
1-naphthyl
1-naphthyl
1--naphthyl
1-naphthyl
1-naphthyl
1-naphthyl
·1-naphthyl
1-naphthyl
1-naphthyl
1-naphthyl
1-naphthyl
1-naphthyl
1-naphthy!
1-naphthyl
9

K1 nM
CB2
CB1
272
47.2
332
1603
2279
4850
1024
116.5
195
5.97
13.5
2656
835
1306
135.8
106
0.08
98.9

281
38.6
693
1 511
1019
1972
2968
46.2
29.5
3.8
49.5
1519
526
111 6
314.7
110
1.44
22.9

63.6

88.9

5659

3353·

116.9

195. 7

105.1
126.8
359.6
3.,
283.3
133.4
117.2
1509
1.3
2958
2.5
0.28
4.90
33.1
7.8

150.5
102.8
78.64
18. 1
237.3
100.8
196.5
1289
10.5
1804
30.7
1.48
23.9
110.6
45.8
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TABLE 2
analoq

z

AM2204
AM2201
AM1233
AM1234
AM1235
AM1236
AM1237
AM1238
Am1230
AM2210

H
H

NO,
NO,
NO,
NH,
NH,
I
I
H

R1

X

R,

5
5
5
5
5
5
5
5
5

NCS

H
H
H
H
H
H
H.
H

F
.OAc

OH
F
OAc

OH
OH
F

4

I

AM2213

H

4

I

AM2216

H

4

I

AM1256

H

5

H

R-

1-naphthyl
1-naphthyl
1-naphthyl
1-naph_thyl
1-naphthyl
1-naphthyl
1-naphthyl
1-naphthyl
1-naphthyl
H
H
4-nitro1-naphthyl
H
4-azido1-naphthyl
4-isothicocyano-1H
napthyl
CH 3 4-diniethylamino-1naphthyl

K1 nM
CB2
CB1
7.5
1 .0 .,
141. 7
77.6
1.5
1127
836.8
3.1
1. 1

The above materials were generally prepared as follows.

10

24.4
,p,.-,;0c:,,--

1.8

153.9
196.8
20.4
558.8
244.4
17.3
2.4
11 .3

3.0

30

42.4

213

4.74

18.6
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A. General Preparation procedures for materials listed in Table 2
The materials liste.d iri Table 2 can be prepared by methods outlined in Scheme
1.
5
Scheme 1

n--n
.

~ t;J ~ R2
z

1. EtMgBr
2R3-COCI
3 NH,CI/H20

1/

z

H

O

O

~

I

"'

N
H

I

R3

I

R3

R2

R2

N

------ z

I

NaHIDMF

(CH2ln

I

OAc

R2 =Hor CH 3
Z =Hor N0 2

1

KOH/MeOH

z

ol~R3
7

R2

3

(X=N 3 , I. or CN)

(CH 2 ) 0

3

O

I

LJl)lR2

I

l

z

N

R2

I

(CH 2) 0

I

OTs

OH

lI

CSCl2 , Php
THF

O

z

I

I

DAST
CH 2Cl 2

O

R3

R3

I

I
N

R3

TsCI

I

I

J)

z

(CH 2) 0

X
(X =

~R

NaX

R2

z

N
I

R2

(CH 2 ) 0

(CH2ln

I

I

F

NCS

When Z = N0 2 , the structures can be. transformed to the different
10

substituents as listed in Table 2 using methods outlined in Scheme 2_

l1 ·
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Schef!le 2

O
1. HCI
2. NaNO 2

-

3. Nal

R3

I
N

I

I

R2

(CH 2 ln

I

X

The commercially unavailable R3-COCI
used
in Scheme 1 can be prepared
. .
.
5

according to Scheme 3.

Scheme 3

COOH

'D

is
"

...-c:

N0 2

10

HN03
H2 S0 4

.

------,...

COOH

'U
.

·1. NaOH!Hp
2. AcOH/Hg(OAc) 2
3. HCI

COCI

SOCl 2
N02

·c¢
"

/,

N0 2

'U

SOCl 2

N0 2

o$
"

/'.

. N0 2

After these acid chlorides were connected to indole 3-position, the nitro
group in them can be further transformed into amino, iodo, azido, and
isothiocyanate groups according to the methods outlined in Scheme 4.

12
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Scheme4

o_

0

Ar·NO 2

z

N

R2

I

-

(CH 2 ) 0

Ar·NH 2

Hydrazine
Raney Ni
·

or H/PO2

z

~

I

X

R2
I
(CH2Jn
I

1. HCI
2 NaNO2

N

3. Na!

X

1. HCI
2.NaNO 2
3. NaN 3

1, 1'-Thiocarbo)~t/
· diirnidazo/

.
\

0

.

0

Ar·NCS

Ar·N 3

I
N

z

I

I
R2

z

(CH 2 ) 0

N

I

R2 .

(CH 2 ) 0

I

I

X

X

B. General preparation procedures for materials listed in Table 1
5

· These materials -can be prTpared in similarly manners as those compounds
listed in Table 2 by using N-fnethyl-2-piperidinemethyl chloride instead of
acetoxylalkylhalides for the alkylation of indole 1-position in Scheme 1.

Examples of specific analogs were prepar~d as follows:
10

3-Acyl-1 H-indole.

17 .5 ml C?f a 3M solution of methyl magnesium bromide in

ethyl ether was added dropwise with stirring to a solution of indole (5.85 g, 50
mmol) in 50 ml of ethyl ether at O °C. After addition, the reaction mixture was
warmed up to room temperature and. stirred for 2hours (h). Then the reaction
15

mixture was cooled down again to O °C and to it was added slowly with violent
stirring a solution of acyl chloride (50 mmol) in .50 ml of ethyl ether.

The

resulting reaction mixture was warmed up to ~oom temperature and stirred for
another 1 h followed by the slow addition ·of 375 ml of ammonium chloride
aqueous soiution. Aft_er violently stirring for 30 min, a white solid was formed
20

and filtrated.

The filtrate was washed successively with ethyl ether and

recrystallized from ethyl acetate:hexane to afford the product.
13

The foregoing procedure was repeated using 2methyl indole in place of indole.
2-methyl-3-acyl-1H-indo!e.

5

1-Alkyl-2-methyl-3-acyl-1H-indole. To a 1.2 mmol suspension of sodium hydride
(48 mg, 60% in mineral oil) in 2 ml ofdimethylformamide (DMF) was added 2-

methyl-3-acyl-1 H-indole (0.4 mmol). After stirring at room temperature for 30
min, alkyl bromide (0.6 mmol) was adde9 dropwise. The resulting mixture was
heated to 65 °C and stirred for 3 h followed by removal of solvent under
10

vacuum. The residue was separated by flash column chromatography (silica gel,
petroleum ether-ethyl acetate, 5:1, v/v) to afford the product.
A person of ordinary skill in the art, understanding the d·1sclosures for the general
preparation and specific preparation examples would know how to modify the
disclosed procedures to achieve the above listed analogs.

15

The materials were tested for CB2 receptor binding affinity and for CB 1
receptor affinity (to determine selectivity for the CB2 receptor). As used herein,

t

"binding affinity" i_s represented by the IC5 value which is the concentration of

.I

an analog required to occupy the 50% of the total number (Bmax) of the
receptors. The lower the IC 50 value the higher the binding affinity. As used
20

herein an analog is said to have "binding. selectivity" if it has higher binding
affinity for one receptor compared to the other receptor; e.g. a cannabinoid
analog which has an IC 50 of 0. 1 nM for ~B 1 and 10 nM for CB2, is 1 00 times
more selective for the CB1 receptor. The binding affinities (Ki) are expressed in
nanomoles (nM) and are listed in TABLE 1 and TABLE 2 above.
For the CB 1 receptor binding studies, membranes were prepared from rat

25

forebrain membranes according to the procedure of P.R. Dodd et al, A Rapid
Method for Preparing. Synaptosomes: Comparison with Alternative Procedures,
Brain Res., 107 - 118 (1981.). The binding of the novel analogues to the CB1
cannabinoid receptor was assessed as described in W.A. Devane et al,
30

Determination and Characterization of a Cannabinoid Receptor in a Rat Brain,
Mo!. Pharmacol., 34,·6o'5 - 613 (1988) and A. Charalambous et al, 5'-azido 6 8
=- THC:

A Novel Photoaffinity Label for the Cannabinoid Receptor, J. Med. Chem.,

14
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35, 3076 - 3079 (1992) with the following c~anges. The above articles are
incorporated by reference herein.
Membranes, previously frozen. at -80°C, were thawed on ice.

To the

stirred suspension was added three volumes of TME (25mM Tris-HCI buffer, 5
5

mM MgCl 2 and 1 mM EDTA) at a pH 7.4. The suspension was incubated at 4°C
for 30 min.

At the .end of the incubation, the membranes were pelleted and

washed three times with TME.
The treated membranes were subsequently used in the binding assay
described below.

Approximately 30 µg of membranes were· incubated in

silanized 96-well microtiter plate with TME containing 0. 1 % essentially fatty

10

acid-free bovine serum albumin (BSA), 0.8 nM [3 H] CP-55,940, and various
concentrations of test materials at 200 °C for 1 hour. The samples were filtered
using Packard Filtermate 196 and Whatman GF/C filterplates and washed with
wash buffer (TME) · containing 0 .. 5% BSA.
15

Radioactivity was detected using

MicroScint 20 scintillation cocktail added directly to the dried filterplates, and the
fi~t-er.plates were counted ~sing a Packard lnstrumenis Top-Count. Nonspecific

I

binding was assessed using 100 nM CP-55,940.
independent

experiments

performed

with

Data collected from three

duplicate determinations

was

normalized between 100% and 0% specific binding for [3 H] CP-55,940,
20

determined using buffer and 100 nM CP-55,940.

The normalized data was

analyzed using a 4-parameter nonlinear logistic equation to yield IC 50 values.
Data from at least two independent experiments performed in duplicate was used
to calculate IC 50 values which were converted to Ki values using the assumptions
of Cheng et al, Relationship Between the Inhibition Constant (KiJ and the
25

concentration of Inhibitor which causes 50% Inhibition pC 50 ) of an Enzymatic
Reaction, Biochem. Pharmacol., 22, 3099-3102, ( 1973), which is incorporated
by reference herein.
For the CB2 receptor binding studies, membranes were prepared from
frozen mouse spleen essentially according to the procedure of P.R. Dodd et al,

30

A Rapid Method for Preparing Synaptosomes: Comparison with Alternative

Procedures, Brain Res., 226, 107 - 118 ( 1981) which is incorporated by
15
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reference herein. Silanized centrifu_ge tubes were used throughout to minimize
receptor loss due to a·dsorption. The C(32 binding assay was conducted in the
-

.

same manner as for the CB1 binding assay. The binding affinities (K;) were also
expressed in nanomoles (nM).
5

The physiological and therapeutic advantages of the inventive materials
can be seen with additional reference to the following references, the disclosures
of which are hereby incorporated by reference.

Arnone M., Maruani _J.,

Chaperon P, et al, Selective inhibition of sucrose and ethanol intake by
SR 14171 6,
10

an

antagonist

of

central

cannabinoid

(CB 1)

receptors,

Psychopharmacal, (1997) 132, 104-106. Colombo G, Agabio R, Diaz G. et al:
Appetite suppres_sion and

weight loss after the

cannabinoid antagonist

SR141716. Life Sci. (1998) 63-PL13-PL117. Simiand J, Keane M, Keane PE,
Soubrie P: SR 14171 6, A CB 1 cannabinoid receptor antagonist, selectively
reduces sweet food intake in marmoset. s·ehav. Pharma col ( 1998) 9: 179-181.
15

Brotchie JM: Adiuncts to dopamine replacement a pragmatic approach to
reducin

the

roblem of d skinesia in Parkinson's disease .. Mov\ Disord. (199_8)

13:871- 76. Terranova J-P, Storme J-J Lafon Net al: lmproverhent of memory
in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716.
Psycho-pharmacol (1996) 126: 165-172. Hampson AL Grimaldi M. Axpirod J.
20

Wink D: Cannabidiol and (-)

t:,

9

tetrahydrocannabinol are neuroprotective

antioxidants. Proc. Natl Acad Sci. USA (1998) 9S:8268-8273.

Buckley NE,

McCoy Kl, Mpzey E et al lmmunomodulation by cannabinoids is absent in mice
deficient for the cannabinoid CSL receptor. Eur. J Pharmacol (2000) 396:141149. Morgan Dr: Therapeutic Uses of Cannabis. Harwood Acader:nic Publishers,
25

Amsterdam. (1997).,_ · Joy JE, Wagtson SJ, Benson JA: Marijuana and Medicine
Assessing the Scie~ce Base. National Academy Press, Washington, DC, USA
( 1999}. Shen M. Thayer SA: Cannabinoid receptor agoriists protect cultured rat
.

.

hippocampal neurons from excitotoxicity_- Mol: Pharmacol {1996) 54:459-462.
DePetrocellis L, Melck D, Palmisa_no A. et al: The endogenous cannabinoid
30

anandamide inhibits human breaast cancer cell proliferation. Proc Natl. Acad. Sci
USA (1998) 95:8375-8380. Green K. Marijuana smoking vs. cannabinoids for

16
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glaucoma therapy. Arc~. Ophibalmql. (1998) feb 433-1437. · Hemming M,
Yellowlees PM, Effe_ctive treatment of Tourette's syndrome with marijuana. J. ·
Psychopharmacol, ( 199~) 7:389-391. Muller-Yahl KB, Schneider U, Kolbe H,
Emrich,

5

HM.

Treatment

of

Tourette's

syndrome

with

delta-9-

tetrahydrocannabinol. Am. J. Psychiat. (1999) 156-195. Muller-Vahl KB, Kolbe
H, _Schneider U,

Emrich,

HM Cannabis in movement disorders.

Kompicmentarmed (1999) 6 (suppl. 3)-23-27.

Porsch.

Consroe P, Musty R, Rein J,

Tillery W, Pertwee R. The perceiv.ed effects of smoked cannabis on patents with
multiple sclerosis, Eur. Neural. (1 997) 38-44-48.
10

Pinnegan-Ling D, Musty R.

Marino! and phantom limb pain: a· case study. Proc Inv. Cannabinoid Rea. Sec.
(1994):53. Brenneisen R, Pgli

A

orally and rectally administered

t:,

Elsohly MA, Henn V. Spiess Y: The effect of
9

-

tetrahydrocannabinol on spasticity, a pilot

study with 2 patients. Int. J. Clin Pharmacol Ther. ·( 1996) 34:446-452. Martyn
CN. lllis LS, Thom J. Nabilone in the treatment of multiple sclerosis. Lancet
15

( 1995) 345:579.

Ma~rer M, Henn V, Dittrich A, Hofmann A. Delta-9-

tetrah drocannabi al shows antis astic and anal esic effects in a sin le case
double-blind trial. E r. Arch. Psychiat. Clin. Neurosci. (1990), Z40:1-4. Herzberg

U, Eliav E, Bennett GJ, Kopin IJ: The analgesic
effects of R( +) WIN 55,212-2
.
.
.
mesylate, a high affinity cannabinoid aqonist in a rare model of neuropathic pain.
20

Ne1,1rosci. Letts. (1997) 221 :157-160.' Richardson JD, Kilo S. Hargreaves KM,
Cannabinoids reduce drypera!gesia an·d inflammation ·via interaction with
peripheral C81 receptors. Pain (1998) 75:111-119. Ricardson JD, Aanonsen I,
Hargreaves KM: Antihyperalgesic effects of a spinal cannabinoids. Eur. J.
Pharma col. ( 1998) 346: 145-153. Calignano A, La Rana G. Diuffrida A, Piomelli

25

D: · Control of pain initiation by endogenous cannabinoids.

Nature (1998)

394:277-291. Wagner JA,
Yarga K, Jarai
Z, Kunos G: Mesenteric vasodilation
.
.
mediated by endothelia anandamide receptors. Hypertension (1999) 33:429.

434.

.

Schue!, H., Burkman, L.J., Picone, R.P., Bo, T., Makriyannis, A.,

Cannabinoid receptors in human sperm. Mo!. Biol. Cell., (1997) (8), 325a.
30

As can be seen from the results in the TABLES, some of the compounds,
for example, AM1295, AM1235, AM1288 and AM694, show a high selectivity
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for the CB 1 receptor. Other compounds, for example, AM2230, AM1289, and
AM1237, show a high selectivity for the CB2 receptor. The inventive analogs
described herein, and physiologically accept~ble salts thereof, have high potential
when administered in therapeutically effective amounts for providing· a
5

physiological effect useful to treat pain, peripheral pain, glaucoma, epilepsy,
nausea such as associated with cancer chemotherapy, AIDS Wasting Syndrome,
cancer, neurodegen·erative diseases including Multiple Sclerosis, Parkinson's
Disease, Huntington's Chorea and Alzheimer's Disease, mental disorders such
as Schizophrenia and depression; to prevei:it· or reduce endotoxic shock and

10

hypotensive shock; to modulate appetite; to reduce fertility; to prevent or reduce
diseases associated with motor function such as Tourette's syndrome; to prevent
or reduce inflammation; to provide neuroprotection and to effect memory
enhancement. Thus, another aspect of the invention is the administration of a
therapeutically effective amount of an ·,nventive compound, or a physiologically

15

acceptable salt thereof, to an individual or animal to provide a physiological
effect.

I

..
_
.
In add1t1on, some of tHe iodide and fluoride containing compounds, for

example, AM694 and AM 1230, are potential radioactive probes which would be
useful for imaging in vivo the distribution of cannabinoid receptors.
20

Further,

azido containing compounds, for example, AM2212, AM2213 and AM 1224,
would be useful as affinity probes for characterizing binding pockets of
cannabinoid receptors.
Those skilled in the art will recognize; or be able to ascertain with no more
than routine experimentation, many equivale~ts to the specific embodiments of

25

the · invention disclosed

herein.

Such equivalents _are intended to

encompassed by the scope of the invention.

18
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What Is Claimed Is:

1.

A compound of the formula:

and physiologically acceptable salts thereof wherein,
Z may be in the 4-, 5-, 6- or 7- position and is selected from the group

consisting of nitro, nitroso, amino, alkylamino, dialkylamino, azido, cyano,
isothiocyano, and phenyl;
X is selected from the group consisting of halogen; hydrogen; hydroxy,

low alkanoate, formyl, amino, cyano, isothiocyano and azido;

R, is selected from the gro~p consisting of saturate·d or unsaturated
straight carbon chains with a maxim'um l~ngth of seven car.ban atoms, saturated
or unsaturated branched carbon chains wlith a maximum length of seven carbon
atoms, cyclic aliphatic rings interconnected to the indole-1 position with one or
two carbon atoms, bicyclic aliphatic rings interconnected to the indole-1 position
with ·one or two carbon atoms, and heterocyclic rings interconnected to the
indole-1 position with one or two carbon ·atoms;

R2 is selected froni the· group consisting of H and lower alkyl;
Y is selected from the group consisting of carbonyl and CH= CH (cis or

trans); and
R3 is selected from· the group consisting of phenyl, napthyl, 9-anthracenyl,

phenyl with no more than two substituents selected from the group consisting
of halogen, nitro, nitroso, amino, alkylamino, dialkylamino, hydroxy, methoxy,
lower alkyl, azido, cyano and isothiocyari~,- riapthyl with no more than two
substituents selected from the group consisting of halogen, nitro, nitroso, amino,
alkylamino, dialkylamino, hydroxy, methoxy, lower alkyl, azido, cyano and
isothiocyano and 9-anthracenyl with no more than two substituents selected
19
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from the group consisting of halogen, nitro, nitroso, amino,· alkylamino,
dialkylamino, hydroxy, methoxy, lower alkyl, azido, cyano and isothiocyano.

2.

The compound of claim l, wherein Z is in the indole-6 position and 1s

selected from the group consisting of H, N0- 2 , NH 2 and halogen.

3.

The compound of claim 1, wherein Y is C = O.

4.

The compound of claim 1, wherein R 1 is an alkane with a maximum length

of seven carbon atoms.

5.

The compound of claim 1, wherein R2 1s selected from the group

consisting of H and CH 3 •

6.

A method of stimulating a cannabinoid receptor in an individual or animal

comprising administering to the individual or animtl a therapeutically effective
amount of a compound having the formula:

z-0-1Y-R3
~:_)lR
.
N

2

I

R,
I
X

and physiologically acceptable salts thereof wherein,
Z may be in the 4-, 5-, 6- or 7- position and is selected from the group
consisting of nitro, nitroso; amino,. -alkylamino, dialkylamino, azido, cyano,
isothiocyano, and phenyl;
X is selected from the group consisting of halogen, hydrogen, hydroxy,
low alkanoate, formy.1, amino, cyano; isothiocyano and azido;
R 1 is selected from the group consisting of saturated or unsaturated
straight carbon chains wlth a maximum length of seven carbon atoms; saturated

20
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or _unsaturated branched carbon chains with a maximum length of seven carbon
atoms; cyclic aliphatic rings interconnected to the indole-1 position with on~ or
two carbon atoms, bicyclic aliphatic ririgs interconne~ted to the indole-1 position
with one or two carbon atoms, and heterocyclic rings interconnected to the
indole-1 position with one or two carbon atoms;
R2 is select_ed from the group ~onsisting of H and lower alkyl;
Y is selected ·from the group consisting of carbonyl and CH= CH {cis or
trans); and
R3 is selected from the group consisting ·of phenyl, napthyl, 9-anthracenyl,
phenyl with no more than two substituents selected from the group consisting
of halogen, nitro, nitroso, amino, alkylamino, dialkylamino, hydroxy, methoxy,
lower alkyl, azido, cyano and isothiocyano, napthyl with no more than two
substituents selected from the group consisting of halogen, nitro, nitroso, amino,
alkylamino, dialkylamino, hydroxy, methoxy, lower alkyl, azido, cyano and
iso~hiocyano and 9-anthracenyl with rio more than two substituents selected
from the I group consisting of halogen, nitro, nitroso, a min~, alkyl amino,
dialkylamiro, hydroxy, methoxy, lowe·r alkyl, azido, cyano and is~thiocyano.

7.

A compound of the formula:

and physiologically acceptable salts thereof wherein,
Z may be in the 4-, 5-, 6- or 7- position and is selected from the group
consisting of halogen, hydroxy, methoxy, and lower alkyl;
X is selected from the group consisting of halogen, hydrogen, hydroxy,

lower alkanoate, formyl, cyano, and isothiocyano;

R, is selected from t·he group consisting of saturated or unsaturated
21
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straight carbon cha'1ns with a maxim·um· length of seven carbon atoms, saturated
or unsaturated branched carbon chains with a maximum length of seven carbon
atoms, cyclic aliphatic rings interconnected to the indole-1 position with one or
two· carbon atoms and bi cyclic aliphatic rings interconnected to the indole-1
posit.ion with one or two ·carbon atoms;
R2 is selected from the group consisting of H and lower alkyl;
Y is selected from the. group co_nsisting of carbonyl and CH= CH (cis

or

trans); and
R3 is selected from the group consisting of phenyl, napthyl, 9-anthracenyl,
phenyl with no more tha.n two substituents selected from the group consisting
of halogen, nitro, nitroso, amino, alkylamino, dialkylamino, hydroxy, methoxy,
lower alkyl, azido, cyano and isothiocyano, napthyl with no more than two
substituents selected from the group co_nsi?.ting of halogen, nitro, nitroso, amino,
alkylamino, dialkylamino, hydroxy, methoxy, lower alkyl, azido, cyano and
isotbiocyano, and 9-anthracenyl with no. more than two substituents selected
from the group· consisting of halogen, nitro, nitroso, amino, alkylami\no,
dialkylamino, hydrox!y, methoxy, iower alkyl, azido, cyano and isothiocyano.

8.

The compound of claim 7, wherein Z is in the indo!e-6 position and is

selected from the group consisting of H, NO 2 , NH 2 , N3 and NCS.

9.

The compound of claim 7, wherein R 1 is CH 2 and Xis a heterocyclic

structure.

10.

The compounq of claim 7, wherein Y is C = 0.

11.

The compound of claim 7, wher~in R2 is selected from the group

consisting of H and CH 3 •
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A method of stimulating a cannabinoid receptor in an individual or animal

comprising administering to the individual or animal a therapeutically effective
amount of a compound having the formula:

z~Y-R3

~-·.)lR
N

2

I

R1
I
X

and physiologically acceptable salts th.ereof wherein,
Z may be in the 4-, 5-, 6- or 7- position and is selected from the group
consisting of halogen, hydroxy, methoxy, and lower alkyl;
X ·,s selected from the .group consisting of ·halogen, hydrogen, hydroxy,
lower alkanoate, formyl, cyano, and isothiocyano;
R 1 is selected from the group consisting of saturated cir unsaturated
straight carbon chains with a m aximum 'iength of seven ca·rbon atoms, saturated
1

or unsaturated branched .carbo~ chains with a maximum length of seven. carbon
atoms, cyclic aliphatic rings interconnE;ct~d to.the indole-1 position with one or
two carbon atoms and bicyclic aliphatic rings interconnected to the indole-1
position with one or two carbon atoms;
R2 is selected from the group consisting of H and lower alkyl;
Y is selected from the group consisting of carbonyl and CH= CH (cis or
trans); and
R3 is selected from the group consisting of phenyl, napthyl, 9-anthracenyl,
phenyl with no more than two substituents selected from the group consisting
of halogen, nitro, nitroso, amino, alkylamino, dialkylamino, hydroxy, metho·xy,
lower alkyl, azido, cyano and isothiocyano, napthyl with no more than two
substituents selected from the group consisting of halogen, nitro, nitroso, amino,
alkylamino, dialkylamino, hydroxy, methoxy, lower alkyl, azido, cyano and
.

.

isothiocyano, and 97anthracenyl with no more than two substituents selected
from the group consisting of halogen, nitro, nitroso, amino, alkylamino,

23
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dialkylamino, hydroxy, methoxy, lowe·r alkyl, aiido, cyano and isothiocyano.

13.

A pharmaceutical preparation c;ntaining a th.erapeutically effective amount

of a compound having the formula:
Y-R 3

OO

z

N . R2
I

R1
I

X

and physiologica_lly acceptable salts thereof wherein,
Z may be in the 4-, 5-, 6- or 7- position and is selected from the group
consisting of nitro, nitroso, amino, alkylamino, dialkylamino, azido, cyano,
isothiocyano, and phenyl;
X is selected from the group consisting of halogen; hydrogen; hydroxy,
low alkanoate, formyl, amin~, cyano,__is~,hiocyano and azido;
R 1 is selected from the group consisting _of saturated or unsaturated
straight carbon chains with a maximum length of seven carbon atoms, saturated
or unsaturated branched carbon chains with· a maximum length of seven carbon
atoms, cyclic aliphatic rings interconnected to the indole-1 position with one or
two carbon atoms, bicyclic aliphatic rings interconnected to the indole-1 position
with one or two carbon atoms, and heterocydic rings interconnected to the
indole-1 position with one or two carbon atoms;
R2 is selected from the group consisting of H and lower alkyl;
Y is select_ed from the group consisting of carbonyl and CH= CH (cis or
trans); and
. R3 is selected from the group consisting of phenyl, napthyl, 9-anthracenyl,
phenyl with no more than two substituents selected from the group consisting
of halogen, nitro, nitroso, amino, alkyiamino, di'alkylamino, hydroxy, methoxy,
lower alkyl, azido, cyano and isothiocyano, napthyl with no more than two
substituents selected from the group c~nsisting of halogen, nitro, nitroso, amino,
24
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alkyl amino, dialkylamino, hydroxy; methoxy, lower alkyl, azido, cyano and
isothiocyano and 9-anthracenyl with no more than two substituents selecfed
from the group consisting of halogen, nitro, nitroso, am·,no, alkylamino,
dialkylamino, hydroxy, methoxy, lower alkyl, azido, cyario and isothiocyano.

14·.

The pharmaceutical preparation of claim 13 wherein,
Z may be in the 4-, 5-, 6- or

7.-

position and is selected from the group

consisting of halogen, hydroxy, methoxy, and lower alkyl;
X is selected from the group consisting of halogen, hydrogen, hydroxy,
lower alkanoate, tormyl, cyano, and isot~iocyano;
R 1 is selected from the group consisting of saturated or unsaturated
straight carbon chains with a maximum length of seven .carbon atoms, saturated
or unsaturated branched carbon chains. with a .maximum length of·seven carbon
atoms, cyclic aliphatic rings interconnected to the indole-1 position with one or
two carbon atoms and bicyclic aliphatic rings interconnected to the indole-1
position with one or two carbon atoms;·

I .

R2 is selected from the group consisting of H and lower alkyl;
Y is selected from the group consisting of carbonyl and CH= CH (cis or
trans); and
R3 is selected from the group consisting of phenyl, napthyl, 9-anthracenyl,
phenyl with no more than two substi_tuents selected from the group consisting
of halogen, nitro, nitroso, amino, alkylamino, dialkylamino, hydroxy, methoxy,
lower alkyl, azido, cyano and isothiocyano, napthyl with no more than two
substituents selected from the group consisting of halogen, nitro, nitroso, amino,
alkylamino, dialkylamino, hydroxy, methoxy, lower alkyl, azido, cyano and
isothiocyano, and 9-anthracenyl with no more than two substituents selected
from the group consisting of halogen,· nitto, nitroso, amino~ alkylamino,
dialkylamino, hydroxy, methoxy, lower alkyl·, azido, cyano and isothiocyano.
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HOUSE JUDICIARY, RULES, & ADMINISTRATION COMMITTEE
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Tuesday, February 15, 2011

TIME:

1:30 P.M.

PLACE:

Room EW42

MEMBERS:

Chairman Wills. Vice Chairman Luker, Representative{s) Smilh(24), Nielsen,
Shirley, Hart, Bolz, Ellsworth, Bateman, McMillan, Perry, Sims, Burgoyne. Jaquet,
Killen

ABSENT/
EXCUSED:

NONE

GUESTS:

SEE ATTACHED
Chairman Wills called the meeting to order at 1:30 p.m.

MOTION:

Rep. Bolz moved to approve the minutes of February 7; motion carried oh voice
vota.

MOTION:

Rep. Burgoyne moved lo approve the minutes of February 9; motion carried

H 119:

on voice vote.
Debbie l=leld, Office of Drug Policy Director, presented samples of aroma-therapy
bath sa.lts and the "bath salts" synthetic drug sold in smoke shOps as sensuality
enhancers. She explained the ingre~ients in each sample of the bath salts were not
for ~uman consumption. However, the small samples from the body shog, were free,
wh1fe the equally small container of designer drug from the smoke shop old for $35.
Corrina Owsley, Idaho State Police Forensic Chemist, provided the committee a
chart showing the molecular structure of the compound found in the smoke shop
bath sails. She explained the process used when creating the variations of the
drug. Ms. Owsley stated that manufacturers qh11ply substitute cathinones to the
existing compound in order to make them hallucinogenic.

1

Darren Hurst, School Resource Officer for the Meridian School District, stated
thal he had seen the long-term and the shortw term effects of lhe "bath salt" dn.ig.
The user exhibits a racing pulse ~nd dilated eyes (even 24 hours after ingesting
the drug). He stated the user may also show an increased aggressiveness toward
others. Mr. Hurst explained that the long term effects included addiction, dropping
out of high school, or becoming a ward of the stale.
In response to a question on ways of using the subst~mce, Mr, Hurst explained that
users crush the ingredients in order to smoke it or to snort it. They also eat it. He
slated that most teen users did not have the knowledge or tools to melt down the
ingredients and inject with a syringe.
Diane Anderson testified before the committee in opposition to H 119. She
stated that she preferred public education to legislating bans. She said taxpayers
could not afford the costs involved with legislation and enforcement, and that
instead, parents should teach their teens about personal responsibility and the
consequences of personal choice.
Col. Tim Kelly, Idaho National Guard, testified before the committee in support
of H 119. He stated that the misuse of drugs continues to be a problem within ihe
military. He also stated. that twenty five percent of applicants for the military are

ineligible because of drug related problems.
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Lt. Col. Don Weaver, ld.<1ho National Guard, exJ'.)lained the drug r<Jlated affects on

~na

mt¾i:pti11r~ of _the )hil!ta,iy
m,e1rJ,unIU~s.· H~ _91i~~eVp!~ln~q thaJJ11~ trwfana (he
!esq~n;~~ \J~~cl ~Ytb(mlljtaryJ~- h~lpLrTg),?diyi~~er~y{ilh aw~1;te!~t~9 prppJ(3ms~~ci,
mi;;re~~~d: ~~- Slij~~q t,aa,t ~_tl?,p8f,W the ~~Ve of.d~§Jqri~r ~f~f[S ~y t~gl~!§fip11 ~.~s1sts
the m1!1tary in keeping those clrllgs out of the hands of soldiers .:ind their famll!es.

HE!lfn Huff, ld~ho Society of Additive Medicine, encouraged committee rnembers
to supp~rt
H 11s.
,< '
MOTION:

H 139:

~-~Pi NI~ls!3H mov€!g !6 ~~nd H 119to thp flciQIWjth apo fA?~ recomrrien_dation.
Motion carried Ofl Y'5ice vote. Chajrmah Wi!!s Will sponsor the bill oh the flcil)r.
Qe.bbif) Ffold, Office of Pn.lg PqliCY Qireptqr, explained that H 139 would make

paim~flel1t the ban on th~ deiigl\er drug "Spicl3."

Corrtnq PW.{>ley, lcJ~tw§fate Ppllp~ For~l}siq Ch~rQist, providEld the comrnmtle
a diaJjl.J:llll Whiyh f~1iturE:Jg. the liiOl€lRVlaJstr1Jc~µrEi o( the qE}V~ii corppounsfs which
fct!J,) t~~ ~icBtipqe pf ~P]Re, Sh~ s_t~teAtf!'~t lb~e Cc,>!I}QiO,~Ji.qhs Wi?re ori.glnally
deY~!£iPefl by ph;ar9111c~11Jtcpl c;9rnp~N1s !:iYUh1.Y niXf r b~yarrfe a, $UG~ssful
pr1;;~crigti_9n dr,µg. Ms, ow,;;Iey also,:e:l(plaJned ttiat ollly orie carbon made the
difference In all of the sub$1.;anc,e variations.

Mf.

1nx~·spq(l~yJ9 9 q~~§_lipn
ow~!~ysta.t139 th;:it th~ seven C!.flSSes ofcompoynd~
li~!~~J?}J 13~ §.~9(J11,f~fe~Jt ~~"'!!tlJ~t~JI~, St!li~ti~g pj:f~~Jbl~ c!f~~lf1l}$ t11<lt ~qµld be

S!:JQ~~l,~J~dJ'.)¥~~8~~-'-:tlSPJJ;l,~- !9,"~~k~Jn.e.sp,19.~d1te 1n1.g").n,:~~~1J1on sh~ assllred
the CX)IJ)Jl\lltee that (\Jlure legh,lat1ve ~~hoh ~l;lo.uld l:>e unne'.cess,:iry.

the,14~1

I;::,(g~utiy ·· · ··· ctor of
~oar<t of Ph Elf'1)ElRY,;asked
tne ~ornroiftee to lffij~e pe
Jtn~.Mminl~tra:tive·rule ruunt!':i ~ffett by the

M~t~ ~cib:filfori,

0

~oxtmi~~~:ic1itst~!-L~gifi~~/t~ti~i¾t~ thilffhe temppr'.ary

rule expires I

TamrnY deW~td,. l'/lgyor Q~ E~I~. l~a~6•. apfi~f¼f0~ bef9rfthe CO!Jlll}itt~e to
a~fwer ilJgi}It~ri;leQa!fl!ng a~9~ticm,?f o{t~@}e~ ~g~-~t ~j1e ~-'1~ ,of ~~.ice. She
slm~d ~h~~ a _t191J_9JPI oJ ,1£Jll?, ~wrs p,ai:l .~1'?:~~;~ 9.i;.g1m1~~~: to a.~~~lfLfhJlf Jl:lw
enJorcement offiqers w~o were encounte(mg lricreased cases deahng with the
illegal§ub§fonce. she' sfated ·t11afotker bitlfs w~r~ w~iiing f9r tl1is.legi~iaUon.
MOTION;

R1;1p.

Bolt moy~d to se~a H 139 to the floor 0ith '.a DO PAS.SrE,!QOrnmendatlon.
~ui<lr w11fspcmiir ilj~ bili'«fn the "tfock

Motton carifoa' on voice vot~. Rep;

Cf1alrman WIUs turned t_he meeting Qyer to. \li~e Ch~irrpan Lukef.
H 121:

R~p. ,1?uf9,9yne ~xr111p,~d t~Jh~. W!]i.i;i'.'iW~ th~.tH 1if ~~~}ln ~ff9rt _tCl c~rt~ct an
1~81. lqa!lq la"X,. H~ st~tE!P U,ie .bill pr?v19es f9r egu~ tr'e§!JrilerJ cif R(>lh. nusl:lanas
ariq wNes,l)'y 'proyicJiog U'lat th~ir ~epfi,f~tfl prop~rty rn_ayr1Qtbe 9ej~eitto sansry the
sepi!i-a.Je debts ofth~r ~pouses\ He stited, Jh.at the proJfo~~q ligi~l~tion natrows
the oefinitiori of separ9 te propMy in order to be consistentWith current law.

MOTION:

Rep. Jaquet moysd to sencl H 121 to the ~oOr with a PO PASS recr.iinmenclation.
Mo~lon carrfod on volce vote. Rep, Btirgoyne will sponsor
bill on the floor.

S 1014:

t~e

Sen1 parrh1gt9n P,Jesented S 1014. He explained that the legislation concerned

rape by substifutioh,
Hofly l<oqi~. lqrij)q 8r:osetuliqg Atton,eyi; f\5s9clation, explainedJhat an Ada
CqiJfilY 4th ~1,s'trictJM'pge'tlJsJ'1i~~ed aca~e,bftca~se i;if a l9Jipfi~le in the {aw
re~rsJJlig SJ!<fili:SI r~~- Tne £µfr~nt lay.i st,a,tes ''h4sp.<!,fld"; hot ' i:~Xf[ien9" or
"P&rlnlilr,11 She stated !ne .law needed tq be c!,~rigeg to re~ect societal changes and
said any rape Where a partnef is enticed and then deceived should be considered
rape by substitution.
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S11r~h Scott, AttorfleY for lhe ld,;;iho Coalition Against $exual ancl pomestic
Viol!3n<;e, and liannah Brass, American Civil Liberties Union, testified in support of
S 1014.

Diane Artd\1r;:;on stated tbat d9sJng one fo.BphqJe would open another loophole ill
another cotirt case. She stated that this blll and others like it gives pbvier to the
pwsecutirigatto'rneys. Sh{e}press~d coricei-n
the huge 6orde11 on
taxpayer.

for

the

Fairy Hltph,ggp!(, ljitchcoc~Fafhjly As~oclatf;is, al$9te~@M~Jjn(:lt,fhe bill'. She
sla!$3<1 {he pill ¼',OU!~ not help tllose who
lt. $he. 9lscfsw~ that per$6l1~1
e~r1ehce w,ith the courts had given her reason to believe they do not listen to a

ne""d

vicffm pf ,ape.

.

Jean F1$Mr, Deputy P1osec1J!Qr, testifi~g that rap$ by sobstitution is more common
than the ·1;1erteral p{Jl:ilic might assume. She s·~ppoftecl S 1014.

MOTION:

Rep. Bateman move<J to sends ,1014 to t]lElfloprwith a Q9 P.i\.SS recommendation.
Motion carried on voice vote, R!;!p, Kllleh will sponsor the b'ill on the floor.
Vice Chalnnan Luker turned the meeUng back to Chalrman Wllls.

S 1029:

Kevin K:~mpf, Oypqliment of C9rrect!pn, ~xplaine(j S 1029 arn~nds the peace
officer aµlhbrity statute. This change wot.Jld exten(l.peace officer status to

Board-d~si{in~tf {~aho OeR~rtn1ir:i! 9f£;<.irr~c\io9· etnpl~yf!,;~·pre}:efnt dudng times

wha,I) laW.~.DfQr,g~TY1$Ht~eeg~ try~Jr,a.~~1~~1rce,. Mr'. Kyf:lPftt~ied,lj,~ mp~ndment
wo4Jd be aBphcabl~ only to those employees wtw have Pt:?pce pfficer trairnng.
~.eP.. KUlen. moveci to sen!tS 1Q29 to the fl9Clf}Yi{h a DQp~~§ recom,m\:!ndation.
Motign c~rrjed i:>ff voice yote. l{ep. '3,.(}lz will sponsor the gill on the floor.
2

MOTION;

S 1030:

Shane, r;,va,ns, [)epg,lin'le~t of G~tri.=lc!ioo, sli'ltst<LS 1Q~b a~g~q l(l!19U?ge to
exis!jng. !~fio C9cfe, '§Er~tlo!i ZO;~O~: fq pJ~y$!~ "!n~t Jhe 9~@rJfnenl ni.~Y provide
rE'lh@~UU~Uv~ l>eriticel5Jcfsyij~ort s~J~. hJ~n@~aj~rQf J~giJifl~s. Th~ bil! al~<t
addfe~ses ~afe a.rid effecUve reint~ralion of offenders lnto Idaho corrilrl,unities.

MOTION:

Rep ..J~qiet rpove;:I to s.end 1 Q~Q to thE! n9or w1th a DO PA$$ f~CQt,1rQef)dation.
Mo'tlon 4afrieq on voice vote. Rep. Jaquet Will ~pr;ilisor the !:>ill on lh€1 floor.

S 1031:

Brf111t R~ll)ke, D~partrnE)~t

s

pf Cori:egtl9n Director, expla!n~<ithat S 1<f31 is
a J~9rn1c~tror~~H~Pn .toJ~flffot wet~ifhq pe,~~rtmi~t. 9f1§fJ;E':gEin'.s cRtl~~t

OJ!Jj~~~,lJ9~fl,tlf~9JW~ fOJ. !¾~!!!Pt ~:!flPIPXttr~'. y9_rr~pt l,a~.d~p[l~Jt~Jefl'lpt
eir\Rl?Y~]!~ .iu nµme;ng d~t~v!.-, T~r ~trlf)ncirne.q~ sJr/k~~ ~H~DC "f}l,!!~S f~qrrtJpaho
Cotf~•• Section §7-~:iQ3, syb~!a\;JJQH "r",

Mr.. Re!rl~e sJ5'le~ th~,t ~Jrlc~J!ie l;:!W )X~S

~riJei)ieiVr,4QQi, tn~ nurn~~r of ~f;}p~ty-~gmihi~t,~Nt~ ~iJ~'?,~_Qiiii~ft~t§f~(~ilbin
the d~partq,,~11i !19s cpanged nome.rous times, most recently with the deletion of
a deputy ~aministrator.

MOTION:

Rep. Jaqyet moved to send S 1031 to the floor with a DO PASS recgmrriendation.
Motion cafrled on voice vote. Rep. Perry will sponsor the bill on the floor.

S 1008:

Mlchaf!l. l::hmcj~Wse>.n, lda!)o Supmme Court J..eg~I Courisel, explain~d .that ttie
propo~~cl l'¥~!,J9Mn would ~i;11inq lqaho Code, S:$ftiqn 1~~12. Jhe change would
ma_ke ~!.fhs]~!e'ntJ~e aririu?J J~pt5rt_s fr9m tqe Admjnlstra.tive Director of the Courts
wlth tne~ rep~qs from gthe(~J~tfa,g~ncles by making them due at the end of the
fiscal year instead of the cal}mdar year.

MOTION:

Rep. Jaquet moved to senq S 1Q08 to the floor with a DO PASS recommendation.
Motion carried on voice vote: Rep. McMlllan will sponsor the bill on the floor
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Mfop.3el Henderson, ldallo Supreme Court Leg.ii Counsel, explain?d the billJvas
one of a series of qills suhrp]itid by tl1y S~P,[~tpe ~ourt lq c9Ject 1'.1@fect~ i.n trie
law. It \'/OU!~ corr¢ctan anfiq-ua[ed statute. which Stl:¼tes:. ''WMn c!Vil case is filed.

a

each defenoant musfbB $erved wiU{a GOrriplaint and sµmiffohs? Mr. Hen~~rson
cbnHJµeei to explafn by $faff\g ffie f9Jlowfpg: t?pU_oif 5:5pfbf the ld<,J!Jp cQq{;, was
eriacieg in 19Q7. On~ pf Its prov)~ign*l}t~f~~ t~::itjf a de;f<1l)q1mt is ouf of9\tilti¼,

and !f11ji; address Is khQWil, ~he p!~)ntiff c1:m get an qrperJrqm trie court allqwing
th~ gefendani to be servid owt¢f $f?tii irutin 1~61,llsfh6 aqo}ifeg? ~jong arm"

stflt!JJ!r" This st~Jp\~. ~~ptlon $~514, )ta!es t11~t Jg~h~ p9t1,~f Q~ifj'Wspip![p.h o_ver

a pfr$on 9r ~ c.RtnP~IJYth?t dQes b,Qsl[ies~ 1n ldahp, 0V;1n_$ pro~@rty mJclafio, pr
'do'~s some ofheract that for'rils -lhe pasis for a lawsuit. .The n~xtstatute~. secUon
5:515 I sf~te~ tha( the
vtlib ar~
of
the courts untjer SeQliof\5-514 can b~ §-~rved out or st?°te,
I@ a.?opfioh
of the§,e statotes, $$[Vll)t) a pers_pn oyt 9f, Sl?J0 wh9 (ajl~ v,ithin tli~}urisajcFon
of Idaho's courts no longer requires a couft order. But the langul'ige ()f Section
5-56fsllfl lec1ds some p~op/e, including some laY.,Yers, to-thin~ that~
order is
nece"ssary to serve a defendant who is out of state. Mr. Heffderson concluded that
S 1009 would r~inove this corifusion.

pe,rso~~ or-comp~ntes

l>\1tJepffo)6'fluIT§if19liQn

13ecau~e of

coutt

MOnON:

Rep. Luker moved to send S 1009 to the floor with a DO PASS recommend?tion.
Motton carried on voice vote, Rep. Nielsen will sponsor the bill on the floor-

ADJOURN:
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MINUTES

SENATE JUDIC(ARY & RULES COMMITTEE
bArE:

Wednesday, March 02, 2011

TIME:

1:30 P.M.

PLACE:

RoomWN54

MEMBERS.

Chairman Darrington, Vice Chairman Vick, Senators Davis, Lodge, McKague,
Mortimer, Nuxoll, Bock, and LeFavour

PRESENT:
ABSENT/
EXCUSED:

NOTE:

The sign-in sheet, testimonies, and other relsted materials will be retained with
the minutes In tne commi!tee's office until the elld of the session and will then be
located on file with the minutes in the Legislative Services Library.
Chairman Dartlngton called the meeting to order at 1:35 p,m.

MINUTES

Senator Nuxoll made a motion to approve the minutes of February 23, 2011 as
written. Senator McKague seconded the motion. The motion carried by voice

vote.
RS 20140C1

Re{atlng to Security for Compensation (from the Commerce and Human
Resource Committee)

MOTION:

Senator Davis made a motion to send RS 20140C1 to print. Senator Lodge
see-0nded the motion. The motion carried by voice vote. I

CONFIR~ATION

Chairman Darrington stated the committee would vote ory the recommendation
to confirm the reappointment of Olivia Craven as Executive Director of the
Commission on Pardons arid Parole to serve a term commencing January 3, 2011
and expiring Janl!ary 6, 2016.

MOTION;

Senator Lodge moved to send the gubernatorial reappointment of Olivia craven

as Executive Director of the Commission on Pardons and Parole to the Senate
floor with a do confirm recommendation. Senator Nuxoll seconded the motion.
The mo'tion carried by voice vote.
CONFIRMATION

Chairman Darrington stated the committee would vote on the recommendation
to confirm the app6lntment of Norman "Bud" T, Lahgerak II to the Commission
on Pardons and Parole to serve a term commencing February 5, 2011 and
expiring January 1, 2014 .

MOTION;

Senator Mortimer moved to send the gubernatorial appointment of Norman T..
l.angerak II to the Commission on Pardons and Parole to the Senate floor with a
do confirm recommendation. Vice Chairman Vick seconded the molfon. The
motion carried by voice vQte.

H 121

Relating to ExempUons from Attachment - Representative Grant Burgoyne
explained this bill concerning Idaho Code 11-204 which relates to execution by a
creditor with a judgment against a debtor. Representative Burgoyne recounted the
history of I.C. 11~204, summari~ing that In 2010 it was ruled unconslitutional by the
Idaho Supreme Court because It was not gender neutral. He stated when it was
originally written in 1888 it was to protect a wife's property from the separate debts
of her husband. He explained that H 121 will correct the gender inequity of I.C.

11-204, protecting both husbands and wives from each other's separate debts.

000217
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s~n~~or S, ock maqe .:i m9tion to SfJl'\q. H 121 to the floor witp a do pass
recommendation. Senator Davis seconded lhe motion. The motion carried by

vof9~\iote.
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R?l~!li:i~ to.lJpiform C9ntr9Jled §~bsJ~~c¢~: ~~th~~,~ - Oeb~Je Firld,Jrom
the lq~h<>9ffice of prug p9J1cy, sumrnanz.eq H 11~ as a l,)JII th.aty,i1II plpce the
drtig~ t1?rr!Jt1d .·~.\> ''b?tb M!tf it $ydiQn tPrug. {vt~. Fi~!p e~pl~lned the n~eq for
I~QijlJUl'.lQ~n~ Mttfer ot!fi~ed.Jfrat.bfl18~ta~~ ~r~jioJir"J ~Q¥ 1~¥tD~ s~111e _Pcrncluct
sol9 <!S ar9matnerapy hatb s<i!ts,. $fl~ po1nJ~ 04t.th?t the ffi9nuJactµr~r~ 9f this

a,~

0

def:'iig6ef «rug are" tfying to ci(~t:imv~rit th\fr~gul~.UQD~ 1m coj)f(olf~d suhga.nces

and ares~ld.as b~th $al~ or fe'rfmters, bulhotlMended tobe Used as'e]ther. Ms.

Fi~if~_uni'ili~r}ze.d~&e r?tirPo}g. ~~I"Iib;jiiig, ~viffa:B]llty an~ c§wmonJnQi~~ients.

Sh~. t.old .~f ldahs> ci,tiiens th~t Mve recently ~led :Orar~ ip criij<;:al C,Qllmtiqn due
to u(e of tbjs Pt§:tjuct, which alJa.cy;s fl;i,e (;entral nervous system. $he further
indicated fhe ability of ISP to analyze these substances in the forensic laboratory.

Vice ~h~lnJ1:,,11 Vic~ gue:;ti.9nt3,~ co11cerringjt,ie name .and legiUmate yst1 of "bath
sart~tJvrs. f:l~!dJeseo11qy~ inciica,tLngJier rese.¥xh and ~gyca\jon has reve~led
th9t{,hjsJs l:in lru;redi!)J~.PJ~r~~t!.nfl .~tfat~gy. Cq,rrin.tQ'4'sJ.ey, Ch,~!Jlist for the
ldf!h9 Sf~!y P,9H~e, yia t~l~fi:ll~fW~~c.e, iri,dicated there .8-fe f1.Jt:np~O(itj9 iri the
ingrepi~J'lts that are alre,i:idy on Schf~i.lle 4.and 5 ana unstheduled Buproplon !hat
has a legifiniate use requjring a prescription.
.

Chattm.:..n Darrington asked if anyone was present who would like to testify

TESTIMONY

!-) iJppq~i!fOn.
.
.
. RX<lfl Hi>f<!i!W~Y,. oJe!tch~r t HQlda\Ya,y; p~~c. repr\:lS!:lflJjng HQrb lr,icensf,'l
~.~ia
. "'A
.... J.·1.·v·. · ....d ·.,,1···p·.
~. .tri.~}J.. rnei:lic;;in?J
tifigt s.]>·o•. ~.~:i?~W~~~~
ifi...o·· P· ·.p.,o· ·s.thatft
·j· ·.tip·,·.··D····!o.•.· IJ.1J·9
~.c.·..·.1~qg'
tlJ·a····.·.··J
. ·. ·.J·f·.· · <:l· ·n·.Y.io.~ t.<>.th·.nst
e
ii:f J1~l~rjJs
go i.~~y@
· ..fiot
te.
appJ;gR·rip
tfi ,f!l, ~s ,a S~h\:)gUle 1, ut ¼list. tli~li1 as a €~ ,.le ,3 - 5. .S,t)n~t~r ·. gel<
qtJ~li?IJ~~ yt~o_!:,'1.r, l:l.
) reRf~§~tt?f N,lr. Ho!ct,~_~.iX J~~eJu~d A~.se
pr1:1,v.19µ~lyrn1:mt1oneq I ' . ng ~ElJx '
ts otn~r m(!J~!QU,ats .i:mg PU,Sll}6S,Ses
f·••

~irf~J9f l?•IY:l§ ' ...

V(it~.~:po!l~'tW@ irtfrest

tnat,~f\Ya':;' ; ' C '· ' . to .n!!\D?,
i9ned
wt)af ttie.1.a'.'M!-Jl, Of>n-llfe;tbnmtenlng purpo§es s:>f b~th salt,,~ere ang .-. , ttter

he, pr any;{:>~§if!8S~~s iO ~f~fta Wefr .',••, 1)9 Mlf~~.a~·~tfc;li!N,&s J~) baiJl~ IY!r,
Holdawa,f,/,,¥,-:-------_f~-~-.-,.;,,._,·,
referred to Ms.
Field's ctr
tsttlat it was 'a concentrated tof tn
.
-?-':->"~~->-;<~': -:of~~!h ,§a[r ~n9Jh~t fii~(clJ~hts !rt to C,gQfQrr,iJ'{llh tf!~ l~w. by eJ)fC>rcing age
,;·"'.'~;:-_'!(':;"-,-"

._f

~---,-·-

'7•

·-:-~

~,,,_"'"

,_

·-5_·:

·'.<"

·.''-".1--~,-,;;::-,;.·:~!-'-Jt,

:"A_·.. •

r~~@!ti9J1 r~1fuirt3lileritf H(3 furt.fi~f' st~ti;ir;L (ha,t his cli~~'tf~ry to prevent at,u(';e
of ttf~itpfQ9tj~tS::ln{:I that he h~<;i n~Vt3fus~'q fhe product nor was aware of any
bJJsinessthatused them as additives toa bath.
Vic~ Chalrm<1n Vick qu~~tjonad,h()W.lon9 JhisJ:>.rpduct has be~n p;gciuced and
sold .hi this ar~a andmore spet.i{ica!ly MW lohg Mr. Hqlgaway's clien.ts produced
th~Ib- ~r.. H9fda}"~:f J~nswe,fed h_e dig noJ h~Jea_D ex<1<:\ ~ate b~t t~at the
progict h,a~.9a.Ln~d ~e~~Qt p~pul~rity a11,cJ.that2is,cliei'lt, Her!J ln9~l!:· h?s been
inanc,itac:t1,1rmg the prb~lJct.s Slt)Gt3 Qc:tp~~r. ~ena,tqr LeF.:tV9LJ,r qU~J31!oned the
ph slolc:t . ~ff¢cl ofJl)e Px.Pducl Mt Q)r~l~ya~t§'(V~redth~t r~s~ar9tum the
c
11 .Jc~ti;i NUy~iri9gi:i11Jc ptop)rtJ?¥ ~'ts. Fl~l9 tnvrrier~t~q)uryier side
e.. . .... enator Bock quesuon~d Ms:· Owsley cont:erninif Mr. Holdaway's
f~~ ·ie~fff~~t!;!
l~lts.
ccfmpounds
m}h1s ~YCJllJgfJ.~ dr0g ~ri.;?
1'i9rt)'tally fyiurit=f In tr~tjlt.I~q~I ~ath s;:il~. h?Y:~ ne> odor
and when placed in 11:!rge·
of water w.o0ld have
arom~therapy effect.

!ei!iVJpnfcff

M!rAc/~i·or~~~

no.t
a volume

ey,n,)tf~iiuetJli~ttJ,e
no

TESTIMONY

Jan Sylve~ter of Meridian, mother of two teenage girls and OJfi,cer Darren
Hllr~t, Meridian Police Department and SRO for Mendi$n High School spoke in
support of the bill.

TESTJMONY

Mike Medoza, a e-0ncerned citizen, spoke In opposition to the bill.
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STATUS

Recei lied

P. 3

S~natot baVl:S que~tion9,{i c~mcer11ing Mr. Hokfpway's position, cli~Qfs length
of time Jn l?Ys.ine~s end, 9ther procluct~ sol~ by h,i_s c.lien,ts. M.r· Ji(;)J~efw~y
an~ereq trif!t hJf;> client's CQrnf)finie~ h(:ltj .El):i.!lt~d pr.evi~ysly uM~r 9th~( r:rnmes
and fti%,t pro,Qd6tsjold ~d~ifiq6?llY vi~ffpipei~hd
'{if~ Ch~~Iffllc\fl Vick
qy~!i9.Q~d now19f!µ tDf; Jirpducts ho1.~ b!:!tn PJ'.~nutactY:rna ;_,_na qvtil!giple inlc!<iho.
Ms .. Field summariiM ·the hh,tory of this prodtfot and recent appearance within
th~ 1a·sne}v inonth&. M&.fi!31d r~itE?r"at~d rnfp'iYrposi or Mf!~gi?liti.qn wa;; riot to
re· · c· J i:i 6~.th p°fq\lu.cf&Yit t9 tegufa(~ ~ cJfug'(fitit is ho$fri@izi5,gyquth arsJ
p~. . y.,i_1~o ~nort Joeptoclµqt. Sh~ s~ii:l th<:il if Inis Vfii; to pasf at'id .be ~ignfd
by the goyerncir thal)t would J?ec<:>me immediately effective and these products
would be removed from the shelves.

iim~n,s_e.

wmng

S~nator BQck questioned M$. Field concerning FDA review of the ingredients.

Ms. Field ;:;uinrrrari:zyd the FDA review,
MO'flON:

Seriatorpayi!!, rira9e a moti1;m to send H 119 to the floor with a do pass
reCfimine11dation. Senator Bock seconded the motion. The motion carried by
voice vote.

H 139

Re.latl11g to Uniform ControJled ~ypstant;f;}Sj spjce - Def?bl~ Ffold s~mmarized
!hi$, ~ill ~s !he m,~~,ns to pµt i11t~tst~tute, ~J(i~Ung 111Jes o(thE;i Board o(Ph§ff!ll~cy
loc(liding one adaition. Ms, Field stale.a .that H 1~9 cov~rs. seven different

ch~rnfoaJ ~tiu.ciur~${it1~'that Iangu'age ·written into thi~ l~gl§J~fitm specific~Uy

o{i!W

targ~w lhf ~ti9~!ib[J~ itru~~yre
cp~mii;alt us~ij ti> prq{JucfiJailationq of
"spice" so that small changes m~delo the compciurjij Wi!I not avoid prgsecuUon.

Sel)~J~t ~':ftzyiaur q4~s,Uo~ed t~e E!g'{<:lfS~ §[~e e1~~s,_of "Spic€!"._ ~!J: FY~ld'

enyITJs;~a.!.e1 t~o.~7QJJ.IJ!l)~c.! !!) the ~~r:,dou.t Sti~ e;,:pt~in~sJ ho)V "~P!fe~ 1.s rre~ted.
IVl~d?~~J~y 91~nQep !h~t th,e~e t:ir~ "d.~~]j]ner c:lr4~~ tp~t w~ ~ein,!J roar~et<3.g
be~~QJe th.(7yJ1r9umv~ot t~~ drugs. ff;iJ3!Were ~~nn!3~ by t~e {loyernor !1st fall
"'1[:.):f.olC;l~Vf~Y iridi0=Jt~~ traJ H 13fl 1.s .a 9ro.a.d_i:,le,ce of l~~l~}~!lqn ~~~.cJ.tblU,9
Y"'.llol~J~ml~es of.ch(;l£!11Cals man ?Jt~IJ}Pltq capNre ayaJlijUOn. t1~. l[lqig~ted

c .icalsfis1e.d in H 139·could be found in
~g~ufiYe.sj~-~~/!Qtl?:95• . J;J&~i .~P{oth~r .P~ff@.G11y le,QiUrt)~tf ~nd

his c ' !s chemist has fdUricf the

ca99

leg~! . . . ypfs:. !-!ts <;9r;icem wa§Ji]~t theJ~~!?laJ19n 9,~}!Kt~e over,each1ng 1f these
chern1i;:als were listed as a Schedule 1 co.ntrollecJ substance.

Furt~er gu,~~tir.inlnQ by Ch_alrlllan 1JarrJngtq1 en§ueg ft3gan:fng qJs.~greement
apcM legit(mateJJ~~s of \l}e chemi9als: Mr, .1-{()!Mv.,*y_expri:W~~cJ Goi)9~m
fQr HJtifigvM ii:f t_q~ t':J~r.e ino th~ ixissWJiilt gJ fdrcfn 'Ji\~lh~fujc~JsjJ)tO
an underground market with no control. He encou.

. . Idaho to ·allow. these

ch~ri'l!~ars to pa in a -,~gl'!I envjronrW~nfwb=ere~(eg~ .'.ns ~cifi ~~ irtpfa~ in
reftirerice to access arid potency'. Cn,airnian [)~rrli'.!gto~n asked M:,. OW~l!;lY to

re~p-on(f to Mr. Hold~w~y rem~rlt9•, M~. 9W$1(3y st~foa that t~\} COfQR~~JlctS have

be.en r~sxarche~ arid 110110 have b~.eh ·slfoy;h. fo h~ve m_edi¢al valu¢ without
u~wi1nteq sid~ eff~tts. f[)A approval Y(ill beJ~J'.lui,r~gfoi f11Jure compounds
de¥¢lope9 for medicin.:il use. Sffe §Utnmarized that 1J1<1ny sh~tes were adopting
similar legislation to prevent l~gisl~ting each new compbund developed.

Sena!qr Davis quel}ljon~d ~onc:eming other prodµcts pro9u<,ed V(!th the
c~~mica!s, wbE;imer his
~Qlg or rnanuf?"ttured a_ny ofJ~~ j?f<iQ_uct1> and the
nam_~ of the dor;tor wh.o prfJrpareo the r~port for Mr. Holcl~w.ay. Mr, Jtold~w.ay
repeatsi,d his list, an·sWere9 n~ga:Uvely Jo th~ sa,!e or mahdfacture of the products
and ri~rned the doctor - Dr. Richard Parent, with Cohsultox Limited in Maine
and N·evf Or!e,ms, s"enator LtfFavour qu~stione.c;l Ms. O\vsley reiWi:ling lhe
rriagnifud~/potency effect of ~spice i::cimpar~<I Ip alcohol. Ms. Ows\~Y rev,iewed
the research comparisons were to THC in marijuana and not alcohol; further

~lienr$

0
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P. 4

PP!encles vary by prodpd. Ms. F!elds conch.Jd.(:;q that these structures

neE;d t9 ~e da;,\l[ieg as outlined in the legislation and that "spice" is abuse of
synthetic chemic~ls.

MOTION:

.

Vice 9hllirtn~n Vick n:1?~~ "~ mo,lion to sel'ld H139 to the floor wJth a do, pass
recofninenqatioll. Senator Nuxoll seconded the motion .. Vice ChalrllJan Vick

~e~ .~ ~~1~1~mpri.t by }~hJJ,

w. 8ilff~a.n, p~'tr ff91J1 'qit1J1ifo_n Ylii1ie/;fty, }YhO

lnV(',ntetj JWri:018 wli15,,~ 1$ on Jne h?t of syqthet19 C!')n11cib1i:i91cj~, IJK7n_e(l the use
of the i;irugs to "Rus;;lan Roulytle''. 1he mo~ion cprried py voic:e vote.

GUB!:;RN;\TORlAL Ch?trwa11 I;>~ri~g;glJPI:O~e~~f"d \<? the C!)~n~lfn~Ji.(m h,f?rjQ~ Qf Sh!irQn,
Hatrlgfeld. Department of Juvenne Corr~ct1om1 and requested Ms. Hamgfeld

APPOINTMENT

ANr:i .

DEPARTMENT

UPDATE

pre3>en(an up<lf!tejbffM ~~P~til!l~J1t ~J1t?9'n't{~r<lijl~1~"qTl3ii~~. ldahfias

reap&.9i9t~cJ. as qirec5t()r Qf t6~ g$R~I1ir!ffi.t of ~B¥tiiil~ <;:prrec,!ipril.) (or a, .t!lrm

corprn~m:111g~au9~ry 3, 2,011 and e;<pl~lpg J~nµ<;iry 5~ WJ5. MJ.! Harrt~feld
introduced Scott Johnsoh as the Admihlsfrative Services Administrator
enu111ir~jiJg his tespgfi~l~il]ties, Ms: Hiirlgfelg SUJQm~rii,ect'h~r30year history
of ~er.yi~ in'tne J~efii(i Jy~lt\'.:$ 9y~~e111. !i~r M,pi~l!=lf§l jn CQllfls~!fng, ~iid s~Nice
as Qirectqr of the Juv~niJe Cifrr~~tlgYis D_ef;i~rtm,e·nt She rnyiewed (;tfrreht polfcy
~!")fl prn.91<lure cp~!"l~esJOjl ~t~tiW~~ ~yit¢m, 9che'.p~_t.n~
j~veniles
I~ .\Gr.a ~i~t~rr. h~xe to L?,a_ r~.
~~egJW1 J?eC~Q'Je P(8J~S:HV·7~ ~llfffSi{~~ .
~1t1~ylll)'!1t _t'~trl[Jf1?ld 90n . . ..Jf pr~~sJe .9, ijf~!:1r:tment q:ie9~ ~uIT1n:iaqzmg
the Q(:)pwfrul;lnt' s WQrkforce l'lfl. hQLir? \ll0*<3cf, mJl1c~~pg pl(}asµre wl\h th§!

~pf!ort~nlty

cqmrfi.Um~nt l§ I~QYRx j i~· ilm~ !~ cotpilil!,!JitJ;f3, $hf(i'j:9feg tJiep!!rfoef~hiP
b~\w~~!\¢9Jintie,s ajld . Jtt~t Wr;iw t~i:i ~9ppti9H OT a. R8Ja,ri9ed approach to
juvenile j0~tioo Y1hich f*in ate loqa1 leyel hearih~$fqr juver,iles.
Ms.

Harrlgf€!1d 8\]jrlrr:ta,rlied lh_e W<?rk \'{tth fzjrpiliyj~ of ]l1YE,lnu~s t.9 PXO!Jl{)te

!~ii;J~itl~f,!f~i~JJitlt!!iltl~!:l?l~i~ll;;n

year:5 of age. M~- flarrig!el~ r~w~v.iecf cQ.minunity r~~~llt~~s}JrJd speciaJty c9urts
as w1:11a.s.aqq\tioI1<JI sei'vic~~ s{qteWJ(!e ;:it th~ locgl l,ey~~ ass.is{iog withi':)yeniles.

s~~ ~n 1\mJ~~~~~9 tli,e j4ven}IEIB in thf rir?9ra!Ji a~ ·15.~oo 8n prqpa,Jiqri, 200 }n_
deJenUon f?<:il1t1es _and ~3.4 In custoay lri a_g1:ve.r1 g§y. S,hg stat~d th~ r~<:Jd1v1sm
rate Is 25% and noted {fie incfeasejn mental health problems for juvf;!till~S.
Sen~tor LeFavour complimented Ms. Harrigfeld and her Department for their

.

~~

ADJOURNMEN1'

Th!;lre being no further business. Ctialrman Darrington adjourned the meeting
at 3:02 p.m.

'··
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CHRISTOPHER D. RICH, Clerk
By NICOL TYLER
DEPUTY

1

IN Tiffi DISTRICT COURT OF THE FOURIB JUDICIAL DISTRICT OF

2

THE STATE OF IDAHO, IN AND FOR THE COUNTY OF ADA
3

RECEIVED

4

APR 11 2012
5

STATE OF IDAHO,

6

PROSECUTING f , 'TORNEY'S OFFICE
ADA CIJl..?ITY

Plaintiff,

Case No. CR-FE-11-0015480/
CR-FE-11-0015482/CR-FE-11-0015483/
CR-FE-11-0016248

7

8
VS .·

CORRECTED MEMORANDUM

9

10

MORGAN C. ALLEY, TASHINA ALLEY,
AND CHARLYNDA GOGGIN, HIEU NGOC

11

PIHAN,

12

DECISION AND ORDER RE:
MOTION TO.DISMISS

Defendants.

13
14

15
16
17
18

This decision is entered to correct the caption to reflect the participation of Rieu Ngoc
Phan ("Phan") in the motion.

BACKGROUND
Defendant Morgan Alley has moved to dismiss the Indictment in this case. The motion
does not state the_ legal basis for requesting dismissal, but it is clear from the briefing and

19

arguments of counsel at the hearing that Defendant is alleging the Indictment does not state a
20

crime. He does not challenge the specificity of the Indictment or claim it does not put him on
21
22

notice of the crime charged. Th~ factual basis for his motion is the claim that the substance AM-

23

2201 is not illegal. In the alternative, Defendant argues that the Idaho Uniform Controlled

24

Substances Act is unconstitutionally vague as applied to the Defendants in this case because of

25

the asserted ambiguity regarding AM- 2201. He is joined in the motion by co-defendants Tashina

MEMOR.i\NDUM DECISION AND ORDER RE: MOTION TO DISMISS-PAGE 1

000221.
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1

Alley, Goggin, and Phan, but those defendants did not actively participate by the filing of briefs

2

or examining witnesses at the hearing on this matter. This opinion will focus on the case against

3

Mr. Alley while recognizing that· these are consolidated cases and the ruling will apply to the co-

4

defendants joining 1n the motion to the extent the charges against them are the same as those

5

against Mr. Alley. All Defendants have been charged with, among other things, conspiracy to

6

manufacture, deliver or possess with intent to deliver, a Schedule I controlled substance in
7

violation of 37-2732(a), 18~170 I, and 37-2732(£). The conspiracy count of the Indictment does
8

not further define the particular substance that was manufactured or possessed. Mr. Alley is also
9

10

charged with illegal possession of a Schedule I controlled substance in violation of 37-2732(c ).

11

Ms. Goggin is charged with illegal delivery of a Schedule I COntrolled surtance in violation of

12

37-2 73 2(a).11he illegal possession count against Mr. Alley simply specifies "marijuana and/or

13

synthetic cannabinols." The illegal delivery count against Ms. Alley says

14

a Schedule I drug

without further specification. However, the record includes the State forensics laboratory report

15

of the controlled substance analysis. The report reflects the presence of 3 substai,ces identified
16

by the Forensic Scientist as being Schedule I substances-AM-2201, JWM-019, and JWM-210.
17
18
19

20
21
22

The essential argument by Mr. Alley is that AM-2201 is not a Schedule I substance.
· Specifically, It is conceded by Defendants that the other two substances are within the definition
of I.C. § 37-2705(d).

ISSUES PRESENTED
1. Is the substance identified as AM-2201 a controlled substance as defined in

23

Schedule I of the Idaho Uniform Controlled Substances Act?
24

2. Is LC. § 37-2705(d)(30)(ii) unconstitutionally vague with respect to AM-2201,
25
26

MEMORt\NDUM DECISION AND ORDER RE: MOTION TO DISMISS - PAGE 2

JW1v1-019, and JWM-210 as applied to the Defendants in this case?
1

DISCUSSION

2
3

l. Is AM-2201 a Controlled Substance?

Schedule I substances are defined in

4

Idaho Code §37-2705. Subsection (a) provides: "The controlled substances listed in this section

5

are included in schedule I." Subsections (b) and (c) list opiates and opium derivatives.

6

Subsection (d) lists hallucinogenic substances, including marijuana.

7

The substance AM-2201 is a synthetic compound invented by researchers
at the
~

8

University of Connecticut.

It is not named in the Control1ed:Sn:!@~£Gt,£!1i,The name is derived

9

10
11

from the initials of the inventor and conveys nothing about the nature of the substance itself. The

state maintains AM-22T ii described by I.C. §37-2705(d)(30)(ii)(a). Ibat section lovides:

12
13

14

15

(d) Hallucinogenic substances. Any material, compound, mixture or preparation
which contains any quantity of the following hallucinogenic substances, their
salts, isomers and salts of isomers, unless specifically excepted, whenever the
existence of these salts, isomers, and salts of isomers is possible within the
specific chemical designation (for purposes ofthis paragraph only, the term
"isomer" includes the optical, position and geometric isomers):

16

17
18
19

(30) Tetrahydrocannabinols or synthetic equivalents of the substances contained
in the plant, or in the resinous extractives of Cannabis, sp. and/or synthetic
substances, derivatives, and their isomers with.similar chemical structure such as
the foll owing:

20

ii. The following synthetic drugs:
21
22
23

a. Any compound structurally derived from 3-(1-naphthoyl) indole or IHindol-3- yl-(1-naphthyl)methane by substitution at the nitrogen atom of the indole
ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2-(4morpholinyl)ethyl, whether or not further substituted in the indole ring to any
extent, whether or not substituted in the naphthyl ring to any extent.

24

25
26

Rather than name a specific substance, §3 7-2705(d)(30)(ii)(~) describes groups of similar, but
MEMORANDUM DECISION AND ORDER RE: MOTION TO DISMISS - PAGE 3

1

-not chemically identical, substances. The parties pose the question then, as whether AM-2201

2

falls within the compounds described by §37-2705(d)(30)(ii)(a). As discussed below, the proper

3

inquiry is the legislative intent in amending the statue.

4
5

The interpretation of a statute must begin with the literal words of the statute. The words
must be given their plain, usual, and ordinary meaning and the statute must be construed as a

6

whole. If the statute is not ambiguous, the court does not construe it, but simply follows the law
7

as written. State v. Schwartz, 139 Idaho 360,362, 79 P.3d 719, 721 (2003) (citations omitted).
8

"We have consistently held that where statutory language is unambiguous, legislative history and
9

10

other extrinsic evidence. should riot be consulted for the purpose of altering the clearly expressed

ft· Alphonsu~ Reg'! Med. Ctr., 151 Idaho 889,893,265 P.3dl

11

intent of the legislature." Verska v.

12

502,506 (2011) (citing City ofSun ~alley v. Sun Valley Co., 123 Idaho 665,667, 851 P.2d 961,

13

963 (1993). A court must construe a statute as a whole, and consider all sections of applicable

14

statutes together to determine the intent of the legislature. It is incumbent upon the court to give

15

the statute an interpretation that will not deprive it of its potency. Hillside Landscape Const.,
16

Inc. v. City of Lewiston, 151 Idaho 749,264 P.3d 388 (2011). In determining the ordinary
17
18

meaning of a statute effect must be given to all the words of the statute if possible, so that none

19

will be void, superfluous, or redundant. Id. (quoting State v. Merce,~ 143 Idaho I 08, 109, 138

20

P.3d 308,309 (2006)).

21

22

At the hearing on the motion to suppress there was no dispute that the applicable statute
describes compounds with a common parent structfile .a portion of which is composed of an

23
24

25

26
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1

1

indole ring. This is represented in State's Exhibit 10 l:

2
3
4

5
6
7
8

Ncphthayfindo!e (Jdaho Code 37-2 705(d]30 II.a)

The indole.is the portion of the compound represented below:

9

~

10

~N_)l

11

12

N represents a nitrogen atom. R I in the first dJgrarn represents a chain of atoms attached to the

13

nitrogen atom. This chain of atoms is called a substituent. Specifically, the substituent here is a

14

chain containing carbon and hydrogen atoms. This much is agreed upon. The controversy is

15

over whether the chain attached to the nitrogen a.to~ can contain an element other than carbon

16

and hydrogen and still fit within the definition of the statute.

17

AM-2201 is represented structurally as:
18

19
20

21
22

23
24
1

25

What follows here is the Court's best effort to interpret submissions of the parties, including the testimony. This
judge is not an organic chemist and the discussion may not be completely accurate so far as the chemistry is
concerned, but the Court concludes this ultimately is not controlling.

26

MEMORANDUM DECISION AND ORDER RE: MOTION TO DISMISS - PAGE 5

1
2

3
4
5

6

For the non-chemist, these representatio~s are somewhat problematical in that some
7

information contained in the diagrams is implied rather than explicit. For example, in organic
8
2

9

10
11

12

chemistry, when illustrating the structural formula for hydrocarbons, each unlabeled vertex and
unattached endpoint represents a carbon atom. Carbon has 4 valence bonds. Absent notation

I otherwise, it is assumed a hydrogen atom is present whereter a bond is available. 3

A double line

represents a double bond between adjacent atoms.
The portion of the AM-2201 diagram from the N to the Fis the heart of the dispute here

14

and the focus of the evidence and arguments at the hearing on the motion. In particular the
15

parties dispute the meaning of "by substitution at the nitrogen atom of the indole ring by alkyl. .. "
16

Some basic terminology is necessary to understand the arguments made. Both sides refer to the

18

19
20
2

21
22

Used in the mathematical sense of"the point where two sides of a plane figure or an angle intersect."
For example, the written formula for butane is CJ110_ The structural formula is shown below along with the
skeletal structural formula generally used by chemists and as represented in the exhibits in this case. All three
represent the same compound.

3

H H H H
23

I

I

l

I

H-C-C-C-C-H
24

25
26

j

I

I

13

17

I

I

I

I

l

H H H H
Butane is also known as n-Butane, Diethyl, Butyl hydride, and Methylethylmethane. Source: National Center for
Biotechnology Information website accessed at http://pubchern.ncbi.nim.nih.gov/summary/summary.cgi?cid=7843>
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:

4

l

illPAC nomenclature to explain the statute in question. A hydrocarbon is a compound

2

composed only of carbon and hydrogen atoms. Alkanes are acyclic (chain structure)

3

hydrocarbons having the general formula CnH2 n+2, and therefore consisting entirely of hydrogen

4

atoms and saturated carbon atoms. Alkyl groups are univalent groups derived from alkanes by

5

removal of a hydrogen atom from any carbon atom: C0 H20 +1-. The groups derived by removal of

6

a hydrogen atom from a terminal carbon atom of unbranched alkanes form a subclass of normal
7

alkyl (n-alkyl) group~. Alkyl radicals are carbon-centered radicals derived formally by removal
8
9

10

of one hydrogen atom from an alkane. The court could not locate, and the parties did not cite, a
stand-alone definition of all.-yl.
Defenrant's witnesses testified that AM~2201 is not within the sc pe of the statute. Dr.

11

1

12

McDougal based his conclusion on the structure ofthe·substituent being an alkyl halide rather

13

than an alkyl group.

14

He contrasts this with the
15

structure of JWH-018 that has a·simple 5 carbon chain attached at the nitrogen atom on the
16

indole ring: Dr. De Jesu·s essentially says the same thing, only he labels the substituent a fluro17

18

substituted alkyl group. By contrast, Mr. Sincerbeaux testified that it is the removal of the

19

hydrogen atom from the alkane that renders the resulting compound an alkyl group. In his view,

20

it matters not what replaces the missing hydrogen atom. 5 The contrasting views can be

21

22
4

23
24
25

International Union Of Pure And Applied Chemistry; A 9uicfe to !UPAC Nomenclature ofOrganic Compounds
(Recommendations 1993), 1993, Blackwell Scientific publications. Accessed commencing at
http://www.chem.gmul.ac.uk/iupac/class/ and IUPAC Nomenclature ofOrganic Chemistry. Accessed commencing
at http://www.iupac.org/fileadrnin/the-network/index.html.
5
VJl". Sincerbeaux also testifies extensively concerning his involvement in the drafting of the statute and what he and
the others sponsoring the legislation intended. Mr. Sincerbeaux and his colleagues are not legislators. Nor is it
apparent from the legislative history that the lawmakers adopted the sponsor's reasoning along with the proposed

26
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0

illustrated as follows:
1

N-{ CH2-C H2-C H2-C H2-C H2F) represents the interpretation of the

2

statute by the professors. N-(CH2-C H2:_C H2-C H2)-CH2F represents
the view espoused by the state's forensic scientist. In other words, the state treats
the carbon chain with the first 4 carbons as the spine and the fmal compound
(CH2F) as a substituent.

3
4
5

As stated by Dr. De Jesus, the Idaho legislature is not a body of chemists. The issue is
6

7

what did the legislature intend to add to Schedule I? The legislature did not use the term "alkyl

8

group" or "alkyl radical." It used the phrase "any compound structurally derived from [certain

9

named chemicals] by substitution at the nitrogen atom of the indole ring by alkyl ... " The

10

11

legislature was not engaged in miming the resulting chemical compound, which is the point of
much of the testimony re,arding the TIJP AC rules for nomenclature. If naming the re1ulting

12

chemical compound was the purpose of the legislature, it is obvious that neither AM-2201 nor
13

JWH-018 would be derived as names. Those are t~e names of the compounds discussed by
14

15
16

Defendants' experts, both of whom opine that JWH-018 comes within the prohibition of the
statute.

17

The parties, by focusing on the correct name for the portion of the compound represented

18

by the chain attached at the nitrogen atom are ignoring the language chosen by the legislature. It

19

appears undisputed from the testimon

20

i
!
'i•I

I

21

chemistry, substitution refers to a reaction process. According to the Encyclopedia Britannica, a
22

substitution reaction is "any of a class of chemical reactions in which an atom, ion, or group of
23
24
25

language in the bill that ultimately became I.C. §37-2705(d)(30)(ii)(a). Consequently, this is not part of the
legislative history and sheds little light on the intent of the legislature.

26
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tt

atoms or ions in a molecule is replaced by another atom, ion, or group. 6 Wikipedia says "in a
l

2

substitution reaction, a functional group in a particular chemical compound is replaced by

3

another group. 7 Depending on which definition is chosen, the words "by substitution ... by

4

alkyl" could restrict the meaning of the phrase .to mean that the prohibited substance may only be

5

derived using an alkyl functional group, or it may mean that "a group of atoms or ions"

6

containing only hydrocarbons with a missing hydrogen atom is part of the process by which the

7

substance is created. This type of analysis misses the point.
8

The Defendants and their experts derive their interpretation of the statute by reading a
9

10

select portion rather than reading it as a whole. To properly glean the meaning of the statute, one

11

has to read. the statute as a whole, corencing with the hsting of compounds that are defined in

12

Schedule I. In this instance the beginning point is LC. §37-2705(a). This informs the reader that

13

Schedule I drugs are those listed in "this section"-meaning the entirety of §37-2705. There

14

follows 5 subsections listing various types of substances. Subsection (b) deals with opiates;

15

I

subsection (c) deals with opium derivatives; s1:1bsection (d) deals with hallucinogenic substances;

16

17
18
19
20
21
22
23

24

25
26

6

Encyclopedia Britannica Online, s. v. "substitution reaction," accessed April 03, 20 I 2,
http://www.britannica.com/EB checked/topic/57107 5/substitution-reaction
See, also, Illustrated Glossary of Organic Chemistry, which defines substitution reaction as "a reaction in which any
part of a molecule is rep faced (substituted). Harding, Illustrated Glossary of Organic Chemistry, UCLA <
http://www.chem.ucla.edzilhardingliGOCISlsubstitution reaction.html>; accessed April 03, 2012.
7
http://en:wikipedia.org}\viki/Stlbstitution reaction ; accessed April 03, 2012. To the amazement of the Court, the
defendants' scierrtific experti.'fotli cite Wikipedih in.their written submissions. Wikipedia may be a common source
of information, but given its editorial policies, the Court hardly views it as an authoritative source. While any given
article may be completely accurate, it is not possible for one not familiar with the topic of the article to tell the
accurate from the false. From Wikipedia itself:
Wikipedia is written collaboratively by largely anonymous internet volunteers who write without
pay. Anyone with Internet access can write and make changes to Wikipedia articles (except in
certain cases where editing is restricted to prevent disruption or vandalism). Users can contribute
anonymously, under a pseudonym, or with their real identity, if they choose.
<http://en.wikipedia.org/wiki/Wikipedia:About > accessed April 03, 2op (emphasis added).
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1
2

3
4
5

subsection (e) deals with central nervous system depressants; and subsection (f) deals with
stimulants. We are concerned here with subsection (d):
( d) Hallucinogenic substances. Any material, compound, mixture or preparation
which contains any quantity of the following hallucinogenic substances [their
salts, isomers, etc.]:
Subsection (d) has 35 sub-subsections. The first 29 are substances from 4-bromo-2,5-

6

dimethoxy amphetamine to marijuana, to peyote, to psilocin. _The last 5 also list specific
7

substances. Sub-subsection (30) does not list a specific substance, but a description of types of
8

substances:
9

10
11

(30) Tetrahydrocannabinols or synthetic equivalents of the substances contained
in the plant, or in the resinous extractives of Cannabis, sp. and/or synthetic
substances, derivatives, and their isomer9 with similar chemical structure such as
the following:
I ·
·

12
13
14

Sub-subsection (30) has two sub-sub-subsections. Sub-sub-subsection (i) is titled
"Tetrahydrocannabinols" and has a lettered list of 4 specific substances. We are concerned with

15

Sub-sub-subsection (ii). It is titled "The following synth~tic drugs:" and contains lettered sub16

sub-sub-sections (a) through (i).
17

18
19
20
21
22
23
24

By stripping the statute down to the component parts to be construed it is fairly easy to
discern the intention of the legislature:

37-2705. Schedule I.
(a) The controlled substances listed in this section are included in schedule I.
(d) Hallucinogenic substances.
(30) synthetic equivalents of the substances contained in the plant, or in
the resinous extractives of Cannabis, sp .. and/or synthetic substances, derivatives,
and their isomers with similar chemical structure such as ...
ii. The following synthetic drugs:
[list].
·

25
26
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'

1

__,..,

"Cannabis, sp". is marijuana. The psychoactive substance in marijuana is Tetrahydrocannabinol

2

or THC. " ... and/or synthetic substances, derivatives, and their isomers with similar chemical

3

structure" is referring to synthetic marijuana or s·ynthetic substances that mimic the

4

hallucinogenic properties of marijuana. Use of the words "such as" by the legislature means the

5

list is not exclusive. It could as well read "for example." Whether the Defendants are correct

6

that AM-2201 is not derived "by substitution ... by alkyl," or the state is correct in its view to the
7

contrary, it.is clear the legislature intended to include it and substances like it in Schedule I. The
8

legislative statement of purpose provides:
9

10
11

I.

12

The chemical structure of AM-22
13
14

certainly similar. The difference amounts to the presence of a fluoride atom rather than a

15

hydrogen atom at the end of the carbon chain attached to the nitrogen atom on the indole. Dr.

16

McDougal makes this point with his diagrams on his letter dated 6 January 2012 [sic]. 9 Dr. De

17

Jesus makes the point with his discussion alternative language that could have been used by the

18

legislature. He suggests that it should have simply left out the words "by alkyl, alkenyl,

19

cycloalkylmethyl, cycloalkylethyl or 2-(4-morpholinyl)ethyl." While this indeed would have
20
21
22
23
24
25

8

9

Affidavit of Heather Reilly, Exhib it l.
Defendant's Exhibit 2.
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000231

1

made the language broader, including it does not make the language of the entire statute

2

narrower. It simply makes narrower the list of examples given by the legislature of the type of

3

substances being added to the list. The minutes of the legislative committees also make clear

4

that the purpose behind the legislation is the bcµining of categories of substances, not just

5

particular compounds.

6

The contrary conclusion is reached only by ignoring the portion of the statute which indicates the
9

10

specific formulations are given by way of example. It was the intent of the legislature to not deal

al new analogs for THC

11

with the so-/called "spice" problem by constantly amendi~g the statute

12

are developed or discovered in the scientific literature by purveyors of mind altering substances.

13

.2. Is J.C. §37-2705(d)(30)(ii) unconstitutionally vague?
(a) Legal standards.

14
15

A party challenging the constitutionality of a statute "bears the burden of establishing that

16

the statute is unconstitutional and 'must overcome a strong presumption of validity."' State v.
17

Korsen, 138 Idaho 706, 711, 69 P.3d 126, 131 (2003) (citing Olsen v. J.A. Freeman Co., 117
18
19
20

Idaho 706, 709, 791 P.2d 1285, 1288 (1990). Under both the U.S. Constitution and Idaho
Constitution, "[a] criminal statute must be sufficiently certain to show what the legislature

21
22
23
24
25

3-{1-naphlhoyl)lndole

3-{ 1-naphthoyf)indola

qyc/5?
1
NAI-k:-,~:.-e~:-:-,-sn-ot__,15-pecified
n legis)atlon

.

N

WH-018/,!

.

yl group; I& spec!(iOO
eg!sfatton

,
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1

intended to prohibit and punish; otherwise it is void for uncertainty." City of Lewiston v.

2

Mathewson, 78 Idaho 347, 350, 303 P.2d 680, 682 (1956). "The void-for-vagueness doctrine is

3

premised upon the due process clause of the Fourteenth Amendment to the U.S. Constitution.''

4

State v. Korsen, 138 Idaho 706, 711-12, 69 P.3d 126, 131 (2003) (holding that provision in

5

Idaho's trespass statute was not unconstitutionally void for vagueness under applied vagueness

6

analysis). It "requires that a statute defining criminal conduct be worded with sufficient clarity
7

and definiteness that ordinary people can understand what conduct is prohibited and that the
8

statute be worded in a manner that does not allow arbitrary and discriminatory enforcement." Id.
9

10

(citing Village ofHoffman Estates v. Flipside, Hoffi.nan Estates, Inc., 455 U.S. 489 (1982)). "It

11

is a basic principle of Jue process that an enactment is void for vagueness if its prorbitions are

12

not clearly defined." Id. (citing Grayned v. City of Rockford, 408 U.S. 104 (1972)). Due process

13

also provides that "no one may be required at the peril ofloss ofliberty to speculate as to the

14

meaning of penal statutes." Id. (citations omitted).

15

As such, the Idaho Supreme Court "has held that due process requires that all 'be
16

ii.1.formed as to what the State commands or forbids' and that 'men of common intelligence' not
17

18

be forced to guess at the meaning of the criminal law." Korsen, 138 Idaho at 712, 69 P.3d at 132

19

(citing State v. Cobb, 132 Idaho 195,969 P.2d 244 (1998), Smith v. Goguen, 415 U.S. 566,574

20

(1974)). "A statute may be void for vagueness if it fails to give adequate notice to people of

21

ordinary intelligence concerning the conduct it J>ro~cribes ... or if it fails to establish minimal

22

guidelines to govern law enforcement or others who must enforce the statute." Id. (citations

23

omitted). "A statute may be challenged as unconstitutionally vague on its face or as applied to a
24

defendant's conduct." Id.
25
26
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In a facial challenge of vagueness, "the complainant must demonstrate that the law is
1

2

impermissibly vague in all of its applications," such that there are no circumstances where it is

3

constitutional. Korsen, 138 Idaho at 712, 69 PJd at 132 (citing Hoffman Estates, 455 U.S. at

4

497) (reiterating that "the challenger must show that the enactment is invalid in toto"). In an

s
6

applied challenge, "a complainant must show that the statute, as applied to the defendant's
conduct, failed to provide fair notice that the defendant's conduct was proscribed or failed to

7

provide sufficient guidelines such that the police had unbridled discretion in determining whether
8

to arrest him." Id. A facial challenge and applied challenge are mutually exclusive. Id.
9

(b) Arguments o(the parties

10

~he ~efendants do not expfes sly mo~t a facially un~onstitutional ~hallenge, .but. use

11

I

12

langue m their arguments. that could be construed as suggesting the statute 1s unconstrtut10nal on

13

its face. 10

14

15

Defendants argue that I.C. § 37-2705(d)(30)(ii) is unconstitutionally vague because a
person of common intelligence cannot determine what conduct is being prohibited and

16

ambiguities exist that open the door to arbitrary and discriminatory enforcement of the act.
17

Defendant asserts that LC.§ 37-2705(d)(30) must necessarily be of<!- highly technical nature and
18

19

therefore very specific as to its meaning and application. ·Idaho House Bill 139 instead created

20

confusion and uncertainty as to the meaning of LC.§ 37-2705(d)(30) according to Defendants.

21

This is demonstrated by the disagreement between the parties' experts as to whether AM-2201 is·

22

covered by the statute within subsection§ 37-2705(d)(30)(ii). As such, a person of common

23

24
10

25
26

The Defendants' brief is somewhat short on law and long on argument. The Defendants do not make explicit
whether the challenge is based on the language of the statute alone or as applied. The cases cited by Defendants do
not make the distinction.
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1

experience could not be expected to know of the statute's application to AM-2201. Defendant

2

points out that most people in the U.S. population could not know whether they were possessing

3

a chemical potentially covered by 2705(d)(30)(ii)(a) without first seeking professional input.

4
5

Defendants note that Dr. Parent's services were obtained in order to remain compliant
with the law. They claim was only because Dr. Parent concluded that AM-2201 was not covered

6

that the manufacturers and retailers switched to the chemical. Defendant also point out that Utah
7

passed its own law in which the legislature named numerous chemicals that were banned, but
8

that Idaho instead decided to describe the chemicals. Thus, Defendants argue that, because is
9

10
11

only one chemical by the name AM-2201, the legislature should have simply named AM-2201 as
an illegal substance rather than describe poteTial chemic~l structures.

12
13

14

Ultimately, Defendants suggest that the only way for the State to constitutionally regulate
drugs is through legislation specifically naming individual chemicals. Defendants recognize that
the state never likely be able to make the list long enough to capture all of the potential chemicals

15

that can be abused.

11

Defendants theorize it is not possible use a description other than

16

substance by substance to·ban chemicals without the statute suffering from unconstitutional
17

18

vagueness and over-breadth.
The State sets forth that the statute provides actual notice and enforcement guidelines

19
20

sufficient to satisfy due process standards. The State argues that the statute sufficiently informs a

21

person of common intelligence that AM-2201 and similar types of synthetic drugs are illegal.

22

The State also asserts that Defendants understood the legislation based on their attempt to

23

circumvent the law by relying on a chemist to recommend a substitute substance and the
24

25
11

In fact it appears Defendants are counting on this to stay in business in the future.

26
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maintaining of a clandestine operation. The State characterizes Defendant's production of AM1
2
3
4

5
6

2201 as a calculated risk based on the erroneous belief that the legislature could not ban AM2201 without specifically naming it.
The· State disagrees with the argument that the statute is vague because of its technical
nature. This would yield absurd results by invalidating all statut~s requiring specialized
legislation or using specialized terminology where a defendant can locate an expert to disagree.

7

The State also notes that scientific or technical terms of art in a regulated field do not
8

automatically render a statute unconstitutional. See Omaechevarria v. Idaho, 246 U.S. 343, 348
9

10

(1918). The State points out that' the Defendant concedes that the description in I.C. § 3 7-

11

2705(d)(30)(ii)(a) "intentionally covers thousands ofpoterial chemical_s/' and the State asserts

12

that Defendant and his counsel were well aware of the highly publicized rise of synthetic drug

13

use in Idaho such as "spice."

14

15

The State also notes.that Defendant Alley's s counsel participated extensively in
committee hearings in opposition to enactment of the law.by attempting to dissuade lawmakers

16

from prohibiting designer drugs, including cannabinoids. The Court does not find this argument
17

on point. While counsel may have been representing Mr. Alley at the time of counsel's
18

19

20

appearance before the legislature, there is no evidence to that effect in the record.

In an abundance of caution, given the Defendants' overall lack of specificity of the nature

21

of the challenge being mounted., the State, in its brief, discussed enforcement guidelines as they

22

pertain to vagueness challenges to a statute. Defendants did not brief the issue. At the hearing

23

Defendants stated the issue was not briefed because Defendants were lacking evidence to support

24

the challenge on an "as applied basis." At the hearing, Defendants sought to interject the issue
25
26
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1

into the case through recently obtained preliminary hearing transcripts. The Court declined to

2

allow this evidence which. apparently concerned events involving pending criminal cases in

3

eastern Idaho. The exclusion was discretionary and based on the late disclosure to the State. The

4

Court will not discuss it further.

5

(c) Discussion

6

To the extent the Defendants are making an argwnent that the statute is facially overbroad
7

(see footnote No. 10, above), the argument must fail.

The answer is in the testimony of

8

Defendant's experts. The essence of a facial challenge is that the complainant must demonstrate
9

10

that the law is impermissibly vague in all of its applications, such that there are no circumstances ·

11

where it is Tnstitutional. Here all three of Defendant's experts agree tlat JWH-210 and JWH-

12

019 are unambiguously described by the statute. This is obviously a circumstance where the

13

State has banned a substance and there is no confusion over whether it is banned. Defendants do

14

not claim they were confused over the legality of these substances.

15

Ultimately, the Defendants' arguments are ·aUbased on the same faulty premise-that §
16

37-2705(d)(30)(ii) is a stand-alone statute. That sub-sub-subsection of the statue is part of a
17
18

larger statute as discussed above. That discussion will not be repeated here. In drawing the

19

conclusion that AM-2201 is a legal substance, Defendant's experts focused on whether the

20

particular substance was described by the isolated subsection rather than on the proper question

21

6f whether the substance is "synthetic equivalents of the substances contained in the plant, or in

22

the. resinous extractives of Cannabis, sp. and/or synthetic;: substances, derivatives, and their

23

isomers with similar chemical structure ... "

In lay terms, is this substance a synthetic

24

cannabinoid?
25
26
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The following is taken from a website cited by Dr. McDougal in Exhibit 2:

1

AM-2201-A Hyperpotent Halogenated Unintended Consequence

2

With the recent legal issues surrounding certain synthetic cannabinoids in the
United States, the market has changed .

3

4

The effects of AM-2201 also appear to differ from natural cannabis and the first
generation synthetic cannabinoids, both to start and as tolerance builds. Initially
the effects are quite similar, although doses for AM-2201 are approximately a
third of JWH-018. This has resulted in matJ.y ~eports of self-reported "seasoned"
synthetic cannabinoid users having anxiety reactions as a result of apparent
overdose due to increased sensitivity to inaccurate measurement. Tolerance builds
quickly, and frequent users have reported psychedelic-style effects typically
previously only associated with high-dose oral consumption of marijuana.
<http://countyourculture.com/2011/01/12/am-2201-a-hyperpotent-halogenatedunintended-conseguence/ > last accessed April 5, 2012.

5
6
7

8
9

10
11

There is a link to comments on the same page that contain a series of commentary on AM-22O1

12

that can only lead

13

Wikipedia, the seeming source of information of choice by. the general population, contains the

14

J

the conclusion the posters are discussing a marijuaJ substitute. u

following under the entry discussing Cannabinoid:

15

Synthetic cannabinoids encompass a variety of distinct chemical classes: the
classical cannabinoids structurally related to THC, the nonclassical cannabinoids
(cannabimimetics) including the aminoalkylindoles, 1,5-diarylpyrazoles,
quinolines, and arylsulphonarnides, as well as eicosanoids related to the
endocannabinoids.

16

17
18
19
12

20

21
22
23

24
25

A sample:

DailyToker
December 3rd, 2011

REPLY

I QUOTE

Well I rnake_and sell herbal incense, AM-2201 is the active ingredie1_1t in my company's product.
I add lg of AM to 30g of Marshmallow leaf, and it last me about 10 days or so.
I have been using AM220 l for over a year now and have not noticed any ill effects ... its just like smoking weed to
me.
I guess everyone reacts differently.
<http://countyourculture.com/2011/0 l /l 2/am-2201-a-hyperpotent-halogcnated-unintended-conseguence/#cornrnents
> last accessed April 5, 2012
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Other notable synthetic cannabinoids include:
1
2

AM-2201, a potent cannabinoid receptor agorµst.
<http://en.wikipedia.org/wiki/Synthetic cannabinoid#Synthetic and patented ca
nnabinoids > last accessed April 5, 2012.

3

4
5
6
7

If this weren't enough, one has only to look at the name AM-2201. The name was given to the
chemical by its inventor. Mr. Alley is apparently engaged in the business of marketing synthetic
cannabinoids. 13 Assuming, based on his counsel's argument, that someone such as Mr. Alley

8

went looking for information to determine the nature of AM-2201, it does not great effort or
9

10

ingenuity to get from the Wikipedia entry on AM-~201 to the patent. 14 Footnote No. 1 in the

11

Wikipedia article is a link to the palnt. The patent makes clear that AM-2201 intended to

i2

mimic marijuana. It was specifically invented in the hope of discovering a compound that could

13

be used in medical research in place of marijuana. See Exhibits 111 and 112.

14

15

There is no real ambiguity or uncertainty over the nature of AM-2201. Nor is the statute
vague or incapable of being understood by a person of ordinary intelligence. The Defendants are

16

of the mistaken impression that it is somehow improper for the legislature to outlaw "thousands
17

of compounds." Defendant's claimed ambiguity only exists because Defendant's asked their
18

19

20
21

22
23
24

13

Mr. Alley did not testify and not submit any affidavit in support of the motion. His counsel argued that Mr. Alley
and the other Defendants were assiduously attempting to follow the law and were attempting to find a legal substance
to market in light of the actions of the Board of Pharmacy anq the legislature. He suggest~d by argument that Mr.
Alley is merely a businessman doing bis best to make his ~vay in the world , but there is no evidence in the record
that any Defendant, including Mr. Alley, took any particular action. Dr. Parent's letter was addressed to Counsel and
there is no evidence that any Defendant relied on Dr. Parent's opinion in any way.
14
Cf. Village of Hoffman Estates v. Flipside, Hoffman Estates, Inc., 455 U.S. 489, 501, 102 S.Ct. 1186 (1982)
holding that the technical term "roach clip" has sufficiently clear meaning in the drug paraphernalia industry such
that, without undue burden, the defendant could easily determine the meaning of the tenn, citing dictionaries
defining "roach."

25
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l

experts the wrong question. Rather than ask whether AM-2201 is described in I.C. §37-

2

2705(d)(30)(ii)(a), they should have asked the experts whether AM-2201 is a synthetic

3

cannabinoid. If they had asked that question, the answer would no doubt have been "yes."

4

5

CONCLUSION

6

AM-2201 is a schedule one substance. Tbis is so whether or not it is specifically
7

described ill I.C. §37-2705(d)(30)(ii)(a). It is on Schedule I because it is a "synthetic equivalent
8
9

10
11

of the substances contained in the plant, or in the resinous extractives of Cannabis, sp. and/or
synthetic substances, derivatives, and their isomers with similar chemical structure."

Idaho Code §37-2705(d)(3 0)(ii)(a) is

nr unconstitutionally vague nor are the 2011

12

amendments to Idaho Code §37-2705 applicable here. The Idaho Legislature intended to outlaw

13

synthetic marijuana and it did so'in terms such that a person of ordinary intelligence is on notice

14

of the conduct prohibited.

15

Defendants' Motion to Dismiss is DENIED.
16

IT IS SO ORDERED.
17
th

18

Dated this 9 day of April, 2012, nunc p,.ro tune this 6 th daY,

19

20

reenwood
istrict Judge

21

22
23

24
25

26
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CERTIFICATE OF MAILING

1
2
3

4

5
6

I hereby certify that on this ~ a y of April, 2012, I mailed (served) a true and correct

copy of the within instrument to:
ADA COUNTY PROSECUTING ATTORNEY
HEATHER REILLY/JONATHAN MEDEMA
VIA: INDERDEP ARTMENTAL MAIL
&VIA: EMAIL

7
8

ADA COUNTY PUBLIC DEFENDER
KIMBERLEY SIMMONS
VIA: INDERDEPARTMENTALMAIL

9

10
11

12

&VIA: EMAIL
RYAN HOLDAWAY/DIANE PITCHER
PITCHER & HOLDAWAY
40 W. CACHE VALLEY BLVD., STUB 3B
LOGAN UTAH 84341

I

13

14

15
16

& VIA FAX: 435-787-1200

R. KEITH ROARK
ROARK LAW FIRM
409NMAINST
HAILEY, ID 83333

17
18

19
20

& VIA FAX: 208-788-3918
JOHN MEIENHOFER
ATTORNEY AT LAW
300 W MYRTLE ST, STE 200
BOISE, ID 83702

21

& VIA FAX: 338-7808
22
23
24
25
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i

~

.

1
2

ROBS. LEWIS
/2.TTORNEY AT LAW
PO BOX 1061
BOISE, ID 83701

3

& VIA FAX: 338-1273
4
5
6

MARCO DEANGELO
RATLIFF LAW OFFICES, CHTD
290 S 2ND E
MOUNTAIN HOME, ID 83647

7

& VIA FAX: 587-6940
8
9

10

JAMES K. BALL
MANWEILER BREEN BALL & HANCOCK, PLLC
PO BOX937
BOISE, ID 83701-0937

11

& VIA

F4X: 424-3100

12
13
14
15

16
17
18
19

20
21

22
23
24

25
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IN THE DISTRICT COURT OF THE THIRD JUDICIAL DISTRICT OF THE
STATE OF IDAHO, IN AND FOR THE COUNTY OF CANYON
PRESIDING: MOLLY J. HUSKEY DATE: DECEMBER 27, 2012

THE STATE OF IDAHO,
Plaintiff,

vs.

)

)
)
)
)
)

COURT MINUTES
CASE NO: CR-2012-14826-C
CR-2012-21064-C
TIME: 8:15 A.M.

)

SHANNON M. MCKEAN,
Defendant.

________

)
)
)
)

REPORTED BY: Laura Whiting
DCRT 2 (819-850)

This having been the time heretofore set for Conclusion of Defendant's Motion

to Suppress in the above entitled matter, the State was represented by Mr. William
Fletcher, Deputy Prosecuting Attorney for Canyon County. The defendant was present
in court with counsel, Mr. Alexander Briggs.
The Court noted receipt of a Motion for Payment of Expert at County Expense,
as well as an Affidavit of lndigency
The defendant was sworn and examined by the Court.
In answer to the Court's inquiry, the State had no objection to appointment of an
expert at county expense.
The Court inquired of Mr. Briggs as to the total cost of the expert.
The Court ordered payment of services of an expert at county expense in an
amount not to exceed $2500.00; and signed an order to the same.
COURT MINUTES
DECEMBER 27, 2012

Page 1
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Mr. Briggs indicated he had no further witnesses.

Michael Eldridge was called as the State's first rebuttal witness, sworn by the
clerk, direct examined and cross examined.

Cary Salazar was called as the State's second rebuttal witness, sworn by the
clerk and direct examined.
The State rested.
The Court reviewed exhibits in evidence. Neither counsel wished to move for
admission of additional exhibits.
Mr. Fletcher made statements in Iclosing and indicated he would address the
remaining issues in his brief.
The Court noted simultaneous briefing due the 11th day of January 2013 on the
issue of probable cause.
Mr. Briggs indicated he would address his closing argument in his brief.
In answer to the Court's inquiry, Mr. Fletcher indicated the State would proceed
on the AM 2201 charges.
In answer to the Court's inquiry, Mr. Fletcher indicated the State's original offer in
this matter was to plead guilty to one (1) felony count, dismiss the remainder, and the
State would recommend probation. The defendant previously rejected the same.
In answer to the Court's inquiry, the defendant indicated she had been previously
advised of the offer as reiterated by the State.

COURT MINUTES
DECEMBER 27, 2012

Page 2
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The defendant was released on the bond previously posed in CR12-14826-C and
continued released on her own recognizance in CR12-21064-C.

Deputy Clerk

COURT MINUTES
DECEMBER 27, 2012
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Alexander B. Briggs - ISB No. 6251
BRIGGS LAW OFFICE
706 E. Chicago
P.O. Box 1274
Caldwell, Idaho 83606
Telephone (208) 459-4446
Fax (208) 459-7771

L E D

_____A.M._ _ __.P.M.

DEC 2 7 2012
CANYON COUNTY CLERK
S FENNELL, DEPUTY

Attorney for Defendant

IN THE DISTRICT COURT OF THE THIRD JUDICIAL DISTRICT OF THE
STATE OF IDAHO, IN AND FOR THE COUNTY OF CANYON

STATE OF IDAHO,
!Plaintiff,
vs.
SHANNON MARIE McKEAN,
Defendant.

--------------------

)
)
)
)
)
)
)
)
)
)
)

CASE NO. CR-2012-14826

~
ORDER FOR PAYMENT OF

SERVICES

IT APPEARlNG TO THE COURT from the records and files therein and from the
Petition for Authorization for Use of County' .ll~ds Pursuant to §19-851 and §19-852 filed by
Alexander B. Briggs, concerning expert witness, Owen McDougal, Ph.D., on behalf of the above
named defendant;
NOW, THEREFORE, IT IS HEREBY ORDERED, AND THIS DOES ORDER
That the County of Canyon, State ofidaho, pay to Owen McDougal, Ph.D., as and for expert witness
services rendered in the above entitled action, the amount of$
.

2- SOO · -

~

J+--1*AM--"---'-""----------

Dated this R_ day of Decem-~-11-e=r,"'--2....,::0_1_2.__

Dts1Jb Judge

~

CERTIFICATE OF SERVICE
I hereby certify that I served true and correct copies of the foregoing document upon
the following:
Canyon County Prosecuting Attorney
Canyon County Courthouse
Caldwell, ID 83605
Alexander Briggs
Attorney at Law
PO Box 1274
Caldwell, ID 83606
by placing a copy of the same in their respective baskets on the Second Floor Clerk's Office at the
Canyon County Courthouse, Caldwell, Idaho.
Dated this

d1

day of December, 2012.
CHRIS YAMAMOTO, Clerk

By: _ _~/a~c.-,.~..,_._j//~JV~}.__L~_·- - Deputy Clerk
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IN THE DISTRICT COURT OF THE THIRD JUDICIAL DISTRICT OF THE
STATE OF IDAHO, IN AND FOR THE COUNTY OF CANYON
PRESIDING: MOLLY J. HUSKEY DATE: JANUARY 08, 2013

THE STATE OF IDAHO,
Plaintiff,

vs.
SHANNON M. MCKEAN,
Defendant.

THE STATE OF IDAHO,
Plaintiff,
vs
TROY HARRELL,
Defendant.

)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)

COURT MINUTES

CASE NO: CR-2012-14826-C
CR-2012-21064-C

TIME: 1:30 P.M.
REPORTED BY: Laura Whiting
DCRT 5 (130-323)(338-418)(422-454)

CASE NO: CR-2012-14825-C
CR-2012-21093-C

This having been the time heretofore set for State's Motion in Limine - Day 1 in the
above entitled matters, the State was represented by Mr. William Fletcher, Deputy Prosecuting
Attorney for Canyon County.

Defendant, Shannon McKean was present with counsel; Mr.

Alexander Briggs. Defendant, Troy Harrell was present with counsel; Mr. Gregory Ferney.
The Court noted the State's Motion in Limine set to be heard this date.

The Court

indicated its understanding was this motion was in regard to whether AM 2201 was a controlled

COURT MINUTES
JANUARY 08, 2013
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substance; each of counsel concurred.

Each of counsel stated they were not contesting the

substance JWH.
The Court referenced portions of Defendant's Expert's report and inquired of Mr. Briggs.
Mr. Briggs made comments for the record.
The Court expressed opinions and further inquired of Mr. Briggs.
Mr. Briggs made further comments for the record.
The Court inquired if the State wished to have Dr. McDougal testify or if they agree with
his analysis.
Mr. Fletcher indicated the State disagreed with Dr. McDougal's analysis of alkyl.
The Court indicated it would proceed withl testimony on the narrow issue of alkyl, and
would broaden if needed.
Corinna Owsley was called as the State's first witness, sworn by the clerk and direct
examined.
State's exhibit 16 was marked by the clerk and identified as a portion of the statute,
previously House Bill 139.

Mr. Fletcher moved for admission of the Exhibit, there being no

objection it was admitted into evidence.
State's Exhibit 11 was marked by the clerk and identified as a diagram of the structure
AM 2201.

Mr. Fletcher moved for admission of the Exhibit, there being no objection it was

admitted into evidence.
State's Exhibit i 2 was marked by the clerk and identified as pages from Morrison Boyd
text book.

Mr. Fletcher moved for admission of the Exhibit, there being no objection it was

admitted into evidence.

COURT MINUTES
JANUARY 08, 2013

0
Page 2

0

State's Exhibit 15 was marked by the clerk and identified as a diagram of structure JWH122. Mr. Fletcher moved for admission of the Exhibit, there being no objection it was admitted
into evidence.
The Court recessed at 3:23 p.m.
The Court reconvened at 3:38 p.m.
The witness was cross examined.
The Court recessed at 4:18 p.m.
The Court reconvened at 4:22 p.m.
The Court reminded the witness that she was still under oath. The witness was redirect
exam1ned and re-cross examined.
The Court inquired of counsel as to language in the statute.
Mr. Briggs responded.
Mr. Fletcher responded.
The Court inquired further.
Each of counsel responded.

Deputy Clerk

COURT MINUTES
JANUARY 08, 2013
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IN THE DISTRICT COURT OF THE THIRD JUDICIAL DISTRICT OF THE
STATE OF IDAHO, IN AND FOR THE COUNTY OF CANYON
PRESIDING: MOLLY J. HUSKEY DATE: JANUARY 09, 2013

THE STATE OF IDAHO,
Plaintiff,

vs.
SHANNON M. MCKEAN,
_ _ _ _ _D._.,_ef_e_nd_a_n_t._ _ _

)

COURT MINUTES

)
)
)
)

CASE NO: CR-2012-14826-C
CR-2012-21064-C

)
)
)
)

TIME: 8: 15 A.M.

~

REPORTED BY: Laura VVhiting

1

THE STATE OF IDAHO,
Plaintiff,
vs
TROY HARRELL,
Defendant.

________

)
)
)
)
)
)
)
)
)
)
)

DCRT 5 (816-822)(835-904)(914-952)
(1105-1135)
CASE NO: CR-2012-14825-C
CR-2012-21093-C

)

This having been the time heretofore set for State's Motion in Limine - Day 2 in
the above entitled matters, the State was represented by Mr. William Fletcher, Deputy
Prosecuting Attorney for Canyon County.

Defendant, Shannon McKean was present

with counsel; Mr. Alexander Briggs. Defendant, Troy Harrell was present without his
counsel.

COURT MINUTES
JANUARY 09, 2013
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The Court noted counsel for Defendant Harrell, Mr. Gregory Ferney was not
present at this time, but would appear later this date.
understanding was Mr. Briggs would continue with questioning.

The Court indicated its
Mr. Briggs concurred.

Mr. Fletcher addressed the question(s) posed by the Court the previous day and
provided case law.
The Court recessed at 8:22 a.m., to allow Mr. Briggs time to review case law
provided.
The Court reconvened at 8:35 a.m.
Mr. Briggs responl ed.
Mr. Fletcher responded.
The Court inquired of each of counsel. Counsel responded.
The Court expressed opinions.
The Court recessed at 9:04 a.m.
The Court reconvened at 9:14 a.m.

Owen McDouglal was called as the defendant's first witness, sworn by the clerk
and direct examined.
The Court recessed at 9:52 a.m.
The Court reconvened at 10:06 a.m.
The witness was cross examined.
The Court advised Mr. Briggs it wished to have all the diagrams he used, marked
as exhibits for purposes of the appellate record.

COURT MINUTES
JANUARY 09, 2013

Page 2

Mr. Fletcher had no objection.

Defendant's Exhibit A was marked by the clerk and identified as the opinion of
Dr. Owen McDougal. Mr. Briggs moved for admission of the Exhibit, there being no
objection it was admitted into evidence.
The clerk and Bailiff marked Mr. Briggs' diagrams as Defendant's Exhibits B-G,
which were admitted for illustrative purposes.
The Court recessed at 10:33 a.m.
The Court recessed at 11 :05 a.m.
The Court noted for the record that Mr. Ferney was now present.
Mr. Fletcher presented tie State's closing argument.
Mr. Briggs presented the defendants' closing argument.
Mr. Ferney had nothing to add.
The Court presented Findings of Fact and Conclusions of Law and granted the
State's Motion in Limine.
The Court indicated it would not do written findings, merely an order granting the
motion. If the parties wish, they may request a transcript.
Mr. Fletcher inquired as to whether or not the defendants were contesting the
other substances charged.

The Court indicated its understanding was the defendants

were not contesting substances JWH-122 and JHW-210. Mr. Briggs concurred.
The Court noted that cases involving Defendant Troy Harrell, CR 12-14825-C and
CR12-21093-C would be referred back to the assigned Judge Ford.

COURT MINUTES
JANUARY 09, 2013

Page 3

In regard to cases involving Defendant, Shannon McKean, CR12-14826-C and
CR12-21093-C the Court noted the three (3) day jury trial set to commence the 4th
day of February 2013.
The Court ordered Mr. Briggs to submit witness and exhibit lists as well as
proposed jury instructions no later than the 28th day of January 2013.
In answer to the Court's inquiry, Mr. Fletcher indicated he planned to file an
additional motion in regard to the "ignorance of the law" defense.
The Court instructed Mr. Fletcher to file the motion no later than early the
following week to allow Mr. Briggs adequr e time to respond.
The Court indicated it would hear argument on the motion at the time of pretrial
conference currently set the 28 th day of January 2013 at 2:00 p.m.
The Court noted its heavy trial schedule during the month of February 2013 and
requested a notification from counsel if these matters settle.
Defendant McKean was continued released on the bond previously posted in
CR12-14825-C and on her own recognizance in CR12-21064-C.

Defendant Harrell,

was continued released on the bond previously posted in CR 12-14825-C and on his
own recognizance in CR12-21093-C.

Deputy Clerk
COURT MINUTES
JANUARY 09, 2013
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BRYANF. TAYLOR
CANYON COUNTY PROSECUTING ATTORNEY
Canyon County Courthouse
1115 Albany Street
Caldwell, Idaho 83605
Telephone: (208) 454-7391
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IN THE DISTRICT COURT OF THE THIRD JUDICIAL DISTRICT OF
THE STA TE OF IDAHO, IN AND FOR THE COUNTY OF CANYON

THE ST ATE OF IDAHO,
CASE NO. CR2012-21064
Plaintiff,
vs.
Shannon Marie McKean,

SUPPL~MENTAL BRIEF IN OPPOSITION
TO DEFENDANT'S MOTION TO
SUPPRESS

Defendant.

The State of Idaho, through its representative, Will Fletcher, hereby provides the
following supplemental briefing in opposition to the defendant's motion to suppress. At hearing,
the court requested the parties brief the issues of whether probable cause to search can arise
where the information giving rise to probable cause is obtained in violation of a defendant's
Miranda rights.
In this case, any statements obtained by police in possible violation of the defendant's
Miranda rights have no consequence upon whether or not police possessed probable cause to
conduct a warrantless search of the defendant's vehicle. This is because Miranda warnings are
not themselves rights protected by the Constitution, but are instead measures to insure a
SUPPLEMENTAL BRIEF IN OPPOSITION TO DEFENDANT'S MOTION TO SUPPRESS

defendant's right against compelled self-incrimination at trial. Michigan v. Tucker, 417 U.S. 433
(1974). The penalty for ignoring the Miranda warning requirement is the exclusion at trial of any
statements or confessions by the defendant. However, evidence discovered as a result of
statements obtained in violation of Miranda does not trigger the exclusionary rule requiring
suppression. See generally Id. In the U.S. Supreme Court case of Michigan v. Tucker, police
obtained evidence of an alibi witness through unwarned statements by the defendant. There,
however, upon speaking with the alibi witness, police were given incriminating evidence against
the defendant. In Tucker, the Court articulated that absent evidence of coercion, testimony from
the alibi witness at trial was permissible, despite the fact that police only learned of this witness
through unwarned statements by the defendant. Id.
Anolther case helpful to this issue is US. v. Patane, 542 U.S1630 (2004). There, the court
considered whether a failure to give a suspect warnings prescribed by Miranda requires
suppression of the physical evidence derived from the suspect' s unwarned but voluntary
statements. There, the Court found that because Miranda protects against violations of the SelfIncrimination Clause, a violation of a suspect's Miranda rights does not require suppression at
trial of the physical fruits of a suspect's unwarned but voluntary statements. US. v. Patane, 542
U.S. 630 (2004).
In this case, the record contains no evidence to support the conclusion that the
defendant's statements were coerced. Here, Investigator Salazar testified that he asked the
defendant, while she was in custody in the back of a police car, for the combination to her safe to
avoid having to break it in order to search it pursuant to the search warrant on the defendant's
business. In response to that question, the defendant volunteered that she had $20,000 in her
vehicle. The U.S. Supreme Court allows for the introduction of physical evidence discovered in

SUPPLEMENTAL BRJEF IN OPPOSITION TO DEFENDANT'S MOTION TO SUPPRESS 2

violation of Miranda. It follows, then, that even if a statement is obtained in violation of a
suspect' s Miranda rights, that fact has no bearing on whether those statements can be used in
support of probable cause to perform a warrantless search on the defendant's vehicle.

DATED This

I \ ~ y of January, 2013.

CERTIFICATE OF SERVICE
I HEREBY CERTIFY that on or about this
/ { rft"-day of January, 2013, I
caused a true and correct copy of the foregoing instrument to be served upon the attorney for the
defendant by the method indicated below and addressed to the following:
Alexander B. Briggs
P.O. Box 1274
Caldwell, ID 83606
FAX: 459-7771

() U.S. Mail, Postage Prepai~
() Hand Delivered
·
(X) Placed in Court Basket
() Overnight Mail
() Facsimile
() E-Mail

Deputy Prosecuting Attorney

SUPPLEMENT AL BRIEF IN OPPOSITION TO DEFENDANT'S MOTION TO SUPPRESS 3
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Alexander B. Briggs - ISB No. 6251
BRIGGS LAW OFFICE
706 E. Chicago
P.O. Box 1274
Caldwell, Idaho 83606
Telephone (208) 459-4446
FAX (208) 459-7771

JAN 1 12013
CAN~ON COUNTY CLERK
ci HILL, DEPUTY

Attorney for Defendant

IN THE DISTRICT COURT OF THE THIRD JUDICIAL DISTRICT OF THE
STATE OF IDAHO, IN AND FOR THE COUNTY OF CANYON

*****
STATE OF IDAHO,

Plaintiff,

vs.

SHANNON MARIE MCKEAN,
Defendant.

)
)
)
)
)
)
)
)
)
)
)
)

CASE NO. CR-2012-14826
CR-2012-21064

/

CLOSING ARGUMENT ON
MOTION TO SUPPRESS

--------------~)

COMES NOW The above named defendant, SAHNNON MARIE MCKEAN, by
and through counsel of record, ALEXANDER B. BRIGGS, and hereby submits her closing argument
on the Motion to Suppress held on the record before this court on December 3, 7, and 27, 2012.

FACTS

In this case, the Defendant is challenging the search of her car on June 6, 2012.
CLOSING ARGUMENT ON MOTION TO SUPPRESS EVIDENCE - 1

On that

date, members of the City County Narcotics Unit (CCNlJ) served a search warrant for the
Defendant's business located at 221 North Kimball Avenue in Caldwell.

Police officers entered

the store at approximately 4:20 p.m. and immediately ordered everyone to the ground and
handcuffed everyone in the business, including the Defendant.

At this point, the Defendant said,

" ... I want my lawyer, I would like to speak to my lawyer, or I need my lawyer."
Dec. 7 hearing).

(fr. p. 26 ln. 5-8,

After getting up off of the ground, the Defendant again requested her lawyer and

also that an audio recorder be turned on.
testimony supports these claims.

(fr. p. 27 ln. 3-12, Dec. 7 hearing).

Officer Eldridge's

Eldridge then asked the Defendant to turn over her keys, to

which the Defendant did and was told by Eldridge that he was going to lock her car for safekeeping.
(fr. p. 29 ln. 15-25, p. 30 ln. 1-24, Dec. 7 hearing).

After providing Eldridge with her keys, he took

her to a patrol car and placed her into the back rat.

A short time later, Officer Salazar escorted

Troy Harrell to where the Defendant was sitting in the back of the patrol car and began to ask her
questions.

(fr. p. 31 ln. 19-25, p. 32 ln. 1-21, Dec. 7 hearing).

Officer Salazar contends that the

Defendant made statements regarding money in a car, which is disputed by the Defendant.
44 ln. 12-25, p. 45 ln. 1-23, Dec. 3 hearing).

(Tr. p.

Officer Salazar testified that he was not aware of any

particular car involved and did not know which car the Defendant was referring to.

(fr. p. In.

24-25, p. 46 ln. 1-6, Dec. 3 hearing).

Salazar allegedly spoke with Eldridge about the Defendant

stating there was money in the car.

Eldridge did not necessarily believe that they had probable

cause to search a black Honda parked on property adjacent to the business so he consulted with a
Deputy Prosecuting Attorney, who apparently told Eldridge to go ahead and search the car.

(Tr. p.

157 ln. 11-25, p. 158-159 ln. 1-25, Dec. 27 hearing).

Upon

No search warrant was sought.

searching the car, currency in excess of $20,000 was located and collected as evidence.

Despite

testimony from both the Defendant and Officer Eldridge that an audio recording may have been
made by one of the other Caldwell Police officers, no such audio has been produced.
CLOSING ARGUMENT ON MOTION TO SUPPRESS EVIDENCE - 2

0

ARGUMENT

Searches conducted without a warrant are deemed per se violations of a person's right to be
free from unreasonable searches and seizures and will fruits from such a violation will be suppressed
unless the state can establish that one of the well-delineated, closely guarded exceptions to the
warrant requirement exists.

State v. Tucker, 132 Idaho 841,842,979 P.2d 1199, 1200 (1999); Katz v.

United States, 389 U.S. 347, 357, 88 S.Ct. 507 (1967).

One exception to the warrant requirement is

the automobile exception, which essentially dictates that a warrant is not required if the vehicle is
readily mobile and probable cause exists that the vehicle contains contraband.

Stars, 267 U.S. 132, 45 S.Ct. 280 (1925).

Carroll v. United

I

In this case the officers had no search warrant for the Defendant's black Honda Civic.

It

was not included in the search warrant because the officers did not have probable cause to believe
that it contained contraband.

In order for the state to meet their burden of establishing an

exception to the warrant requirement, it must come from any evidence obtained at the scene of the
search, the Defendant's place of business.
Inherent in the tenn probable cause is the concept of ''likely."

Even though probable cause

has been defined as a "flexible, common sense standard" and a "practical nontechnical probability
that incriminating evidence is present," it still must be based on "more likely than not."
Law Dictionary defines probable as:

"Having more evidence for than against."

Black's

That being said,

the state must show that it was like/y that contraband was in the car before it was searched.

In this case, we must look at the fact that there is no audio recording.

Without an actual

recording of the conversation, the court must determine from the testimony what was said and what
was not said.

The portions of the discussion that are disputed essentially are whether or not the

CLOSING ARGUMENT ON MOTION TO SUPPRESS EVIDENCE - 3

Defendant made statements regarding transporting product and money from a storage unit.
Officer Eldridge testified that he believed the Defendant had invoked her right to counsel prior to
Officer Salazar questioning her in the back of the patrol car.
regarding these statements came from Officer Salazar.

The only testimony from the state

The Defendant testified that she made no

such statements regarding transporting anything from the storage unit nor did she make any
statements regarding cash in the car.
The State relies on a U.S. Supreme Court case wherein there were unwarned statements
made that lead to the discovery of evidence.
(2004).

United States v. Patane, 542 U.S. 630, 124 S.Ct. 2620

Essentially the Court ruled that in such a scenario, the fruits of the poisonous tree

doctrine would not apply to the physical evidence seized.

In this case, we have an invocation of

the Defendanjs right to counsel followed by a custodial interrogation of its functional equivalent in
the back seat of a police car. The Defendant asserts that such a factual distinction from the Patane
case allows this court to make a determination that the fruit of the poisonous tree doctrine can
apply.
If the Court believes the Defendant's testimony then no probable cause can exist because

the only source of any potential probable cause would have to be established via statements made by
the Defendant.

The Defendant made no such statements, and as such the Court should suppress

the evidence.
Even if the Court believes Officer Salazar.

That is, that the Defendant made said

statements, the evidence is insufficient to make a finding that probable cause existed.

Specifically,

that it was more likely than not that contraband was present in that particular vehicle.

No

testimony was elicited that the Defendant told Officer Salazar that the black Honda was either, her
car or that it was the car used to allegedly transport the substances and money.
The state has not met their burden.

No probable cause existed.

CLOSING ARGUMENT ON MOTION TO SUPPRESS EVIDENCE - 4

The evidence must be

suppressed
CERTIFICATE OF SERVICE:

This certifies that a true and correct copy of the above and

foregoing instrument was delivered to the CANYON COUNTY PROSECUTING ATTORNEY,
by placing said document mhis box at the Canyon County Courthouse.
Dated this

/f

day ofJanuary, 2 ~

ALEXANDER B. B R I G ~
Attorney for Defendant

CLOSING ARGUMENT ON MOTION TO SUPPRESS EVIDENCE - S
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BRYAN F. TAYLOR
CANYON COUNTY PROSECUTING ATTORNEY
Canyon County Courthouse
1115 Albany Street
Caldwell, Idaho 83605
Telephone: (208) 454-7391

IN THE DISTRICT COURT OF THE THIRD JUDICIAL DISTRICT OF
THE STATE OF IDAHO, IN AND FOR THE COUNTY OF CANYON

THE STA TE OF IDAHO
CASE NO. CR2012-14826/CR2012-21064
Plaintiff,
vs.
Shannon Marie McKean

MOTION IN LIMINE TO PRECLUDE THE
DEFENDANT'S EVIDENCE AND
I
ARGUMENT OF IGNORANCE OF THE
LAW AND MISTAKE OF FACT

Defendant.

The state ofldaho, through its representative, Will Fletcher, Deputy Canyon
County Prosecuting Attorney, hereby respectfully moves this court in limine to preclude the
defendant, during all stages of trial, from offering any evidence, testimony, comment, or
argument regarding any claimed ignorance of the law, mistake of fact, or lack of knowledge that
the substances possessed or delivered were controlled substances.
The state anticipates the defense will attempt to present evidence and argue to the jury
that the defendant did not know the substances she is alleged to have possessed and/or delivered
were controlled substances, did not know it was against the law to possess such substances, or
MOTION IN LIMINE TO PRECLUDE
THE DEFENDANT'S EVIDENCE AND
ARGUMENT OF IGNORANCE OF THE
LAW AND MISTAKE OF FACT

was mistaken regarding the type of substances she possessed. The state makes this motion on the
grounds that the above arguments and evidence are not relevant toward proving or disproving the
elements of possession of a controlled substance or delivery of a controlled substance under LC.
37-2732. Under IRE 402, irrelevant evidence is not admissible.
Ignorance of the law is not a defense. State v. Fox, 124 Idaho 924, 866 P.2d 181 (1993).
This rule has been further explained in Idaho Criminal Jury Instruction 1511, which states:
When the evidence shows that a person voluntarily did that which the law
declares to be a crime, it is no defense that the person did not know that the act
was unlawful or that the person believed it to be lawful.
The Idaho Supreme Court's holding in Fox states that when a defendant is charged with
possession of a controlled substance, the onl;1lintent element at issue is whether the defendant
knowingly possessed the substance, not whet er the defendant knew the substance was an illegal
substance. 124 Idaho 924, 866 P.2d. The Fox case involved a defendant on trial for possession of
ephedrine in violation of I.C. 37-2732(c). Id. In Fox, the defendant claimed he did not know that
ephedrine was illegal and attempted to introduce evidence to that effect at trial. Id. at 926, 866
P.2d at 18. At issue in Fox was whether a defendant charged with possession of a controlled
substance could assert an ignorance of the law defense. Id. The Court viewed this as a mistake of
law claim. Id.
In its holding, the Idaho Supreme Court stated that a defendant charged under I.C. 372732(c) could not claim as a defense a good faith mistake of law. Id. The Court also stated that
I.C. 37-2732(c) does not expressly require any mental element, and that the offense of possession
of a controlled substance only requires a general intent that one is in possession of the substance.
MOTION IN LIMINE TO PRECLUDE
THE DEFENDANT'S EVIDENCE AND
ARGUMENT OF IGNORANCE OF THE
LAW AND MISTAKE OF FACT
2

Id. at 926, 866 at 183. In other words, the statute does not require the state prove the defendant

knew the substance was a controlled substance. Thus, the court found, that the district court was
correct in refusing any evidence tending to establish the defendant's lack of knowledge that
ephedrine was a controlled substance, holding that such evidence was irrelevant. Id. at 926, 866
P.2d at 183.
The facts and issues in the Fox case have many parallels to the present case. In Fox, the
defendant ordered the ephedrine from an out-of-state mail order distributor. Id at 925, 866 P.2d
182. At the time of the Fox opinion, ephedrine was a legal, over-the-counter drug in some states,
but was a Schedule II substance in Idaho. Id. Here, like in Fox, regulations regarding the
controlled substances at issue vary by state; what is illegal in Idaho may not be legal in other
/tates, and vice versa. In this case, the state anticipates pfroviding evidence at trial that the
defendant mail ordered synthetic marijuana from the internet from distributors in other states.
The defendant also made statements to police that she did not know the substances she is alleged
to have possessed were controlled substances and had taken measures to ensure that the
substances she ordered were "DEA complaint" or in other words, were not regulated under
federal law. The defendant did state, though, that she did not check to see if the substances she
possessed were regulated under Idaho Law.
However, as the Idaho Supreme court articulated in the Fox opinion, such defenses are no
defense under the law and are not relevant under IRE 402. Accordingly, the state seeks an order
precluding the defense from making any reference or argument, or providing any evidence or
testimony regarding any claimed ignorance of the law or claim that the defendant did not know
the substances possessed are controlled substances.
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Similarly, the Idaho Court of Appeals has also ruled that a defendant's claimed mistake
of fact is no defense where such criminal intent is not an element of the crime. State v. Simpson,
137 Idaho 813, 54 P.3d 456 (Ct. App. 2002). As the Idaho Supreme Court made clear in Fox,
possession of a controlled substance is a general intent crime. State v. Fox, 124 Idaho, 924, 92526, 866 P.2d 181, 182-83 (1993). The Court explained that proving this intent is satisfied by
showing the defendant knowingly possessed; there is no requirement to show the defendant
specifically intended to possess an illegal substance or specifically knew the substance she
possessed was illegal. Id. at 926, 866 P .2d at 183. As a result, any defense by the defendant in
this case that she believed the substances she is alleged to have possessed were legal or that she
took measures to ensure that the types of synthetic marijuana she possessed was not illegal is
also an irrllevant mistake of fact defense prohibited under Simpsol
The Simpson, the defendants were charged with possession of an unlawfully taken elk
under I.C. 36-502(b). 137 Idaho at 814, 54 P.3d at 457. There, the defendants claimed at trial that
they believed in good faith that their hunting took place on public lands, which would have made
their possession legal. Id. The defendant's characterized their defense as a mistake of fact claim
going to the intent element of the charge. Id. at 816, 54 P.3d at 459. In Simpson, the Court of
Appeals held that whether a defendant's claimed mistake of fact constitutes a defense turns upon
the language of the statute charged and the mental state, if any, that is legislatively required as an
element of the offense. Id. However, like Idaho's possession of a controlled substance statute, the
statute at issue in Simpson contains no requirement that the state prove criminal intent to violate
the law. Instead, both statutes are violated by the act of possession. See Id. at 817, 54 P.3d at 460.
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In Simpson, the Court of Appeals stated, "The burden is placed upon the actor to ascertain at his
peril whether his deed is within the probation of the statute. Id.
In this case, any claimed defense that the defendant believed the substances she possessed
were legal is not a viable defense under I.C. 37-2732. Citing the Idaho Supreme Court's
precedent in State v. Sterrett, the Court of Appeals in Simpson stated that "Error cannot be
predicated upon the action of the court in excluding evidence tending to show the defendant's
good intention and good faith, where a criminal intent is not a necessary element of the offense
charged." Simpson, 137 Idaho at 816, 54 P.3d at 459 (quoting State v. 35 Idaho, 580, 58283, 207
P. 1071, 1072 ( 1922) ). As a result, the state moves this court for an order precluding the
defendant from at any stage of trial making comment, argument, or introducing evidence related
to the defendant's claimed mistake of fact that the substances she possessed jere legal.
CONCLUSION
Based on the above, the state respectfully requests the court preclude the defendant at all
stages of trial-including vior dire, opening statements, evidence, or closing arguments-from
making any comment, argument, or presenting any evidence or testimony regarding any mistake
of fact or law concerning the controlled substances in question. The state further requests the
court provide the jury with instructions stating that a mistake of law and a mistake of fact are not
defenses to the alleged offenses.
DATED this

f ¥ : ~ a y of

January, 2013.

Deputy Prosecuting Attorney
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CERTIFICATE OF SERVICE

[r}---

I HEREBY CERTIFY that on or about this
J
day of January, 2013, I
caused a true and correct copy of the foregoing instrument to be served upon the attorney for the
defendant by the method indicated below and addressed to the following:
Alexander B. Briggs
P.O. Box 1274
Caldwell, ID 83606
FAX: 459-7771

() U.S. Mail, Postage Prepaid
() Hand Delivered
(X) Placed in Court Basket
() Overnight Mail
() Facsimile
() E-Mail
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